location^key^class^originating_source^type^identifier_local^identifier_url^name^description_full^description_brief^electronic_url^doi^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014703"^"http://purl.org/au-research/grants/nhmrc/2014703"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SMARTERscreen: A randomised controlled trial of patient SMS messaging in general practice to increase participation in the National Bowel Cancer Screening Program,Targeted Call for Research"^"Most people invited to take part in free screening for bowel cancer do not participate. We will test whether a personalised SMS from the doctor, to their patients phone, will people completing and returning the home test kit sent. The SMS will contain a message from the person's doctor recommending they do it, a video testimonial from someone affected by bowel cancer, a link to the website of the screening program for more information, and an animation of how to complete the home test kit."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014837"^"http://purl.org/au-research/grants/nhmrc/2014837"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A breakthrough approach to define screening gaps in priority groups to target screening,Targeted Call for Research"^"Improving breast screening participation requires accurate data of screening rates including within priority groups such as Aboriginal and Torres Strait Islander women, women from diverse cultural and language backgrounds and with different levels of educational attainment and income. Linkage between Census and NSW screening records can provide best evidence of screening rates overall, within priority groups, and following the impact of COVID and previous attempts to improve screening."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014908"^"http://purl.org/au-research/grants/nhmrc/2014908"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people,Targeted Call for Research"^"Aboriginal and Torres Strait Islander people face an unfair burden of cervical cancer. A new screening option lets people take their own sample; this may make screening easier. Working with communities and health services dedicated to Aboriginal and Torres Strait Islander health needs we will co-design ways services can use self-collection and other strategies that best suit them and their communities. This work will engage more people to participate in screening in a culturally safe environment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014964"^"http://purl.org/au-research/grants/nhmrc/2014964"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"MAIL, GP, and SCALE: Mobilising nAtIonaL bowel cancer screeninG Program participation through combining individual, health ServiCe, and populAtion Level intervEntions,Targeted Call for Research"^"We aim to better understand how Australians are screening for bowel cancer and design a new method for GPs to advocate for the National Bowel Cancer Screening Program, especially for people who screen outside the program but should not and those who have never or forgotten to screen. This project will take new and existing information on ways in which we can improve screening for bowel cancer and assess how they could be combined most effectively to prevent the greatest number of deaths."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015178"^"http://purl.org/au-research/grants/nhmrc/2015178"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"It’s a gamechanger” – using HPV self-collection to improve equity and participation in Australia's National Cervical Screening Program,Targeted Call for Research"^"Integrating self-collection into Australia’s National Cervical Screening Program has game-changing potential to increase participation. We know that healthcare providers need more support to offer this option, and women need information to support decision-making. Our project will enable innovative solutions to support providers, women, and the scale-up of self-collection, and create an enabling environment for the consideration of models of care to increase access and equity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015215"^"http://purl.org/au-research/grants/nhmrc/2015215"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Overcoming Inequity: Increasing Cervical Screening Participation for People with Intellectual Disability (CIRCE),Targeted Call for Research"^"People with intellectual disability (PWID) are under-screened for cervical cancer in Australia. Through a qualitative process, this project seeks to identify facilitators and barriers to screening. A cluster randomised controlled trial will be undertaken to test the effectiveness of a co-designed, co-produced suite of resources designed to support informed decision making and increase access and uptake of screening in the National Cervical Screening Program for PWID."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015286"^"http://purl.org/au-research/grants/nhmrc/2015286"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"BreastScreenPlus: A novel intervention targeting obesity-related barriers to mammographic screening,Targeted Call for Research"^"Eight breast cancer deaths are prevented for every 1,000 women aged 50-74 years who undergo biennial mammographic screening. However, despite the demonstrated benefits of (free) screening, many women fail to return for screening when next due. This project will evaluate a novel intervention nested within BreastScreen WA to improve the screening experience for both obese women and service delivery staff and thereby, increase rescreening participation in women with obesity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015290"^"http://purl.org/au-research/grants/nhmrc/2015290"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A preference-informed model to improve access and equity in bowel screening for Australia’s First Nations people through home care services,Targeted Call for Research"^"Bowel cancer is the third-most common cancer affecting Aboriginal and Torres Strait Islander Australians. Participation in the National Bowel Cancer Screening Program by Aboriginal and Torres Strait Islander people is lower than for non-Indigenous Australians. This project aims to increase participation among the Aboriginal and Torres Strait Islander Home Care Clients by co-developing and implementing a bowel cancer screening program that is informed by their preferences and values."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2007402"^"http://purl.org/au-research/grants/nhmrc/2007402"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying the predictors and consequences of disparities in the uptake of HIV prevention and treatment programs in Australia: a national data linkage study,Partnership Projects"^"We will create a national e-cohort of people with HIV, linking HIV diagnoses from 1997-2025 with nine other national datasets. This comprehensive dataset will enable us to achieve our aims of tracking and analysing: missed clinical opportunities for HIV testing, PrEP uptake and usage, HIV treatment uptake and adherence, and HIV-related morbidity and mortality. Outcomes will be used by Partner Organisations to develop tailored HIV programs, to achieve elimination of HIV transmission in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2013921"^"http://purl.org/au-research/grants/nhmrc/2013921"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A national program to scale-up point-of-care hepatitis C testing and treatment,Partnership Projects"^"Hepatitis C testing and treatment has declined in Australia, slowing elimination progress. Our team evaluated a new point-of-care test for detection of active hepatitis C infection in one hour, enabling same-visit diagnosis and treatment. This test is now approved in Australia and has changed how testing and treatment can be delivered. This Partnership Project will evaluate a national program funded by the Australian government to scale-up point-of-care hepatitis C testing in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014633"^"http://purl.org/au-research/grants/nhmrc/2014633"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A non-surgical alternative to hysterectomy for the treatment of endometrial cancer,Partnership Projects"^"This project aims to develop a personalised treatment decision tool used to counsel endometrial cancer patients about their surgical and non-surgical (hormonal) treatment options. It will take into account key attributes of importance such as fertility preservation, risk of surgical morbidity, risk of relapse, genetic factors, quality of life, patient values and treatment preferences. This work is of critical importance for patients with early onset endometrial cancer, and for frail patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014684"^"http://purl.org/au-research/grants/nhmrc/2014684"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel strategies to improve protection for pregnant women and medically at risk children from influenza and COVID-19,Partnership Projects"^"Pregnant women and children with chronic medical conditions are at increased risk of hospitalisation, intensive care admission and death from influenza and COVID-19 infections. However, there appears to be a high level of vaccine hesitancy among women of reproductive age. We will develop “nudge” interventions to improve influenza and COVID vaccine uptake among pregnant women and medically at risk children and test the effectiveness of the interventions using randomised controlled trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014821"^"http://purl.org/au-research/grants/nhmrc/2014821"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising functional and social independence and safety of older people living with dementia in care homes: Implementation research,Partnership Projects"^"This program builds on true collaboration with the project partner organisations and decades of the research team's track records in promoting evidence informed best practice in dementia care, leveraging their extensive network of partners in research and the aged-care industry. The outcomes will inform researchers, service providers and policymakers working in the aged care sector about implementation of person centred, reablement approaches to dementia care, nationally and internationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015197"^"http://purl.org/au-research/grants/nhmrc/2015197"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An integrated platform for the early diagnosis and treatment of biotoxin-related illnesses in Australia like Chronic Inflammatory Response Syndrome,Targeted Call for Research"^"While many studies now suggest that living in dampness and mould can adversely affect the immune system in some people, few studies define tests that doctors could use to diagnose and treat affected individuals. This research project will study both affected individuals and healthy controls, examining their blood, urine, and sweat along with other tests such as brain scans and environmental testing in their homes, in order to identify appropriate diagnostic tests that doctors can use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014696"^"http://purl.org/au-research/grants/nhmrc/2014696"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Indigenous Australian HPV Cohort Study 2; continuation 5 to 10 years,Clinical Trials and Cohort Studies"^"Continuing a large, representative Indigenous adult cohort through which to track oral HPV infection, monitor early throat cancer and estimate cost-effectiveness of extensive HPV vaccination coverage in culturally safe ways is essential to yield critical information to include in the management armamentarium of health and wellbeing recommendations for Australia’s First Peoples."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014723"^"http://purl.org/au-research/grants/nhmrc/2014723"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"INTErGenerational intervention to Reduce fraIlTY trial (INTEGRITY).,Clinical Trials and Cohort Studies"^"The recent ABC TV show ‘Old People’s Home For Four Year Olds’ shows on-screen benefits of bringing together older adults and pre-schoolers. This has enormous potential to benefit our ageing society and similar programs are becoming popular. but a TV show is not the same as everyday life. We now need to establish how these benefits work in a realistic everyday setting. We will test this using a community-based clinical trial: the INTErGenerational Intervention to Reduce fraIlTY trial (INTEGRITY)."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014729"^"http://purl.org/au-research/grants/nhmrc/2014729"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Making Inroads: RCT of a web-based early intervention to interrupt the vicious cycle of co-occurring anxiety and hazardous alcohol use among young adults,Clinical Trials and Cohort Studies"^"Anxiety and alcohol disorders often co-occur, fueling each other in a self-perpetuating cycle. Early intervention is crucial to engage people with effective management strategies when problematic symptoms first emerge, and before anxiety and alcohol use disorders become entrenched. This study will evaluate the Inroads program, an online early intervention to empower young adults, enhance coping skills, and interrupt the vicious cycle between anxiety and hazardous alcohol use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014740"^"http://purl.org/au-research/grants/nhmrc/2014740"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study (CALIPSO): multicentre, adaptive, double-blind, three-arm, placebo-controlled, non-inferiority trial examining antimicrobial prophylaxis duration in cardiac surgery,Clinical Trials and Cohort Studies"^"Infections following surgery lead to significant patient suffering and healthcare costs. The administration of antibiotics at the time of surgery is an important strategy to prevent infections. In patients undergoing heart surgery we do not know whether there is an additional benefit to giving longer courses of antibiotics following surgery to help prevent infections or if this will lead to patient harm, such as drug-resistant infections. This project will answer these important questions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014750"^"http://purl.org/au-research/grants/nhmrc/2014750"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PRECeDe: Prevention of neonatal Respiratory morbidity with antenatal corticosteroids prior to Elective Caesarean section in women with Diabetes: A Randomised trial,Clinical Trials and Cohort Studies"^"This research trial will determine whether giving corticosteroid injections to pregnant women with diabetes before elective Caesarean section between 35+0 and 39+6 weeks reduces the rate of breathing problems in their babies. We will study the short-term benefits and side effects in the mothers and babies, and also determine whether giving corticosteroid injections is good value for money."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014763"^"http://purl.org/au-research/grants/nhmrc/2014763"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Epigenetic Protection Predicts Risk Diabetic Nephropathy (EPICENTRE),Clinical Trials and Cohort Studies"^"Diabetes affects over 1 million Australians and disproportionately affects Indigenous Australians. We have established an international EPICENTRE consortium now seek to explore the potential role of epigenetic modifications to explain the development of diabetic renal disease. Over the last decade we have developed contemporary genomic technologies and new approaches that specifically characterise epigenetic modifications using overt renal disease as the primary outcome."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014800"^"http://purl.org/au-research/grants/nhmrc/2014800"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalised Selection of Medication for Newly Diagnosed Adult Epilepsy – the PERSONAL Trial,Clinical Trials and Cohort Studies"^"We have trained a machine learning prediction model that can assist neurologists to select the most effective initial antiseizure medication for individual patients with newly diagnosed epilepsy. We propose a randomised controlled trial (PERSONAL) to evaluate whether incorporating the machine learning model in initial drug selection can render more patients seizure-free compared to usual care. A total of 234 patients will be recruited from 14 epilepsy centres across all six states of Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014833"^"http://purl.org/au-research/grants/nhmrc/2014833"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A primary care provider intervention to improve early child neurodevelopment in Urban Aboriginal children,Clinical Trials and Cohort Studies"^"Despite a high level of developmental issues in Aboriginal babies, there has been no primary health care delivered early child development program starting in the first 4 weeks of life. We will address Aboriginal child’s development by improving primary health care’s ability to deliver child development services. We will do this by seeing if the CCD program commenced in the first 4-weeks of life will improves a child’s developmental needs in the first year of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014841"^"http://purl.org/au-research/grants/nhmrc/2014841"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The LifeTrack Project: Population-based longitudinal cohort study to understand suicidal transitions,Clinical Trials and Cohort Studies"^"We don't understand why some people who think about suicide go on to make a suicide attempt, while others recover. There have been very few studies following individuals at risk of suicide over an extended time period. We will test a group of people with suicidal thoughts for three years to work out whether there are certain types of people who are more resistant to suicide attempt. We will use the information from the study to identify new ways to reduce suicide risk in the population."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014868"^"http://purl.org/au-research/grants/nhmrc/2014868"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis,Clinical Trials and Cohort Studies"^"Tuberculosis (TB) is an infectious respiratory disease affecting 10 million people each year worldwide. Resistance to isoniazid, one of the most important first-line antibiotics used to treat TB, leads to increased mortality and more advanced drug resistance. We will undertake the first clinical trial to evaluate the effectiveness of new-generation fluoroquinolones antibiotics in treating isoniazid-resistant TB. This trial will be conducted in Australia, Vietnam and Canada."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014896"^"http://purl.org/au-research/grants/nhmrc/2014896"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Are calcium channel blockers associated with breast cancer? Assessing the impact of long-term use in large longitudinal cohorts,Clinical Trials and Cohort Studies"^"Breast cancer is the commonest cancer in women. Calcium channel blockers (CCBs) are frequently used worldwide to treat high blood pressure. A link between use of CCBs and breast cancer has been proposed with mixed findings in North American, European and Asian women. No data exist for Australian women or across populations. Since 1 in 8 Australian women will be diagnosed with breast cancer by age 85 years, it is important to determine whether this risk is increased by the use of CCBs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014899"^"http://purl.org/au-research/grants/nhmrc/2014899"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Perinatal depression and antidepressants treatment: wave 7 follow up of the MPEWS longitudinal cohort study,Clinical Trials and Cohort Studies"^"When examining the longer term outcomes from pregnancy treatment with antidepressants on maternal depression and on child developmental outcomes, randomized controlled trials for antidepressants are not ethically possible and as such cohort data are required. Currently there remains uncertainty about antidepressant treatment in pregnancy for clinicians and women. We will address this gap in cohort studies through undertaking a follow up wave of a prospective longitudinal pregnancy cohort study."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014900"^"http://purl.org/au-research/grants/nhmrc/2014900"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SNAP-PY: Staphylococcus aureus Network Adaptive Platform trial for Paediatrics and Youth,Clinical Trials and Cohort Studies"^"Staphylococcus aureus is the most common cause of bloodstream infections resulting in hospital admission for children. The best antibiotic treatments for children are not known. The Staph aureus Network Adaptive Platform trial for Paediatrics and Youth (SNAP-PY) will find out the best antibiotic treatments for children and adolescents. This will optimise antibiotic treatment for children with Staph aureus bloodstream infections and reduce premature deaths."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014930"^"http://purl.org/au-research/grants/nhmrc/2014930"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translatable Evidence To Improve Lung Health Outcomes In First Nations People – A Cohort Study From Birth to 6 Years,Clinical Trials and Cohort Studies"^"Good lung health as an adult depends on how healthy we are as children. Good lung health predicts future heart health and how long we live. First Nations children have unacceptably high rates of lung disease which means poorer adult health. There are certain exposures or events in childhood that can be protective or damaging to our lungs. This research will look at a range of these exposures and events and study them in detail to discover ways to help improve the health of FirstN People."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014932"^"http://purl.org/au-research/grants/nhmrc/2014932"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Can mass drug administration reduce the incidence of adverse perinatal outcomes and other health consequences of endemic sexually transmitted infections? A community effectiveness trial,Clinical Trials and Cohort Studies"^"Sexual and reproductive health is an urgent global public health priority in Fiji and the Pacific region, where curable sexually transmitted infections (STIs) are endemic. This world first trial will use mass drug administration with azithromycin to reduce the prevalence of chlamydia and gonorrhoeae in a population of &gt;180,000 people in Fiji and will be the first to measure the effect of MDA on serious complications of STIs in the general population."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014936"^"http://purl.org/au-research/grants/nhmrc/2014936"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ICON9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian cancer,Clinical Trials and Cohort Studies"^"In Australia ovarian cancer is the most common cause of gynaecological cancer death. Despite surgery and chemotherapy 80% of affected women have cancer relapse which is ultimately fatal. This international randomised clinical trial examines if combining 2 targeted therapies, cediranib and olaparib tablets taken after finishing chemotherapy, will help women live longer without cancer progression. The trial will complete recruitment in 2022 and this funding will ensure patient follow-up continues"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014937"^"http://purl.org/au-research/grants/nhmrc/2014937"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Resuscitation in Paediatric Septic Shock using Mega-Dose Vitamin C and Hydrocortisone - A Randomised Controlled Multicentre Trial (RESPOND study),Clinical Trials and Cohort Studies"^"Globally, a child dies from sepsis every 10 seconds; in Australia, a child dies every week. Many surviving children experience long term adverse outcomes. Australian states are implementing mandates for sepsis treatment. Yet, the evidence for sepsis treatment other than antibiotics is limited. We will perform an international study for children with sepsis which will test the use of mega-dose vitamin C and steroids - a promising treatment that has already shown some benefit in adults."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014952"^"http://purl.org/au-research/grants/nhmrc/2014952"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding intergenerational change in the health and well-being of older adults and its effects: The Sydney Memory and Ageing Study 2.,Clinical Trials and Cohort Studies"^"Has there been a generational change in health of older Australians? We aim to compare the cognitive, physical, psychological and social health of current older Australians and those from 17 years ago. Each generation undergoes different experiences compared to previous ones; these can effect health. We will repeat and expand (using new technology) on our 2005+ survey of 1037 70-90 year olds to answer this question. Answers will shed light on protective factors and inform health planning."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014954"^"http://purl.org/au-research/grants/nhmrc/2014954"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"AAT-APP Trial: A RCT of alcohol approach-avoidance training to reduce heavy drinking in people with alcohol use disorders,Clinical Trials and Cohort Studies"^"When people undergoing alcohol treatment are given computerised training to avoid alcohol images, and approach positive images instead, it reduces their likelihood of relapsing. We have developed and tested the world’s first smartphone app that delivers a personalised version of this “approach/avoidance training” (“AAT-App”). We now aim to determine how effective AAT-App is at reducing alcohol use and craving in a large sample of people with alcohol dependence who are not receiving treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014960"^"http://purl.org/au-research/grants/nhmrc/2014960"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SODA-BIC: Sodium Bicarbonate For Decompensated Metabolic Acidosis in the Intensive Care Unit, A Multicentre, Randomised, Double-Blind Clinical Trial,Clinical Trials and Cohort Studies"^"Metabolic acidosis is a term that means that the blood is acidic. Patients with this condition are typically very ill and may die. No specific therapy exists, but sodium bicarbonate (a cheap and widely available drug) may improve the condition of these patients. We will randomly (like tossing a coin) treat severe patients with either sodium bicarbonate or inactive fluid given into a vein by continuous drip. We will compare the mortality rate and the use of haemodialysis within the first 30 days."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2014980"^"http://purl.org/au-research/grants/nhmrc/2014980"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence,Clinical Trials and Cohort Studies"^"Cannabis use is increasing in Australia, yet there are few effective treatments for cannabis dependence. This study will evaluate cannabidiol (CBD) combined with counselling to reduce illicit cannabis use and improve health and social outcomes, compared to placebo in a randomised trial with 250 participants across services in NSW and Victoria. Aboriginal people comprise 20% of people in treatment for cannabis, and we will purposively examine their outcomes and experiences in the study."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015020"^"http://purl.org/au-research/grants/nhmrc/2015020"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Magnetic Resonance imaging outcomes in the Colchicine After Stroke to Prevent Event Recurrence (MR-CASPER) trial,Clinical Trials and Cohort Studies"^"MR-CASPER is a multi-centre, prospective, randomised, double-blind trial of the anti-inflammatory agent colchicine to prevent recurrent stroke and rapid progression of atherosclerotic disease. The trial uses novel, serial Magnetic Resonance Imaging (MRI) of the brain and cerebral blood vessels to measure outcomes alongside cognitive, mood and quality of life assessments. MR-CASPER will give crucial mechanistic insights into the effects of colchicine on brain and blood vessel inflammation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015060"^"http://purl.org/au-research/grants/nhmrc/2015060"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Childhood febrile convulsions - do treatment patterns determine the risk of early recurrence?,Clinical Trials and Cohort Studies"^"A febrile convulsion in a young child is incredibly stressful. Parents often think their child is dying. Currently, no specific treatment is offered to parents when their child is discharged from hospital. Our research, to be conducted across 25 hospitals, will compare the current "wait and see" approach to treatment recommendations for regular doses of paracetamol or ibuprofen to control fevers. We hope to test if the new treatment reduces the risk of more seizures occurring in the same illness"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015100"^"http://purl.org/au-research/grants/nhmrc/2015100"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Accelerating clot lysis in ischemic stroke with dornase alfa in an Umbrella Bayesian Optimised Phase 2 trial,Clinical Trials and Cohort Studies"^"Stroke remains a major cause of disability. Clot-dissolving medicines targeting fibrin can be rapidly delivered at most Australian hospitals. DNA extruded by white blood cells is another key structural component of clot. Dornase, an approved medicine for other diseases, dissolves DNA and we showed accelerated clot dissolving when combined with standard treatment. Our trial will test whether dornase can accelerate restoration of blood flow to improve outcomes in up to 300 patients with stroke."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015133"^"http://purl.org/au-research/grants/nhmrc/2015133"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Avatar-mediated therapy for hallucinations: superiority trial (AMETHYST),Clinical Trials and Cohort Studies"^"Hearing hostile and critical voices is a highly distressing experience that characterises psychosis. Current treatments have limited impact, and more potent therapies are urgently needed. A promising new approach uses virtual reality technology to recreate the voices the person hears as digital avatars, used in therapy sessions to help overcome this experience. This clinical trial will determine whether this therapy offers a more powerful therapeutic option than current recommended treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015140"^"http://purl.org/au-research/grants/nhmrc/2015140"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Surfactant Treatment Method for Modern Neonatal Care: SURFactant by SUPraglottic Airway (The SURFSUP RCT),Clinical Trials and Cohort Studies"^"This trial will assess a new method of giving surfactant treatment into the lungs of premature babies with breathing difficulties. 'Supraglottic airway' are soft plastic devices that are easier to insert and more comfortable than current methods, which are challenging to learn and not possible for some neonatal units. We will test the effectiveness of supraglottic airway surfactant treatment, which will allow all babies who need surfactant to receive it in their birth hospital without delay."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015146"^"http://purl.org/au-research/grants/nhmrc/2015146"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"EFFECT OF A VAPORISED NICOTINE PRODUCT vs VARENICLINE ON SMOKING CESSATION FOR LOW-SOCIOECONOMIC STATUS SMOKERS: A RANDOMISED TRIAL,Clinical Trials and Cohort Studies"^"Smoking cessation aids can support long-term smoking cessation, but quit rates from current approaches remain low. VNPs are one such approach that has shown some promise for cessation, but government and regulatory bodies have called for more trial evidence. Newer generation pod VNPs have not been evaluated in a clinical trial despite their popularity and wide use globally. Trial findings will have immediate practical applications and provide much needed evidence on a new alternative quit aid."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015147"^"http://purl.org/au-research/grants/nhmrc/2015147"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"ORVAC Stage 2 - Optimising Rotavirus Vaccine in Aboriginal Children: a double-blind, randomised, placebo-controlled, adaptive clinical trial of a third scheduled dose of oral rotavirus vaccine for Australian Aboriginal children.,Clinical Trials and Cohort Studies"^"Rotavirus can cause such bad diarrhoea in children that they need to be hospitalised. Aboriginal children in remote and rural parts of Australia are up to 20 times more likely to need hospitalisation with rotavirus than non-Indigenous children. There is a vaccine for rotavirus. Optimising Rotavirus Vaccination in Aboriginal Children (ORVAC) will test whether giving Aboriginal children aged 6-11 months an extra (booster) dose of rotavirus vaccine will give them better protection from rotavirus."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015173"^"http://purl.org/au-research/grants/nhmrc/2015173"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"NUDG-ED: Trial of behavioural ‘nudging’ interventions to reduce unnecessary care for low back pain in the Emergency Department,Clinical Trials and Cohort Studies"^"In 2018 over 120 000 people went to an emergency department in Australia because of low back pain. Most had 'simple' low back pain, where medical care such as diagnostic imaging (x-Ray, CT, MRI) and strong opioid medicines offer little benefit. Yet 3 in every 4 patients still received this kind of care. Unnecessary care can harm patients and diverts substantial resources from where they are most needed. This project tests a new way to reduce unnecessary care in Australian hospitals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015177"^"http://purl.org/au-research/grants/nhmrc/2015177"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving health outcomes in people with a dual diagnosis released from prison: a multi-jurisdictional, prospective cohort study,Clinical Trials and Cohort Studies"^"People released from prison have poor health and die at a rate much higher than the general community. Among this already vulnerable group, people with co-occurring mental health and substance use problems (‘dual diagnosis’) are particularly at risk. This study will examine health and health service outcomes for 4,232 adults released from prisons in QLD, WA, NSW and VIC, and followed for more than 9 years through data linkage. The findings will inform improvements to throughcare nationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015203"^"http://purl.org/au-research/grants/nhmrc/2015203"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Maternal and early life origins of adolescent menstrual disorders and pelvic pain,Clinical Trials and Cohort Studies"^"Menstrual disorders – irregular, heavy, or painful periods – and pelvic pain are common among adolescent girls and disrupt life activities. Not enough is known about the maternal and early life factors linked with these conditions. This study addresses evidence gaps with new data on menstruation in adolescence, combined with previous data available from these girls and their mothers. The new knowledge on the development of these conditions will inform and guide their prevention and management."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015208"^"http://purl.org/au-research/grants/nhmrc/2015208"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"‘The Next Generation Aboriginal Youth Cohort Study’: Co-designing a strengths-based study to identify evidence-based, culturally strong, implementable strategies to improve youth health outcomes,Clinical Trials and Cohort Studies"^"The project aims to undertake two waves of follow-up of young Aboriginal people from the 'Next Generation Youth Wellbeing study' in partnership with young people, their families and Aboriginal Community organisations. The study will examine changes in key health outcomes (social and emotional wellbeing, cardiovascular risk factors and avoidable injury) and factors that impact on those outcomes such as connection to culture, health behaviours and social challenges."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015248"^"http://purl.org/au-research/grants/nhmrc/2015248"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Testing an implementable strategy to improve infant skin barrier to prevent asthma and preserve lung function: a 4-year follow-up of the existing PEBBLES RCT,Clinical Trials and Cohort Studies"^"We will test if improving the infant skin barrier by using daily regular skincare treatment can reduce early life asthma and lung function deficits. This trial may change infant skincare practices and reduce the amount of respiratory disease in our community. This is a follow-on study of our large NHMRC funded trial, testing if this intervention can improve skin barrier, and reduce the incidence of allergic sensitisation and food allergy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015584"^"http://purl.org/au-research/grants/nhmrc/2015584"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre for Safe Air,Centres of Research Excellence"^"Outdoor air hazards like allergens, traffic emissions, and smoke cause a substantial health burden by contributing to diseases of the lungs, heart and brain. Some threats, like bushfire smoke, are increasing but research and policy responses remain fragmented across health and environmental fields. We will bring together experts, policymakers, and consumers to create synergistic, innovative solutions for protecting community health in the face of existing and escalating airborne threats."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015587"^"http://purl.org/au-research/grants/nhmrc/2015587"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Violence Perpetration: Profiling, Prediction and Prevention,Centres of Research Excellence"^"Violence is a major public health issue. It is a major cause of death, suffering and economic loss worldwide. The focus of this CRE is to better understand violence perpetration, and to facilitate improvements in its prediction and prevention. Eleven projects will observe individual factors such as early life experiences, cognition and medication use, and consider broader issues such as sentencing practices in court and how to optimize the collection and use of large violence-related data."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015611"^"http://purl.org/au-research/grants/nhmrc/2015611"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CRE for STrengthening Health Systems in Remote Australia (CRESTRA),Centres of Research Excellence"^"The Centre of Research Excellence for Strengthening Health Systems in Remote Australia brings together Australia’s leading remote health researchers and remote primary care services across four states to carry out a program of research that will ensure: (1) stable and competent staffing; (2) fair funding; and (3) well-coordinated health services, thereby improving access to high quality health services in remote areas, reducing hospitalisations and improving health outcomes at a lesser cost."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015613"^"http://purl.org/au-research/grants/nhmrc/2015613"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CRE for Interstitial Lung Disease - towards Individualised Care,Centres of Research Excellence"^"The Centre for Research Excellence in Interstitial Lung Disease (ILD) – towards Individualised Care (CRE-ILD) aims to transform and extend the lives of people with ILD, through effective, personalised approaches to identify and manage ILD. Building on our successful CRE for pulmonary fibrosis, exceptional national platforms and multidisciplinary expert team, CRE-ILD will broaden our focus to all ILD, in a personalised approach specifically addressing our patients’ identified research priorities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015615"^"http://purl.org/au-research/grants/nhmrc/2015615"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network,Centres of Research Excellence"^"The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network was established in 2015 to address the immense burden of musculoskeletal conditions. With the aid of NHMRC-CRE investment (2018-22) we have already driven improvements in care. Our new CRE will significantly extend our reach, scope, depth and impact. Three new foci will be to bridge the bench to bedside gap, state-of-the-art trials of complex interventions, embedded in usual care, and 3) globalisation of our work."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015622"^"http://purl.org/au-research/grants/nhmrc/2015622"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Science Translation for e-Psychological Perinatal Supports (STePPS CRE),Centres of Research Excellence"^"Over 300,000 women give birth in Australia each year and 20% experience clinical depression, often with severe anxiety, either in pregnancy or the first postnatal year. By bringing together cutting edge Australian and international research in perinatal mental health, the goal is to reduce the burden of mental health difficulties on families and future generations. This CRE will produce better Knowledge, better Interventions and e-mental health treatments, Improved access and treatment uptake."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015705"^"http://purl.org/au-research/grants/nhmrc/2015705"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Centre of Research Excellence to Accelerate Stroke Trial Innovation and Translation,Centres of Research Excellence"^"Stroke remains a serious medical problem affecting tens of thousands of Australians each year. This CRE application will deliver better healthcare for those with stroke, by co-designing new stroke trials with consumers, and using new technology to deliver stroke interventions in rural and remote Australia. Our 'whole of system" approach will speed up translation of new treatments and we will build a new generation of clinician researchers to increase future stroke research capacity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015724"^"http://purl.org/au-research/grants/nhmrc/2015724"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards eradicating food allergy: from population to precision prevention, early intervention and management,Centres of Research Excellence"^"Australia has the world’s highest rate of food allergy. We have made significant progress understanding strategies to prevent food allergy and are testing these in large clinical trials. We now aim to understand who will benefit from these strategies, to reduce the number of children developing allergies, how best to treat and manage allergy to improve the lives of those living with food allergy, and to rapidly transfer research findings into public health policy and clinical practice changes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015727"^"http://purl.org/au-research/grants/nhmrc/2015727"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translational Centre for Speech Disorders,Centres of Research Excellence"^"One in 5 children have a speech or language disorder at school entry, with lifelong deficits in psychosocial, academic and employment outcomes. Current speech pathology management is severely limited because it focuses on symptoms and ignores critical growing evidence on underlying genetic and neural aetiologies. The vision of our CRE is to transform speech pathology, by identifying, understanding and targeting the underlying aetiology that results in the symptomatology."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015739"^"http://purl.org/au-research/grants/nhmrc/2015739"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre for Research Excellence in Cervical Cancer Control (C4),Centres of Research Excellence"^"This proposal will continue the work of our successful Centre of Research Excellence in Cervical Cancer Control - “C4”. To realise the elimination goal of cervical cancer, we will tackle the enormous inequities in access to cervical cancer control interventions, through implementation activities focused on achieving high and equitable participation in HPV vaccination, cervical screening, triage and treatment, including developing and evaluating new pathways for HPV self-collection for screening."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015747"^"http://purl.org/au-research/grants/nhmrc/2015747"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Centre of Research Excellence in Bipolar Disorder (CORE-BD),Centres of Research Excellence"^"Bipolar disorder (BD) is a pervasive and debilitating disorder. The Centre of Research Excellence in Bipolar Disorders (CORE-BD) presents a unique opportunity for Australia to position itself as an international leader in BD research, spanning early detection and intervention, through to helping those with chronic BD. By growing workforce capacity, we will ensure research findings are implemented into practice in order to help reduce the burden experienced by those impacted by BD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015820"^"http://purl.org/au-research/grants/nhmrc/2015820"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Centre of Research Excellence in Urban Indigenous Health,Centres of Research Excellence"^"Unmet health needs for urban Indigenous Australians are well documented, alongside a persistent gap in health research conducted with this population. Australia’s first Centre of Research Excellence in Urban Indigenous Health will drive innovative research aimed at achieving excellence in health care delivery. Our CRE will harness existing partnerships and infrastructure to develop the next generation of health researchers to drive Australia's first urban Indigenous health research agenda."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015821"^"http://purl.org/au-research/grants/nhmrc/2015821"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Frailty ADD: Improving Hospital Outcomes for Frail Patients Across Different Disciplines,Centres of Research Excellence"^"Frail patients are often harmed in hospitals. This CRE will improve hospital outcomes for frail patients by helping healthcare systems understand the impact of frailty on outcomes and costs, developing clinical practice guidelines for frailty informed care across multiple disciplines, developing a core outcome set for frail patients, and upskilling the next generation of researchers and clinicians to continue the legacy of this CRE."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015843"^"http://purl.org/au-research/grants/nhmrc/2015843"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"DRIVE CP: Directing Research In Very Early Cerebral Palsy,Centres of Research Excellence"^"Cerebral Palsy (CP) is common (1 in 700) and the cost is immense (0.14% GDP). The rate has fallen by 30% meaning more is possible. Our CRE is co-designed with consumers to directly address the priorities set by consumers in our National CP strategy. Together we will diagnose CP early through a national screening program, then develop and transmit new early interventions, that reduce severity and improve independence. We will use artificial intelligence to automate screening for diagnosis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015501"^"http://purl.org/au-research/grants/nhmrc/2015501"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pathway Of Low Anterior Resection syndrome relief after Surgery (POLARiS) trial,International Collaborations"^"Disease-free survival is usually regarded as the most important consideration after rectal cancer surgery. As survival outcomes have improved, there is increasing focus on ‘survivorship’ and QoL. One important determinant of QoL is post-operative bowel function which can be deleteriously impacted by surgery. Optimal management of bowel dysfunction following surgery (LARS) remains unclear. This trial will compare 3 interventions for LARS, and assess their influence on QoL and cost-effectiveness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015726"^"http://purl.org/au-research/grants/nhmrc/2015726"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial),International Collaborations"^"Lumbar fusion is an operation in which bones in the spine (vertebrae) are fixed together to try to help patients who have persistent low back pain that is thought to be related to specific spine changes seen on scans. We do not know whether this type of surgery for these patients is better than offering further high quality non-surgical care. We will conduct a large trial to test whether lumbar fusion surgery is better for patients and the healthcare system than high quality non-surgical care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017548"^"http://purl.org/au-research/grants/nhmrc/2017548"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Youth-GEMs: Gene Environment interactions in Mental health trajectories of Youth,International Collaborations"^"Mental disorders in children and adolescents have a large impact on the individuals, their families and society. This project aims to improve prediction of mental health trajectories by including biological markers as that will facilitate targeted intervention. We will make use of already collected data in various cohorts in the general population, but will also collect longitudinal data in at risk clinical populations, presenting to emergency departments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017566"^"http://purl.org/au-research/grants/nhmrc/2017566"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Clinical validation of Artificial Intelligence for providing a personalized motor clinical profile assessment and rehabilitation of upper limb in children with unilateral Cerebral Palsy,International Collaborations"^"Cerebral Palsy is the most common physical disability in childhood (1 in 700) and Hemiplegia is the most common form (40%). Children with hemiplegia have impairments to hand function and mobility that impact self care, participation in school and leisure and long term vocational aspirations. Accurate diagnosis is important for accessing tailored interventions, individualised rehabilitation and prognosis for education, employment and independent living."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017666"^"http://purl.org/au-research/grants/nhmrc/2017666"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors,International Collaborations"^"Cancer and its treatment can lead to sustained deleterious side effects. Exercise can improve long-term cancer side effects and quality of life; yet, access to high-quality exercise support is not routinely available. PREFERABLE-II evaluates the (cost)-effectiveness of a convenient, live-remote exercise intervention that targets common cancer-related side effects. The project aims to improve the accessibility of best-practice exercise to all cancer survivors and improve supportive cancer care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017786"^"http://purl.org/au-research/grants/nhmrc/2017786"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improvement of school indoor air quality and children's health,International Collaborations"^"This Australian project will conduct short-term controlled trials to assess the effect of change in indoor air quality in primary schools on the health and cognitive outcomes of children in Melbourne. Together with InChildHealth supported by H2020, this project will fill information gaps for the indoor air quality legal framework, providing guidelines and recommendations that support health promotion and disease prevention for children in the schools."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017837"^"http://purl.org/au-research/grants/nhmrc/2017837"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identification of chemical and biological determinants, their sources, and strategies to promote healthier homes in Europe (INQUIRE),International Collaborations"^"While Australians are estimated to spend roughly 90% of their time indoors, we understand little about the air pollutants that may be present in homes. As part of a broader European study, this project aims to assess air and dust samples from Australian homes, along with urine samples from residents, to characterise indoor air pollutants, map their sources, and determine impacts on health. This knowledge can be used to guide policy and industry towards approaches to improve indoor air quality."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018124"^"http://purl.org/au-research/grants/nhmrc/2018124"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Risk and Resilience in Developmental Diversity and Mental Health,International Collaborations"^"Mental health problems affect a staggering 20% of the Australian population and cost our government $11 billion dollars in 2019-2020. Within any 12 month period, over half a million Australian children experience a mental disorder and prevalence is highest for those with pre-existing neurodevelopmental disorders. Current management is failing as it focuses entirely on mental health risk. Our pioneering work will move the field to understand and promote resilience in EU and Australian contexts."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018165"^"http://purl.org/au-research/grants/nhmrc/2018165"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PSYCH-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness,International Collaborations"^"About 30% of people suffering from mental illnesses such as schizophrenia, bipolar disorder, and major depression don't benefit from treatment with standard medicines and have "treatment resistance" (TR). TR leads to great individual suffering and often to a sense of "failure". The vision of PsychSTRATA is to pave the way for a shift from the current step-wise trial-and-error paradigm of psychiatric therapies towards targeted early introduction of intensive treatments for people at risk of TR."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015018"^"http://purl.org/au-research/grants/nhmrc/2015018"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"TRANSMIT: A multifaceted knowledge TRANslation Strategy iMprovIng funcTion in children and youth with cerebral palsy,Partnership Projects"^"One third of children with cerebral palsy (CP) will never walk, and one quarter will never talk. These children receive ineffective treatments 43% of the time, lowering their chance of employment. We will build a mobile health aide that filters effective intervention options for children with CP, that overcomes the need to understand complex health information, and that supports consumers to choose, clinicians to provide, and policymakers to reimburse effective treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015440"^"http://purl.org/au-research/grants/nhmrc/2015440"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Promoting CHANGE (Community Health And Nutrition, and Government Engagement): a Randomised Controlled Trial to accelerate healthy food retail in local government settings,Partnership Projects"^"This grant will test if an intervention to support retail outlets in Local Government settings (e.g. community sports centres) to improve availability and promotion of healthy food and drink is effective and delivers good value for money. The study will provide evidence from a rigorous randomised controlled trial to support the creation of healthier food environments. Ultimately this will improve what people eat and help reduce the risk of diet-related diseases in an effective and sustained way."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015462"^"http://purl.org/au-research/grants/nhmrc/2015462"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"BUBs Quit study: Clinical Midwife Specialist to assist pregnant women to quit smoking using counselling and embedded technology,Partnership Projects"^"This study will determine the effectiveness of the BUBs Quit smoking cessation intervention delivered by trained midwives compared to usual care in assisting pregnant women to quit during pregnancy and maintain abstinence at 6 months post-birth. We will explore factors affecting integration of the intervention into usual maternity care. We expect that the BUBs Quit intervention will reduce smoking rates among pregnant women compared to the comparison group by at least 8.5% and be cost effective."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015470"^"http://purl.org/au-research/grants/nhmrc/2015470"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Delivering a population-based intervention to reduce young driver crashes,Partnership Projects"^"Road crashes are a leading cause of injury mortality and morbidity. As a consequence of advances in telematics technology, there is an opportunity to deliver a unique prevention strategy that will influence a drivers’ risk taking and hence crash propensity. We propose a randomised controlled trial to assess the effects of personalised safety feedback and financial incentives, delivered using a smartphone application, on reducing motor vehicle crashes over the first 6-months of driving"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015514"^"http://purl.org/au-research/grants/nhmrc/2015514"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"MenoPROMPT: a co-designed, comprehensive, evidence-based program to improve the care of women at and after menopause.,Partnership Projects"^"Menopausal symptoms are frequently debilitating. Despite readily available, safe therapy, most severely symptomatic women are not receiving evidenced-based therapy. We will develop a simple menopause assessment and decision-making tool, that will be integrated into general practitioner (GP) software, so that key information is immediately accessible to GPs, together with a pre-consultation women’s health self-assessment tool, delivered by SMS, to ensure menopausal symptoms are not overlooked."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015532"^"http://purl.org/au-research/grants/nhmrc/2015532"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The PeriWarm Trial: Transforming perioperative temperature management for better patient outcomes,Partnership Projects"^"Perioperative hypothermia occurs when patients undergoing surgery lose body heat. As well as discomfort, heat loss also causes other adverse health outcomes including wound infection, increased blood loss, longer hospital stays and increased costs. Although guidance to prevent perioperative hypothermia is available, this guidance is not widely used. This project seeks to reduce perioperative hypothermia through assisting health care providers to use guidance and improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015544"^"http://purl.org/au-research/grants/nhmrc/2015544"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Smarter hospitals: Unlocking the promise of virtual models of care through infrastructure innovation in Australian healthcare facilities,Partnership Projects"^"Virtual models of care can improve patient health outcomes and their healthcare experience, at a reduced cost in comparison to face-to-face care. Significant evidence gaps remain about how to design healthcare facilities to integrate virtual care, how to ensure equitable health outcomes when using virtual care, and how to support workforce change management. Our program of work provides the evidence and solutions required by our Partner Organisations and health services nationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015744"^"http://purl.org/au-research/grants/nhmrc/2015744"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RELEASE: REdressing Long-tErm Antidepressant uSE in general practice,Partnership Projects"^"Our aim is to improve Australian health outcomes by decreasing unnecessary and potentially harmful long-term (&amp;gt;12 months) prescribing of antidepressants in general practice. The outcomes of our research will include a validated antidepressant discontinuation model and proven implementation strategies, including practical resources where currently there are none, to foster sustainable improvement in primary mental health care, including for urban and rural general practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015751"^"http://purl.org/au-research/grants/nhmrc/2015751"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Digitally Enhancing Youth Mental Health Services across Australia: cluster RCT of an Adaptive, TaiLored, and behAvioural Science-informed (ATLAS) Implementation Strategy,Partnership Projects"^"The mental health system is overwhelmed and has catastrophically failed to meet the needs of those with mental-ill health. Despite the potential for digital technology to be a pillar of a modern, sustainable, and adaptive mental health system, digital interventions have not been integrated into mental health services. This aim of this project is to address this global failure by integrating a fully-funded, evidenced-based digital platform (MOST) in a large network of mental health services."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015773"^"http://purl.org/au-research/grants/nhmrc/2015773"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Strengthening Healthcare Systems with Patient Reported Outcome Measures (PROMs),Partnership Projects"^"The collection and use of Patient Reported Outcome Measures (PROMs) enhances two way communication between patients and clinicians, resulting in improved outcomes and quality of life for patients. This research aims to understand what makes PROMs acceptable to clinicians and consumers, when they should be collected, and how PRO data can best be displayed for quality assurance and care. This will facilitate use of PROMs in healthcare, driving change at an individual, service and system level."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015783"^"http://purl.org/au-research/grants/nhmrc/2015783"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising public health notification systems to achieve hepatitis C elimination in Australia,Partnership Projects"^"Australia can eliminate hepatitis C as a public health threat by sustaining high rates of hepatitis C treatment. But Australia’s rates of hepatitis C treatment have stalled over recent years. All hepatitis C diagnoses are notified to health departments and this partnership project will implement and evaluate a series of strategies across all states and territories and identify the most effective ways of following up notifications to enhance rates of hepatitis C treatment and cure in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015784"^"http://purl.org/au-research/grants/nhmrc/2015784"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bipolar Early intervention using New Digital technologies: a hybrid effectiveness-implementation trial of a multi-component model of evidence-based care,Partnership Projects"^"Early intervention for young people with serious mood problems like Bipolar Disorder is largely unavailable in Australia. To address this, we have developed an innovative model of care that combines three effective interventions (BLEND). In this project, we will evaluate how effective the BLEND model is in improving young people’s quality of life, compared with standard mental health care. We will also aim to understand whether the strategies used to implement BLEND are acceptable and feasible."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016268"^"http://purl.org/au-research/grants/nhmrc/2016268"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RBR E3 ubiquitin ligases in health and disease,Investigator Grants"^"Cells in the human body constantly process signals to react to changes in their environment. Errors in cellular signalling cause diseases like cancers and neurodegeneration. One key signalling molecule is the small protein ubiquitin. My program will develop tools to uncover how the processes involved in ubiquitin signalling occur normally and how they can cause disease. This provides new opportunities to understand basic biology, discover and exploit new drug targets, and develop novel medicines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016274"^"http://purl.org/au-research/grants/nhmrc/2016274"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"More accurate disease assessment and improved clinical decision-making for patients with urothelial cancers,Investigator Grants"^"Cancers of the bladder and similar tissues (“urothelial cancers”) can cause major health issues, including shortened survival and significant loss of quality of life. Some patients can benefit from more aggressive treatment while others will not, but we cannot yet tell who. We have developed a simple, quick, and easy method to look for urothelial cancer DNA in the blood. This project will test that method to see if it can help predict who might need more treatment and for whom it can be spared."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016277"^"http://purl.org/au-research/grants/nhmrc/2016277"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging big data to maximise the impact of pharmacists on medicines safety in aged care,Investigator Grants"^"The recent Aged Care Royal Commission recommended urgent action to improve medicines use in aged care services. This project will tell us more about the effects of medicines when they are used by people receiving aged care services, so that health professionals can make improvements. It will also establish a system to guide best practice for pharmacists who work in aged care settings and monitor for improvements in medicines use, health and wellbeing among people who receive aged care services."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016279"^"http://purl.org/au-research/grants/nhmrc/2016279"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^""No Place to Grow Old": Advancing health care and management of Australia's ageing prisoners,Investigator Grants"^"This research was designed in response to the rapid ageing of Australia’s prisoner population, which is creating new, unique and expensive challenges to criminal justice and public health. The research aims to generate important data regarding the health and functioning status of older prisoners. It also aims to inform better health and service provision upon release from prison, where older prisoners are at particular risk of adverse outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016283"^"http://purl.org/au-research/grants/nhmrc/2016283"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Detailing epigenetic mechanisms in cancer evolution for improved patient outcomes,Investigator Grants"^"Cancers are very difficult to cure because they can adapt to therapy, become resistant and recur. The ability to evade treatment is linked to the diversity of cells in a cancer: the more keys a cancer has, the more likely it is to unlock resistance and escape therapy. This research project will explore cell diversity and cancer adaptation in a devastating blood cancer, revealing new treatments that can delay or prevent recurrence."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016286"^"http://purl.org/au-research/grants/nhmrc/2016286"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving access to non-pharmacological treatment in chronic respiratory disease,Investigator Grants"^"For people with chronic lung disease, pulmonary rehabilitation improves symptoms and function, and helps reduce healthcare costs. Yet very few (less than 10%) people who would benefit from pulmonary rehabilitation have ever done a program. This work will explore new ways to deliver pulmonary rehabilitation, including directly to people’s homes, to make access to programs easier. If more people can access and thus benefit from pulmonary rehabilitation, health system costs could be reduced."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016301"^"http://purl.org/au-research/grants/nhmrc/2016301"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Stemming the rising tide of youth mental health problems: prevention through social connection,Investigator Grants"^"Mental health problems, such as depression and anxiety, are rising in recent cohorts of adolescents. This research aims to generate new knowledge about effective prevention for these problems. It will utilise large-scale longitudinal data, include a world-first RCT and generate practical guidelines for the implementation of effective prevention within secondary school settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016308"^"http://purl.org/au-research/grants/nhmrc/2016308"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Structure-function relationships in drug transport and inhibition of membrane proteins,Investigator Grants"^"This project will study how drugs interact with bacterial targets and drug transporters. This work is instrumental in antimicrobial drug development and will also potentially increase current drug potency and effectiveness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016324"^"http://purl.org/au-research/grants/nhmrc/2016324"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving critically ill patient outcomes through randomised trials and registries in intensive care,Investigator Grants"^"Around 50% of Australians will be admitted to an intensive care unit in their lifetime, with more than 175,000 intensive care admissions each year. As a global leader in intensive care, including founding binational infrastructure, my research program using the gold standard of phase III multicentre, randomised, controlled trials and registries will continue to deliver improvements in clinical decision-making and outcomes for critically ill patients, as well as significant healthcare savings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016330"^"http://purl.org/au-research/grants/nhmrc/2016330"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigations into phage biology directed at therapies for antimicrobial resistant (AMR) infections,Investigator Grants"^"The rise of drug-resistant superbugs is a global problem with a bleak outlook. A projected increase to 10 million human deaths per year here and around the world can only be addressed with new, sustainable solutions. My vision applies computational and structural biology as well as biochemistry and microbiology to evaluate and optimize the properties of viruses called "phages" to either resolve infections directly or re-sensitize bacteria in infection sites to existing drugs in clinical use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016334"^"http://purl.org/au-research/grants/nhmrc/2016334"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Microbiota-Growth Hormone Axis - From Metabolic Function to Liver Disease,Investigator Grants"^"Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease. If left untreated, it can progress to advanced scarring, liver failure or cancer. Current therapies are limited and for many patients, ineffective. This project will investigate the involvement of gut microbes in the development of NAFLD and whether their targeted modulation could provide new treatment options."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016338"^"http://purl.org/au-research/grants/nhmrc/2016338"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genetic basis for skeletal muscle formation and regeneration in development and disease,Investigator Grants"^"I am a biomedical scientist who focuses on understanding how skeletal muscle is made and maintained, and how this process is perturbed in diseases of childhood such as muscular dystrophies. I study muscle formation and growth and the role of muscle stem cells during injury and disease, collaborating widely with an international and national clinical networks and with industry. My main research tool is the zebrafish model, where the processes I study can be dissected in living muscle tissue."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016346"^"http://purl.org/au-research/grants/nhmrc/2016346"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Right care, first time: delivering technology-enabled mental health care to young people at scale,Investigator Grants"^"Providing highly-personalised mental health care to young people, as early as possible in an illness, is a global priority. COVID-19 has been particularly harsh on the mental health of youth. This program (‘Right Care, First Time') uses digital technologies, new health planning tools, early intervention services and socio-economic policies to drive local delivery. These approaches require detailed studies to test whether they can deliver better health and economic outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016379"^"http://purl.org/au-research/grants/nhmrc/2016379"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing maternal and newborn deaths: Transforming midwifery in the Asia-Pacific region through research and innovation,Investigator Grants"^"A reduction in maternal and newborn deaths and stillbirths in the Asia-Pacific region is urgently needed. Midwives can save lives; there are, however, significant gaps in the knowledge-base about how best to strengthen midwifery. This Investigator Grant will support primary research across the region to improve maternal and newborn health post COVID-19. The outcomes will ensure that maternal and newborn health services can withstand future shocks such as pandemics and natural disasters."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016380"^"http://purl.org/au-research/grants/nhmrc/2016380"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Outcomes in Paracetamol Poisoning,Investigator Grants"^"Each year paracetamol leads to &gt;10,000 hospital presentations following deliberate self-poisoning and accidental overdose in Australia. It is also the leading cause of acute liver failure. This study aims to improve the management of paracetamol poisoning through evaluating the use and outcomes from updated 2020 guidelines and clinical studies on new tests and treatments. Outcomes from this research will aim to improve management and decrease the rate of liver injury from paracetamol poisoning."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016381"^"http://purl.org/au-research/grants/nhmrc/2016381"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sewers to cures: Bacteriophages as a targeted treatment for Group B Streptococcal infections,Investigator Grants"^"Group B Streptococci are bacteria that can transfer from mother to baby during birth and cause severe disease. Mothers who carry these bacteria receive antibiotics, which kill the bacteria but also affects the baby’s natural beneficial bacteria. My research will investigate a century old treatment using phages, viruses that kill specific bacteria. I will use advanced genetic techniques to achieve a targeted, safe and effective treatment as a future alternative to antibiotic use in pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016390"^"http://purl.org/au-research/grants/nhmrc/2016390"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising lifelong health and development for our most immature newborns,Investigator Grants"^"Extremely preterm births, before 28 weeks of pregnancy, carry lifelong risks to health and development. Many unanswered questions posing barriers to optimising their health and development will be addressed in this proposal. These include outcomes in their mid -30s, and outcomes after change in care practices, and the COVID pandemic. I will advance ways to predict individuals at highest risk, and implement a surveillance program to ensure consistency and best care for this vulnerable group."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016391"^"http://purl.org/au-research/grants/nhmrc/2016391"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tools to curb drug resistance in malaria parasites,Investigator Grants"^"Drug resistance is a major challenge to controlling malaria. Resistant parasites emerge, spread geographically &amp; eventually render our drugs useless. We have been on a treadmill of using, then losing, malaria drugs for decades. I will identify antimalarial compounds to stem the spread of drug resistance. I exploit the fact that malaria must spread via mosquitoes. I find drugs for which resistant parasites get trapped in the mosquito stopping them infecting new people &amp; spreading resistance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016394"^"http://purl.org/au-research/grants/nhmrc/2016394"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing harm from central venous catheters for children treated for cancer,Investigator Grants"^"Children with cancer often need a central line, which is a plastic tube that delivers medicine to directly to their bloodstream. Unfortunately, these tubes can also cause significant harm, like infections and blood clots. My research aims to change clinical practice by testing new technologies and educating healthcare workers to deliver best practice care. We expect outcomes will improve the experience and safety of care for children with cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016396"^"http://purl.org/au-research/grants/nhmrc/2016396"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translational studies in infectious diseases,Investigator Grants"^"Testing new drugs and vaccines for infectious diseases has been impeded by difficulties in finding out how well these work in humans. I have developed a system where healthy human volunteers are experimentally infected with a microbe to test drugs or vaccines in controlled conditions. This has accelerated the development of drugs and vaccines to treat these infectious diseases. In this Program I will extend this work and establish new challenge systems to deliver new vaccines and treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016399"^"http://purl.org/au-research/grants/nhmrc/2016399"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The IVCare adaptive platform trial: Towards zero bloodstream infections in IV catheters,Investigator Grants"^"Life-saving medical treatments are delivered into the bloodstream via intravenous (IV) catheters. This risks bacteria also entering the bloodstream through the catheter and causing a deadly whole-body infection. My research will use an advanced clinical trial design to test new medical equipment and decision support tools to block bacteria entering catheters and avoid infections during IV therapy. This will make patients safer and improve hospital care in developed and developing countries."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016406"^"http://purl.org/au-research/grants/nhmrc/2016406"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising radiopharmaceutical therapy to improve clinical outcomes in advanced prostate cancer,Investigator Grants"^"I will lead innovative clinical trials using radiopharmaceuticals to target a protein called PSMA (prostate-specific membrane antigen), which is found on most prostate cancer cells. Using scans from these trials and tiny fragments of DNA called circulating tumour DNA (ctDNA), I will try to understand why some patients respond better to PSMA radiopharmaceuticals than others. This study will lead to better and more effective treatments for advanced prostate cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016407"^"http://purl.org/au-research/grants/nhmrc/2016407"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluation of antenatal vaccines and vaccination programs in pregnancy,Investigator Grants"^"Antenatal influenza, pertussis and now COVID vaccines reduce the severity of these illnesses and prevent deaths in pregnancy and young babies. We need to know the uptake, safety and effectiveness of these vaccines in pregnancy using large study numbers and gold standard methods. First we must ensure the way we currently collect vaccination information in pregnancy in Australia is valid. Results will be used to advocate including pregnancy status in the Australian Immunisation Register."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016410"^"http://purl.org/au-research/grants/nhmrc/2016410"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"From structural mechanisms of endosomal trafficking to therapies for neurodegenerative diseases,Investigator Grants"^"Disruption of the endolysosomal system is directly linked to neurological dysfunction leading to dementia and other neurodegenerative disorders for which no effective treatments are available. This proposal will build on my world-leading studies of Retromer to better understand its mechanism of action and its role in sporadic and inherited neurodegenerative disorders, and to ultimately deliver new molecular therapies that can promote Retromer’s neuroprotective functions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016415"^"http://purl.org/au-research/grants/nhmrc/2016415"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Ensuring equitable access to care for migrants living with HIV in sub-Saharan Africa: Lessons learnt from an evaluation of Botswana’s migrant inclusive program,Investigator Grants"^"Migration is a key consideration in controlling the spread of HIV. There is no formal evaluation of national HIV public health programs that are inclusive of migrants. Botswana a country in sub-Saharan Africa, the epicentre of the HIV epidemic has run a migrant inclusive public program since 2020. My research will evaluate Botswana's program to document lessons learnt and explore the practicality of implementing a linked HIV surveillance system to track progress to HIV elimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016420"^"http://purl.org/au-research/grants/nhmrc/2016420"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enhancing motor recovery after stroke using a discovery pipeline approach,Investigator Grants"^"Our emergency response to stroke has significantly improved. Nevertheless, many people are still left with disability, and current rehabilitation interventions have limited impact. This Investigator Grant will improve rehabilitation options by advancing the way these options are developed. My work will help establish a higher standard for trials, led by Australia, for global use. Taken together, this research will ultimately drive the most promising rehabilitation interventions into practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016432"^"http://purl.org/au-research/grants/nhmrc/2016432"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Water injections: Transforming childbirth pain management for any woman, anywhere.,Investigator Grants"^"Medical options for relief of childbirth pain are unavailable to many women in rural Australia. My previous research has proven that small injections of water are effective in reducing labour back pain with minimal side effects. My research aim is to develop a water injection technique that reduces abdominal labour pain that can be used safely in childbirth . This will provide a safe, effective and low cost option for labour pain management for women in rural and other birthing settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016438"^"http://purl.org/au-research/grants/nhmrc/2016438"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalised Dementia Prevention: Clinical Trials, Advanced Modelling &amp; Biomarker Discovery,Investigator Grants"^"There is no cure for dementia but understanding why some individuals are more likely to develop dementia, will enable the implementation of effective strategies and treatments to help reduce the risk. This research program will use clinical trials to test new drug treatments for dementia prevention, and large studies in communities of older Australians to better understand who is most at risk and why. Together this research program will deliver major advances in dementia prevention."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016461"^"http://purl.org/au-research/grants/nhmrc/2016461"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Drug Discovery and Chemical Biology of cell Death processes: Novel Insights and First-in-Class Therapeutics,Investigator Grants"^"Cell death processes are key for our development and our health. Most diseases are linked to cell death deregulation, either allowing rogue cells to survive (as in cancer) or inducing the death of healthy cells (inflammatory conditions). This program of work is focussed on developing new small molecules that modulate cell death to achieve two goals: the creation of new medicines for cancer and inflammatory diseases and the provision of new probes to better understand cell death biology."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016464"^"http://purl.org/au-research/grants/nhmrc/2016464"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Childhood cancer precision diagnostics and therapeutics,Investigator Grants"^"Cancer is the lead cause of disease-related death in children in Australia and other developed countries. Resistance to therapy, toxic side effects of treatment, and delivery of effective doses of drugs to aggressive cancers are a major obstacle to cure. Our research will identify the right treatment for the right patient and target treatment delivery to cancer cells, reducing toxicity to healthy tissue. This will provide better treatment options for patients with aggressive cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016491"^"http://purl.org/au-research/grants/nhmrc/2016491"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immunity, Vaccines and Therapeutics for pandemic viruses,Investigator Grants"^"Major ongoing global viral pandemics have swept the world in recent decades, including SARS-CoV-2, influenza and HIV. I present 3 inter-related research themes to address control of SARS-CoV-2, influenza and HIV. My overall vision is to bring our understanding of immunity to SARS-CoV-2, influenza and HIV to the point where we can improve vaccination strategies and treatment paradigms for these viruses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016501"^"http://purl.org/au-research/grants/nhmrc/2016501"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing suicide by improving mass media reporting of suicide in South Asia,Investigator Grants"^"Responsible media reporting of suicide is a core suicide prevention intervention. Yet, there is a profound lack of robust evidence globally on the impacts of optimised media reporting. My proposed research in the South Asia region represents a rare opportunity to conduct trials to address global evidence gaps around the impact of media interventions, given the baseline context of extremely poor-quality reporting, high suicide rates and limited prior suicide prevention activity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016513"^"http://purl.org/au-research/grants/nhmrc/2016513"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the physiological and pathological roles for Transient Receptor Potential (TRP) channels in the mammalian cortex,Investigator Grants"^"My recent discovery that transient receptor potential Ankyrin 1 (TRPA1) is expressed in rodent cortical neurons has shed light on its role in the mammalian brain. Recent studies have proposed a role for cortical TRPA1 in Alzheimer’s disease and Multiple Sclerosis, and further suggested that its activation leads to neuronal death. I will investigate the physiological and pathological roles of cortical TRPA1, focusing on its activation mechanisms to develop targeted therapies for these diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016530"^"http://purl.org/au-research/grants/nhmrc/2016530"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging Polygenic Risk and Genetics for Pre-clinical Discovery in Cardiometabolic Disease,Investigator Grants"^"Cardiometabolic diseases such as obesity, diabetes and cardiovascular disease, account for more deaths in the developed world than any other condition. Our genes play a major part in the development of these conditions, however the specific causal genes remain unknown. This proposal will engage new genetic technologies to identify these specific genes, whilst validation studies in lab based models and exclusive access to human datasets will ensure translational and commercial relevance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016545"^"http://purl.org/au-research/grants/nhmrc/2016545"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integrated genetic approaches to improve glaucoma diagnosis and management,Investigator Grants"^"Glaucoma robs individuals of their vision; however, genetic testing can identify at-risk individuals early and influence management. My research program will advance knowledge on genes and variants for glaucoma, develop novel genetic testing reporting strategies for glaucoma in clinical practice, and assess current genetic testing services. This work will improve glaucoma diagnosis and clinical management, access to genetic services and support for patients and their families."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016547"^"http://purl.org/au-research/grants/nhmrc/2016547"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pioneering data analysis methods to decrypt the cancer transcriptome,Investigator Grants"^"Recent advances in technology mean that RNA, the functional read-out of DNA, can be sequenced to a new level of detail. However, this technology results in masses of information that we do not yet have the capacity to analyse. My program will develop computational methods that will analyse RNA in cancer. This will enable us to understand the cellular events that allow cancers to develop and spread and how these can be targeted to accelerate development of new cancer therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016566"^"http://purl.org/au-research/grants/nhmrc/2016566"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving prognosis and quality of life in children with muco-obstructive lung disease,Investigator Grants"^"Cystic fibrosis and bronchiectasis are life-shortening lung conditions that develop in childhood and progress throughout life. My research is focused on early detection, monitoring, and treatment of these conditions to improve outcomes. Through the analysis of biological samples, we can examine the early pathways associated with worse outcomes later in life. This work can identify new targets for therapies to prevent and slow disease progression, and ultimately improve health outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016596"^"http://purl.org/au-research/grants/nhmrc/2016596"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An integrated approach to antigen discovery in autoimmunity and cancer,Investigator Grants"^"Understanding the targets of immune recognition provides insight into the molecular basis of disease; including vaccine and immunotherapy targets for infections and cancer, as well as insights into aberrant immune recognition leading to autoimmune conditions. As a world leader in antigen discovery, I will apply and further develop technologies to address immune specificity in a variety of cancers and autoimmune diseases to improve vaccine design, immune monitoring and immunotherapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016598"^"http://purl.org/au-research/grants/nhmrc/2016598"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the psychosocial wellbeing of adults with hearing loss through a mHealth intervention,Investigator Grants"^"Hearing loss is common in Australia. People with hearing loss often avoid social situations for fear of mishearing. They can feel left out and disconnected. Hearing aids alone are not enough. Audiologists are well-placed to help people cope with these feelings. My research will develop an App to provide effective emotional support for people with hearing loss. Audiologists will be trained to support client’s using the App within routine audiological care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016627"^"http://purl.org/au-research/grants/nhmrc/2016627"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Role of testosterone in preventing major morbidity in women,Investigator Grants"^"This research will determine if the hormone testosterone (often considered a male hormone) can serve as a new therapy to protect against the leading causes of ill health in older women, namely muscle wasting, heart failure and loss of brain function. We will establish whether this same intervention can prevent premature bone loss and sexual dysfunction in younger women with premature ovarian insufficiency. These are all conditions for which there are no proven preventive interventions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016629"^"http://purl.org/au-research/grants/nhmrc/2016629"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Super smart Smartphones: Sensing changes in mental health and delivering just-in-time adaptive interventions,Investigator Grants"^"Body image concerns impact more than a third of young people and are linked with eating disorders, anxiety, depression and suicidality. This program of research will harness the popularity of smartphones to predict when young people are struggling with their body image from the way they are using their phones, and provide the right level of personalised support via “just in time” online interventions. If effective, this work will translate into improved body image for at-risk young people."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016641"^"http://purl.org/au-research/grants/nhmrc/2016641"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing infectious complications in kidney transplant recipients,Investigator Grants"^"Infections commonly occur following kidney transplantation and are associated with significant morbidity and mortality. My research program addresses this public health burden by designing clinical trials that are of critical importance to patients, caregivers and healthcare professionals. My aim is to ensure views of patients and caregivers are addressed so that my research is relevant to our nephrology community. My research program will benefit patients both in Australia and also globally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016647"^"http://purl.org/au-research/grants/nhmrc/2016647"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing antibiotic overprescribing in dentistry,Investigator Grants"^"Dentists prescribe over 800,000 antibiotic prescriptions yearly and 55% are overprescribed. The aim of this multimodal study is to improve dental prescribing by determining the patient factors that influence dental antibiotic prescribing and providing dentists with a clinical decision prescribing tool, Drugs4dent, to improve prescribing. The outcome is aimed to be improved dental antibiotic use, and transforming the access to drug knowledge for dentists."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016662"^"http://purl.org/au-research/grants/nhmrc/2016662"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Outcomes for Preterm Infants Through Randomised Clinical Trials,Investigator Grants"^"Babies who are born early (premature) can face many health challenges. My research focuses on ways to improve how we care for premature babies in the first days and weeks of life, especially by supporting their breathing. I also want to explore new ways of doing research studies in premature babies so that we can get better at answering the most important questions. By improving the way we care for premature babies early in their lives, we can improve their health into childhood and even beyond."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016667"^"http://purl.org/au-research/grants/nhmrc/2016667"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation research to improve hepatitis C testing and treatment in rural and regional Australia,Investigator Grants"^"I will use implementation research to increase access to hepatitis C testing and treatment in primary care in Western Victoria, and eliminate hepatitis C as a public health threat. Using data from this and a similar project in Cairns, I will determine which interventions are cost-effective in regional settings. Finally, I will help underserved regional areas in Australia to have better access to cost-effective testing and treatment in primary care, especially for people who inject drugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016668"^"http://purl.org/au-research/grants/nhmrc/2016668"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying opportunities to reverse the diabetes epidemic: surveillance of diabetes, its complications and mortality,Investigator Grants"^"Diabetes is a serious disease causing deadly, disabling and costly complications. We need data to help us manage this pandemic. My research will tell us which complications are increasing and who are most at risk, in Australia and worldwide. It will also tell us which interventions are most effective. Together, this understanding will improve care for people with diabetes. It will ensure that interventions are well targeted which will in turn limit the global health expenditure on diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016686"^"http://purl.org/au-research/grants/nhmrc/2016686"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing long noncoding RNAs for cancer diagnosis and treatment,Investigator Grants"^"Cancer cells exploit a newly discovered class of molecules for their growth and resistance to treatment. This research program will develop a better understanding of how these molecules influence cancer initiation, progression, and treatment response. It will also uncover new biomarkers that reveal the presence of cancer, as well as new molecular targets for anti-cancer drugs. Findings from this research will pave the way towards earlier detection of cancer and more effective cancer treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016688"^"http://purl.org/au-research/grants/nhmrc/2016688"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeted neuroprotective treatments for fetal and neonatal brain injury,Investigator Grants"^"Neonatal brain injury is common in infants born preterm, with fetal growth restriction, or who suffer a severe lack of oxygen at birth. Having previously identified the neuropathology specific to these complications, I will now examine targeted neuroprotective treatments that address the specific mechanisms of brain injury. The results of my preclinical studies will inform clinical trials offering new therapies to reduce neonatal brain injury and prevent life-long neurodevelopment deficits."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016695"^"http://purl.org/au-research/grants/nhmrc/2016695"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving alcohol and other drug policy by focussing on values,Investigator Grants"^"What should governments do about alcohol and illicit drugs? The policies that are chosen need to be informed by evidence and reflect the goals and values of communities. This program of work on the role of values in policy development will result in more effective and value-aligned alcohol and illicit drug policies such that the harms experienced across communities from these substances can be reduced."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016698"^"http://purl.org/au-research/grants/nhmrc/2016698"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Strengthening Australian Infectious Disease Clinical Research with a focus on vulnerable populations,Investigator Grants"^"This research aims to study treatments for infectious diseases that affect particularly vulnerable communities including people who inject drugs and people living with HIV. It focuses on finding solutions that will aid progress towards elimination of hepatitis B and C, and towards managing the pandemics of HIV and COVID-19, through the establishment of high quality international collaborative clinical research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016706"^"http://purl.org/au-research/grants/nhmrc/2016706"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Alcohol's harm to others,Investigator Grants"^"This project aims to measure alcohol's harms to others, beyond the drinker, within families, communities, societies and public services. Using a new Australian survey, in-depth interviews and health, crime and welfare system datasets, the project will study how individuals, health and social services, systems and policies respond to problems caused by others’ drinking. The study will model how reduced heavy drinking will decrease harm from others' drinking, in Australia and internationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016719"^"http://purl.org/au-research/grants/nhmrc/2016719"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming health literacy in Australia: a partnership approach,Investigator Grants"^"This program will develop interventions to build health literacy and shared decision making. It will also improve the health system’s capacity to meet the communication needs of people with low health literacy. This program will produce co-designed and tested evidence-based interventions that combine behavioural science with digital innovation and knowledge translation for scalable interventions to improve health literacy nationally and internationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016726"^"http://purl.org/au-research/grants/nhmrc/2016726"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"P. vivax Serological Testing &amp; Treatment: a novel intervention to facilitate malaria elimination,Investigator Grants"^"This research program aims to develop the diagnostic tools and clinical trials evidence to prove that a new public health intervention, P. vivax Serological Test and Treat (SeroTAT) can facilitate PV elimination in vivax endemic countries world-wide. To achieve this, we will develop a new class of malaria point-of-care sero-diagnostic test that can identify those most at risk of recurrent vivax malaria, and prove that treating these people will significantly reduce P. vivax transmission."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016729"^"http://purl.org/au-research/grants/nhmrc/2016729"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Labour Induction Outcomes,Investigator Grants"^"About 1 in 3 Australian women have an induction of labour - an artificial intervention to stimulate the onset of labour when indicated. We know who should have induction of labour and when, but not much about how (which method to use) and where (stay in hospital or at home) to induce labour. In this program, I will lead one international collaborative project, one pragmatic multi-centre clinical trial, and one multi-centre observational study to provide unequivocal answers to these questions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016730"^"http://purl.org/au-research/grants/nhmrc/2016730"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Screening of athletes for cardiovascular disesase and prevention of sudden death,Investigator Grants"^"Sudden cardiac death (SCD) in athletes is a rare but tragic event. Screening programs to prevent SCD are recommended but data are lacking for some groups (indigenous Australians, female athletes) and across sports. The project will develop Australia’s first national registry of athlete screening ECGs, focus on under-represented groups, and make comparisons across sports. The ultimate goal is to improve the accuracy and quality of screening programs to prevent SCD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016732"^"http://purl.org/au-research/grants/nhmrc/2016732"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging Nanoparticle Platforms to Advance Nanomedicine,Investigator Grants"^"Nanoparticles (NPs) afford a revolutionary approach of packaging and delivering medicines to target specific sites within patients. This proposal will address current limitations in NP-based medicines, by understanding and engineering the performance of NPs, and through their reproducible and scalable synthesis. With a focus on cancer, and infectious and neurological diseases, this research will progress nanomedicines towards preclinical studies and commercialisation to improve health outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016756"^"http://purl.org/au-research/grants/nhmrc/2016756"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"N-3 (Omega-3) precision nutrition: preventing prematurity and enhancing cognitive development of very preterm children,Investigator Grants"^"Being born too soon can be devastating for children and their families. My work is designed to overcome omega-3 deficiency in Australian pregnant women to prevent some of those early births. For babies born more than 11 weeks before their due date, my research aims to maximise developmental benefits by feeding extra omega-3 fats in the neonatal unit to match what would have been received in the womb."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016792"^"http://purl.org/au-research/grants/nhmrc/2016792"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Malaria volunteer infection studies for the advancement of antimalarial therapeutics,Investigator Grants"^"At QIMR Berghofer I will lead malaria volunteer infection studies to advance the development of antimalarial therapeutics. This will include studies to characterise the PK/PD profile of existing antimalarials to optimise dose selection, evaluate the transmission blocking activity of new and existing antimalarials, and evaluate strategies to boost antimalarial immunity. These studies will inform antimalarial treatment strategies worldwide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016801"^"http://purl.org/au-research/grants/nhmrc/2016801"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prevention of cardiometabolic conditions in diverse populations,Investigator Grants"^"Cardiometabolic conditions (including heart disease and diabetes) are a leading cause of premature death and poor health in Australia and globally. My research will focus on identifying effective preventive treatments and methods to deliver these treatments to high-risk populations in Australia and other countries in our region, particularly to groups that have not previously had their needs adequately addressed. A focus will be on novel use of affordable and effective preventive drug therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016803"^"http://purl.org/au-research/grants/nhmrc/2016803"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Alzheimer's disease: causes, natural history, early diagnosis and prevention,Investigator Grants"^"Alzheimer’s disease (AD) is a devastating illness for a large number of people in our aging community. We have discovered the major causes of AD from our work over the past 40 years. We are now poised to develop disease modifying therapies (both pharmacological and non-pharmacological) and apply these therapies for prevention. We have defined when and where in the brain AD starts. Armed with this knowledge, we can implement diagnostic and therapeutic strategies for prevention."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016819"^"http://purl.org/au-research/grants/nhmrc/2016819"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dietary protein to improve outcomes from critical illness,Investigator Grants"^"Critically ill patients are admitted to an intensive care unit (ICU) to receive life support therapies but suffer rapid and severe muscle wasting. Dr Deane will evaluate whether increasing dietary protein using existing formula or specific amino acid supplements reduces muscle wasting. This program will determine whether there is a pragmatic and inexpensive solution for a condition that results in considerable mortality and morbidity to a large number of Australians each year."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016820"^"http://purl.org/au-research/grants/nhmrc/2016820"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Deregulated epigenetics and transcription in cancer,Investigator Grants"^"The Investigator grant will support Prof. Ricky Johnstone, a world leader in cancer research. His work focusses on how genes are regulated in normal and cancer cells through a process called epigenetics, and how de-regulated gene expression can result in cancer onset and progression. He and his team will determine how manipulating the proteins and pathways that control the expression of genes can inhibit cancer cell growth and survival, and regulate how our immune system responds to cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016822"^"http://purl.org/au-research/grants/nhmrc/2016822"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating Genomics into Improved Care of Inherited Heart Disease and Sudden Death Families,Investigator Grants"^"Inherited heart diseases are caused by errors in genes we are born with. These genetic errors can lead to heart muscle and rhythm disorders, which can cause sudden cardiac death in the young. This proposed research will use the latest clinical, genetic, and cellular approaches to identify what these genetic errors are, how these errors cause these clinical diseases, and how we can use this new knowledge to improve the care of patients with inherited heart diseases and prevent sudden death."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016825"^"http://purl.org/au-research/grants/nhmrc/2016825"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Knowledge and Interventions to reduce and prevent substance use related harms,Investigator Grants"^"I will study the epidemiology of illicit drug use, and improve estimates of substance use and mental disorders and health burden; and study prospective associations between disorders and harms. I will lead globally focused work on the epidemiology and harms of illicit drugs, and coverage of interventions to reduce harm; and examine interventions to address drug use, including treatment of opioid dependence and other interventions to reduce harm among people who use illicit drugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016826"^"http://purl.org/au-research/grants/nhmrc/2016826"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Illuminating the dark genome in cancer,Investigator Grants"^"Research into the genetic basis of cancer has largely focused on the 2% of human DNA that codes for proteins (what most people refer to as "genes"). In the last decade, it has become clear that a large proportion of DNA outside these genes (referred to as noncoding regions) is functional and can harbour genetic and epigenetic alterations that can promote the development of cancer. This research program will explore the contribution of these noncoding regions to cancer development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016827"^"http://purl.org/au-research/grants/nhmrc/2016827"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Capturing atomic snapshots to visualise epigenetic silencing machinery for identification of novel therapeutic targets,Investigator Grants"^"Heterochromatin, a tightly packed form of DNA prevents genes from being turned on. We know very little about heterochromatin biology at molecular level, despite its critical role in gene silencing. Through cryo-electron microscopy (cryoEM), I will study the protein complexes that lead to heterochromatin formation and maintenance. This information will enable the rational design of a targeted drug discovery program to treat diseases caused by epigenetic dysregulation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016833"^"http://purl.org/au-research/grants/nhmrc/2016833"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using MRI tools to map and mitigate brain harms in chronic cannabis use,Investigator Grants"^"Australia has one of the highest rates of cannabis dependence, and 28% of users report high distress and mental illness. Yet, the neurobiology of cannabis use is unclear. I will fill this knowledge gap by combining advanced brain imaging tools with large longitudinal datasets to map the brain mechanisms which predate, predict and underpin chronic cannabis use, and by trialling new interventions that directly target and mitigate brain dysfunction in chronic cannabis use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016841"^"http://purl.org/au-research/grants/nhmrc/2016841"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the autoimmune response against the brain to improve diagnosis and therapy of neuroimmunological disorders,Investigator Grants"^"Neuroimmunological disorders include neurological and psychiatric disorders affecting the brain, spinal cord, and nerves. Overall, they can affect up to 1% of the human population. They almost always result in a poor quality of life for children and adults and are a high cost burden for the community. The research program will explore the dysregulation of the immune system in these patients and will design new diagnostic and therapeutic approaches."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016851"^"http://purl.org/au-research/grants/nhmrc/2016851"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising strategies for control of neglected tropical diseases,Investigator Grants"^"Neglected tropical diseases (NTDs) are a group of health conditions that affect the poorest of the poor, particularly in remote and rural areas. They affect the most vulnerable communities and cause substantial, chronic health harms impairing personal and social development. Several debilitating NTDs are common in remote indigenous communities and Pacific islands. I propose a series of studies to investigate new strategies to control NTDs in large populations where these diseases are endemic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016866"^"http://purl.org/au-research/grants/nhmrc/2016866"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A pathway to new symptomatic drug therapies in dementia,Investigator Grants"^"The cognitive symptoms of dementia can be devastating for patients and their families. The drugs that are currently available to treat these symptoms are limited and they do not work for everyone. My program will identify new drug treatment options for cognitive symptoms, and, establish faster ways to help us translate these drugs into clinical practice – so that people with dementia can benefit from novel treatment options as soon as possible."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016876"^"http://purl.org/au-research/grants/nhmrc/2016876"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Repetitive Neurotrauma and the Risk for Dementia in Former Athletes,Investigator Grants"^"Contact and collision sports have been popular in Australia for generations, and many millions of people, worldwide, played these sports during their youth. There is tremendous societal concern about whether exposure to concussions and repetitive blows to the head during youth leads to accelerated brain aging and risk for neurological disease later in life. This project will make important advancements in medical and scientific knowledge relating to the long-term brain health of former athletes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016884"^"http://purl.org/au-research/grants/nhmrc/2016884"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building RNA therapies to re-program gene expression.,Investigator Grants"^"Gene mutations cause a wide range of inherited diseases. The delivery of mRNA therapies can replace mutated genes. However, mRNA therapies must be correctly expressed in the diseased tissue and match the expression of the mutated gene. I propose to build a toolkit of RNA structures that control expression of mRNA therapies in different tissues. This will allow their correct expression of mRNA therapies in disease tissues and a new opportunity to treat these currently incurable diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016894"^"http://purl.org/au-research/grants/nhmrc/2016894"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using advanced structural biology to exploit BCL2 effector proteins for new tailored therapies.,Investigator Grants"^"This research aims to identify new cancer drugs like venetoclax, which has revolutionised leukemia therapy by targeting one of eight BCL2 family proteins involved in cell death. Using Australia’s leading facilities, eg. the National Drug Discovery Center and Australian Synchrotron, this research will investigate the structure and function of three additional BCL2 proteins. This is expected to lead to new classes of drugs that can treat diseases where current therapies fail."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016907"^"http://purl.org/au-research/grants/nhmrc/2016907"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"BREATHE EASY - respiratory protection against airborne threats,Investigator Grants"^"MacIntyre is a leading international researcher &amp; woman with a 15-year track record of mask research. This will enable critical research on masks; aerosols &amp; how they are blocked by masks; and development of a novel, sustainable mask to meet global needs. These are seamlessly connected within a new NHMRC CRE, BREATHE on mitigation of airborne threats to health, which she leads. She has strong policy and industry links to ensure this research results in global solutions in respiratory protection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016908"^"http://purl.org/au-research/grants/nhmrc/2016908"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Antibody-based therapies against infectious diseases,Investigator Grants"^"Infectious diseases have resulted in devastating mortality in human populations throughout history. Antibody-based therapies have revolutionised modern medicine and will be important for the prevention and treatment of diseases caused by some of the world’s deadliest pathogens. Our program builds on a deep understanding of the molecular interactions between human and pathogen and leverages advanced antibody platforms to develop novel antibody therapies against malaria and COVID-19."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016909"^"http://purl.org/au-research/grants/nhmrc/2016909"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising the investment in real-time prescription drug monitoring,Investigator Grants"^"Opioid prescribing has increased substantially in recent times and is associated with significant harms. Various approaches have been adopted to prevent these harms, however research has shown some approaches add to harms. This research aims to better understand the impact of prescription drug monitoring programs on clinical decision-making and how these impact patient and population level outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016930"^"http://purl.org/au-research/grants/nhmrc/2016930"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Anti-fibrotic targeting and biosensor imaging in pancreatic cancer (PC): taking cancer targeting to new dimensions,Investigator Grants"^"Pancreatic cancer is a devastating disease in which high levels of dense tissue (otherwise know as fibrosis) surrounds the tumour and effectively protects the tumour from efficient drug delivery and penetrance, causing poor drug response. In this program of work, we outline how we can target this dense impenetrable fibrotic tissue to effectively improve drug delivery and response in this aggressive disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016947"^"http://purl.org/au-research/grants/nhmrc/2016947"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing pulmonary complications after major surgery,Investigator Grants"^"Contracting a chest infection after major surgery can be catastrophic. Despite the seriousness of this complication, we know little about how common it is, how much it costs hospitals, and how it impacts a person’s recovery after surgery. My research will provide world-first data on the impact of chest infections after major surgery, treatment guidelines for clinicians, and online methods to deliver breathing training before surgery - a treatment known to prevent chest infections after surgery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016951"^"http://purl.org/au-research/grants/nhmrc/2016951"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Phosphoinositide signalling in disease,Investigator Grants"^"Breast cancer is the most common cancer in women. Current treatment protocols are initially effective; however, more than half of patients experience relapse presenting an urgent need for new therapies. Lipid signals within cells can be hyperactivated in breast cancer promoting tumour growth and spread. We have discovered genes that regulate these signals, that when altered lead to poor outcomes in breast cancer. Here we will investigate these events to identify new biomarkers and therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016969"^"http://purl.org/au-research/grants/nhmrc/2016969"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Antigen Presentation and Adaptive Immunity,Investigator Grants"^"The research program I will carry out during this fellowship will characterise how the immune system detects and starts responses against pathogens and cancer cells. I will describe proteins and intracellular processes required to fulfil this function, which may be harnessed to develop more effective vaccines against infections, protect critically ill patients from hospital acquired infections, prevent autoimmunity and fight cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016991"^"http://purl.org/au-research/grants/nhmrc/2016991"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Patient-Specific CT-Derived Computational Modelling to Optimise Outcomes in Aortic Stenosis,Investigator Grants"^"Transcatheter aortic valve replacement (TAVR) has revolutionised the treatment of aortic stenosis by offering a less invasive alternative to open heart surgery. This study aims to use non-invasive images from cardiac CT to develop a novel, personalised technique that allow clinicians to perform 3D simulation of aortic valve implantation that predicts short and long term clinical outcomes. These results will provide new tools to make TAVR safer, more durable and accessible to more patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016995"^"http://purl.org/au-research/grants/nhmrc/2016995"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A multidisciplinary approach to reducing complications with extracorporeal membrane oxygenation,Investigator Grants"^"Critically-ill patients with heart and/or lung failure (including COVID19) may require advanced life support using a device called ECMO. Current ECMO systems are riddled with complications related to the patient-device interface, such as a poor surgical connection and a lack of regular and life-like clinical training. This project will improve the ECMO-patient interface through better devices and improved clinical training, and measure improvements in patient outcomes using large databases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017001"^"http://purl.org/au-research/grants/nhmrc/2017001"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Discovery and validation of antifibrotic therapies for kidney disease,Investigator Grants"^"Kidney failure is increasing by 6-12% annually, directly costing up to $1.8B pa. Despite optimum treatment of patients with chronic kidney disease, dialysis, kidney transplant or premature death ensues. This program will assess new treatments for which we have promising preliminary data &amp; dissect differences in the processes leading to kidney recovery vs irreparable damage after kidney injury. Consequently, new therapies will be developed and the next generation of scientists will be trained."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017012"^"http://purl.org/au-research/grants/nhmrc/2017012"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Smart technology for hip osteoarthritis: a personalised real-world ‘move’ into the future,Investigator Grants"^"My program will design and test a new treatment for hip osteoarthritis (OA). The team I lead has proven that people with hip OA load their hip in a detrimental way during daily activities, and that hip load can be improved with laboratory-based movement retraining. To translate changes into everyday life, retraining must now happen in the real-world. My program will partner authentically with stakeholders to co-develop a body-worn smart device for personalised self-management in the real-world."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017023"^"http://purl.org/au-research/grants/nhmrc/2017023"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Statistical bioinformatics at single cell resolution,Investigator Grants"^"This program will generate a framework and innovative bioinformatics tools to extract disease-associated signatures from multiple-modality single cell platforms for large cohort studies. Our strategy is based on contextual focus machine learning methods and novel statistical models to identify stable relationships among clinical and molecular measurements with robust predictive power across multiple platforms. This will accelerate the process of translational significant biomedical research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017033"^"http://purl.org/au-research/grants/nhmrc/2017033"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising novel therapies to improve lymphoma patient outcomes,Investigator Grants"^"Lymphomas are blood cancers that can be cured in some patients, but current treatments cause major side effects and many patients still die from this devastating disease. My research brings together clinical trials testing new therapies that manipulate the immune system, studies of blood and biopsy abnormalities, and new types of scans, in patients receiving these and standard treatments, with studies of real-world registry data, to improve treatment options and outcomes for lymphoma patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017060"^"http://purl.org/au-research/grants/nhmrc/2017060"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Circulating tumour DNA informed management of early-stage colorectal cancer and pancreas cancer,Investigator Grants"^"Colorectal or pancreas cancer is treated with surgery, then potentially chemotherapy, with that decision informed by examination of the cancer tissue that has been removed. This remains an imprecise way of estimating risk of recurrence and possible benefit from chemotherapy. My initial studies show that a blood test for circulating tumour DNA is a far more precise way of determining recurrence risk. I am leading 4 randomised studies looking to prove the benefit of ctDNA informed management."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017070"^"http://purl.org/au-research/grants/nhmrc/2017070"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using muscle-directed gene delivery to study and treat disease,Investigator Grants"^"Effective therapeutics are urgently required to combat the debilitating effects of skeletal muscle-related disease. This program of research will examine how cellular mechanisms control the functionality of skeletal muscle in health and disease, to pursue the development of innovative muscle-directed therapeutics to eradicate the loss of skeletal muscle mass and function as a cause of morbidity and early death, and combat other serious non-muscle diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017080"^"http://purl.org/au-research/grants/nhmrc/2017080"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Outcomes for People with Bone Metastases,Investigator Grants"^"MOST people with advanced cancer will develop bone metastases – where cancer spreads to bone. This leads to devastating physical and mental problems including bone fragility, bone pain and muscle weakness, along with distress, anxiety and depression. My previous work has proven that carefully prescribed exercise is SAFE for these high-risk people. Now, I aim to establish the clinical effectiveness of supervised and targeted exercise to strengthen muscle, rescue bone loss, and improve function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017081"^"http://purl.org/au-research/grants/nhmrc/2017081"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for ICU survivors with anaemia,Investigator Grants"^"More than 170,000 Australians require intensive care treatment each year. At discharge, nearly half are anaemic. This impairs recovery, increasing the risk of prolonged and repeated hospitalisation. My research has identified promising anaemia treatments. This Fellowship will allow me to generate high quality evidence to guide practice and policy with the aim of improving recovery after ICU. I will also develop new blood tests that will enable these treatments to be personalised."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017086"^"http://purl.org/au-research/grants/nhmrc/2017086"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mechanistic and pharmacological insights into peripheral sensory neuron function in physiological and pathological pain,Investigator Grants"^"Chronic pain is a major health issue in Australia and globally. Many currently used pain killers are associated with serious side effects or do not provide adequate relief for patients. One promising approach to develop better drugs is to directly modify activity of peripheral pain-sensing nerves, which often respond abnormally in pain states. This proposal seeks to better understand the molecular mechanisms of pain to facilitate future development of mechanism-based therapeutics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017125"^"http://purl.org/au-research/grants/nhmrc/2017125"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fear extinction as an experimental model for PTSD treatments and course,Investigator Grants"^"Treating psychiatric disorders such as posttraumatic stress disorder (PTSD) is challenging because the biological and cognitive processes involved in the disorders are unclear. This project will benchmark current experimental models of PTSD against real world clinical outcomes, such as treatment success and disease course. The project will design new and data-informed methods for experimentally modelling processes involved PTSD, leading to novel tools that will help to improve PTSD treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017131"^"http://purl.org/au-research/grants/nhmrc/2017131"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a bench to bedside platform for novel therapy development for psychiatric disorders,Investigator Grants"^"My vision for the next five years is to conceptualise, coordinate and lead a program for the bench to bedside development, validation and translation of new, evidence-based therapies for the most prevalent and disabling neuropsychiatric disorders, in particular depression, bipolar disorder, and schizophrenia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017138"^"http://purl.org/au-research/grants/nhmrc/2017138"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Extracellular vesicles-based drug delivery for cancer therapy,Investigator Grants"^"This research program aims to develop a novel treatment for metastatic breast cancer with the use of milk derived packages, an agent with anti-cancer properties. Late-stage breast cancer patients suffer from treatment failure and severe side effects from chemotherapy. Loading drugs into these packages will enhance the delivery, treatment response and limit the side effects. This will ultimately result in positive impact on the quality of life of cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017139"^"http://purl.org/au-research/grants/nhmrc/2017139"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising metabolic and mental health in the management of adolescent obesity,Investigator Grants"^"Effective treatment for adolescent obesity is vital. However, a subset of adolescents with obesity are vulnerable to eating disorders. This research brings together a collaboration of obesity and eating disorder researchers, clinicians and consumers to understand: 1) The prevalence of mental health concerns in adolescents with obesity; 2) How to identify adolescents at risk of developing an eating disorder; and 3) How to optimise obesity treatment to improve both physical and mental health"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017140"^"http://purl.org/au-research/grants/nhmrc/2017140"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing dynamic MRI to enable adaptive lung radiotherapy,Investigator Grants"^"MRI-Linacs are cutting-edge treatment machines that use magnetic resonance imaging (MRI) to image tumour anatomy and biological function with unrivalled quality while radiation therapy is performed with a linear accelerator (Linac). This program will use MRI technology to dynamically track moving lung tumours and identify radioresistant tumour tissue responsible for treatment failure. MRI-Linac advances will enable lung cancer radiation treatments with unprecedented accuracy and efficacy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017170"^"http://purl.org/au-research/grants/nhmrc/2017170"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation research: Delivering impact at the health-food retail interface for healthy food environments, with Indigenous communities,Investigator Grants"^"How food is promoted, priced and made available in food retail impacts consumer behaviour and subsequently population health. In partnership with communities, Aboriginal health services, the retail sector and policy-makers, I will generate new knowledge on determinants of, and effective strategies to address, dietary inequity for Aboriginal and Torres Strait Islander Peoples through a focus on the remote store environment, practice and policy, and establish a global remote store collaborative."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017176"^"http://purl.org/au-research/grants/nhmrc/2017176"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the Genetic Basis of Treatment Response for Depression,Investigator Grants"^"Depression is the most common psychiatric disorder and is most commonly trated with antidepressant medicationd and psychological therapy. However, many people discontinue treatment due to experiencing adverse side effects or experiencing no remission in symptoms. I aim to identify genetic factors that influence depression treatment response by analyzing large-scale genetic data. These insights could be used to understand who is most likely to benefit from certain types of treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017197"^"http://purl.org/au-research/grants/nhmrc/2017197"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Metagenomics Platform to Prevent Future Pandemics,Investigator Grants"^"Genome sequence data has transformed the study of emerging diseases. However, large-scale metagenomic data are cumbersome to analyse and have not been widely used for virus surveillance. This research programme will transform our understanding of the disease threat to Australian and global populations by developing a new bioinformatics pipeline to rapidly and identify viruses of potential public health impact and by performing a metagenomic survey of viruses at the animal-human interface."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017220"^"http://purl.org/au-research/grants/nhmrc/2017220"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Neural regulation of immunity,Investigator Grants"^"Immune responses are essential for the body to fight infections and cancer. It is well appreciated that communication occurs between the nervous system and the immune system, but how this occurs is unclear. Using new tools, genomics and highly advanced imaging, this project will define interactions between the nervous system and the immune system that can be precisely targeted to improve therapies and vaccines for infectious diseases and cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017223"^"http://purl.org/au-research/grants/nhmrc/2017223"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative screening and treatment approaches for diabetic complications,Investigator Grants"^"Diabetes is complicated by damage to the kidney leading to kidney failure and injury to blood vessels leading to heart attacks, strokes and amputations. My program will validate novel biomarkers for earlier detection and will develop novel and better treatments for diabetic complications, including in the Indigenous population. I will initiate clinical trials and translate into practice. As a clinician/ scientist my mission is to reduce the high health burden of diabetes and its complications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017225"^"http://purl.org/au-research/grants/nhmrc/2017225"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Detection and treatment of brain injury in growth restricted newborns,Investigator Grants"^"Babies that grow slowly before birth are more likely to suffer brain damage. There is no way to prevent this brain damage, it is difficult to detect, and there are no treatments. These babies often face a challenging life, with many problems including autism, ADHD, or cerebral palsy. My work will provide new knowledge on not only tests to detect brain damage to identify these babies earlier, this project will also explore treatments to improve life-long outcomes for these children."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017229"^"http://purl.org/au-research/grants/nhmrc/2017229"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving strategies to combat preventable infections,Investigator Grants"^"People living in and visiting resource-poor settings are at increased risk of exposure to infections spread through food, water, mosquitoes and the environment. Preventive strategies that should reduce infection exposure often have limited success in the real world. My research aims to understand and overcome the barriers that limit the effectiveness and uptake of key preventive strategies (such as improved water supplies and vaccination), to improve health outcomes in vulnerable populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017233"^"http://purl.org/au-research/grants/nhmrc/2017233"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Functional amplification of stem cells for tissue repair,Investigator Grants"^"Stem cells are increasingly being used to treat a diverse range of diseases. However, for such therapies to be clinically feasible and widely accessible, a large supply of quality stem cells are needed. Current methods of manufacturing stem cells are inadequate and expensive. This work aims to develop a safe, cost-effective, robust and more efficient way of propagating and preparing stem cells, by exploiting the potent, versatile actions of a human elastic protein on cell lifespan and behaviour."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017256"^"http://purl.org/au-research/grants/nhmrc/2017256"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unlocking precision medicine for 'incurable' child cancers,Investigator Grants"^"Although personalised medicine programs for children with cancer are better matching drugs to their molecular targets, the outlook remains dismal for patients with aggressive high-risk disease. I will develop new optimised combination therapies for treating these children, develop a new drug to prevent and treat childhood cancer, and develop new diagnostics to better predict treatment response and optimise personalised therapy, with the singular goal of improving patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017257"^"http://purl.org/au-research/grants/nhmrc/2017257"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building best-in-class bioinformatics tools to drive next generation biomedical research,Investigator Grants"^"To get a complete picture of disease, the analysis of data obtained from cutting edge biotechnologies applied to clinical samples is essential. To do this successfully, advanced statistical methods are needed. I will develop new software tools and curate large collections of molecular information to improve understanding of healthy ageing and disease processes. The tools will be freely available to researchers anywhere and will drive new discoveries and disease treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017267"^"http://purl.org/au-research/grants/nhmrc/2017267"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Beyond translation: Integrating clinical trials and intelligent health systems for stroke,Investigator Grants"^"Over the next 5 years my research will generate new knowledge with new clinical trials, novel AI-driven stroke assessment tools , and integrated telehealth technologies to enhance rural and regional stroke care. My research will leverage globally unique imaging and biobank data capabilities and my extensive national and international clinical trials network. These will drive the next phase of my successful track record of clinical translation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017278"^"http://purl.org/au-research/grants/nhmrc/2017278"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluation and implementation of a digital health literacy tool to improve written health information,Investigator Grants"^"Providing health information that all people can easily understand is a key step towards a fair and safe public health system, and one that empowers people to become active participants in their own health care. However, we currently lack sophisticated and scalable tools to achieve this goal. This project will evaluate a new online text-editing tool that helps health care providers write health information more simply, and provide strategies to increase its uptake within health organisations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017279"^"http://purl.org/au-research/grants/nhmrc/2017279"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Biomarker discovery informs precision medicine in childhood epilepsy,Investigator Grants"^"Epilepsy is a common problem affecting 3% of the general population, and is associated with comorbidities, affects the quality of life and poses safety risks. However, if diagnosed and treated appropriately, seizures can be reversed, improving morbidity and mortality. My program will generate novel biomarkers on a large clinical registry of refractory epilepsy patients to increase understanding of underlying disease processes and to provide patient specific precision medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017282"^"http://purl.org/au-research/grants/nhmrc/2017282"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Linking Brains: Histology, MRI, Connectivity and Functional Maps of Humans and Mice,Investigator Grants"^"This project uses imaging techniques to produce a new generation of brain atlases. It will advance our understanding of the organisation and connections of the human brain as well as that of the most commonly used animal to model human disease––the mouse. The atlases will inform the development of psychotherapeutic drugs and result in more accurate interventions on the human brain. The new maps will assist those who study the brain of patients with diseases such as Alzheimer’s and Parkinson’s."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017284"^"http://purl.org/au-research/grants/nhmrc/2017284"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evolutionary genomics to inform outbreak responses,Investigator Grants"^"Genomics has been essential to track recent pandemics, including those of COVID-19, Ebola, and drug-resistant bacteria. This project will develop methods to integrate epidemiological and genomic data, for a comprehensive system of infectious disease surveillance that will constantly update estimates of pathogen introductions and infectious spread. Implementation of these techniques in public health will dramatically increase the value of information for pandemic preparedness and mitigation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017289"^"http://purl.org/au-research/grants/nhmrc/2017289"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Determining cellular competency in the mammary gland,Investigator Grants"^"A mother’s ability to produce a nutritionally complete source of food for her baby is of central importance to human health. However, we understand very little about the cells in the breast that produce and secrete milk. I will visualise and quantify the function of individual cells in this tissue to better understand their behaviours and to improve our knowledge of the cellular functions and characteristics that can contribute to the development and progression of breast cancers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017295"^"http://purl.org/au-research/grants/nhmrc/2017295"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"One size does not fit all: achieving patient-centred deprescribing through evidence-based, individualised interventions,Investigator Grants"^"Reducing medicines (deprescribing) through stopping medicines or taking less medicines is a positive intervention that improves health outcomes. Deprescribing should be tailored and patient-centred, but it is complex and unclear how this can be achieved. This body of work will explore and develop evidence-based tools to enable individualised communication about deprescribing. This will ensure patients and GPs make good decisions about medicines use in older age."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017299"^"http://purl.org/au-research/grants/nhmrc/2017299"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Deciphering the rules of T cell residency across intestinal compartments,Investigator Grants"^"Tissue-resident memory T cells (TRM) are key for immune protection against infection at barrier sites such as the gut. While much of our understanding of gut TRM comes from studies on the small intestine, how these cells develop and function in the large intestine is unknown. This project aims to identify and modulate molecular pathways by which the intestinal microenvironment influences TRM development specifically in the small or large intestine to enhance immune protection against infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017302"^"http://purl.org/au-research/grants/nhmrc/2017302"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dietitian-led intervention for physical health disparities in people living with severe mental illness,Investigator Grants"^"Nutrition is a critical underlying issue for the significantly higher rates of chronic diseases, such as heart disease, experienced by people living with severe mental illness. Best practice nutrition intervention is yet to be determined. This project builds on promising pilot projects to determine the most effective interventions and to translate this into practice by formalising a clinical care process for dietitians and a resource for consumers to advocate for best practice nutrition support."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017325"^"http://purl.org/au-research/grants/nhmrc/2017325"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Delivering Precision Medicine to Population-based Cancer Prevention,Investigator Grants"^"My program will build upon my landmark studies that have demonstrated cancer risk factors that are modifications of DNA (epigenomic) rather than mutation of DNA (genomic) by building new, accurate prediction tools for cancer risk in the general population. This research program will advance cancer risk screening by including both epigenomic and genomic assessment and make it widely available in Australia to prevent cases of cancer and to develop new medicines for those who do develop cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017335"^"http://purl.org/au-research/grants/nhmrc/2017335"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Gatekeepers of optimal T cell immune function in health and aging-related decline,Investigator Grants"^"T cells protect from infectious disease and cancers, and boosting T cell activation is the goal of current immunotherapies. In older individuals, T cells become dysfunctional placing the elderly at much greater risk. However, precisely what is required for effective T cell activation, and what goes wrong in older individuals, remains poorly understood. This study will advance fundamental knowledge around T cell activation, critical for the ongoing development and optimisation of immunotherapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017353"^"http://purl.org/au-research/grants/nhmrc/2017353"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Uncovering new targets for cancer immunotherapy through multiplexed genomic screens in cytotoxic T cells,Investigator Grants"^"Immunotherapy is a modern approach to treat cancer and works by training the immune system, particularly T cells, to attack cancer cells. Immunotherapies are proving to be very successful in treating certain cancers, however, not all patients respond positively to this treatment for reasons that are still unclear. This project will identify the genetic factors that determine whether T cells have the capacity to fight cancer and discover new ways to improve patient responses to immunotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017370"^"http://purl.org/au-research/grants/nhmrc/2017370"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fallopian tube on-a-chip for understanding human reproduction,Investigator Grants"^"Infertility is on the rise, affecting &gt;180 million individuals worldwide. However, our knowledge of fertilisation is still insufficient and advances in treatment methods are infrequent. This project aims to develop new microfluidic technologies that closely represent the physiology and function of the female fallopian tube to directly study human reproduction. The project expects to bring new insights into unknown causes of infertility and improve treatment methods worldwide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017373"^"http://purl.org/au-research/grants/nhmrc/2017373"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the Breast Cancer Burden in Young Women,Investigator Grants"^"I aim to reduce the breast cancer burden in young women by finding out the causes of breast cancer in young women and how cancer risk can be accurately predicted and prevented. I will also investigate the future health of young women diagnosed with breast cancer so that health support is provided to young survivors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017382"^"http://purl.org/au-research/grants/nhmrc/2017382"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting the gut microbiota to treat cardiovascular disease,Investigator Grants"^"After four decades of research, we now know the association between fibre intake and lower blood pressure is dependent on our gut microbes. While our bodies are incapable of digesting some types of fibre, it feeds the community of ‘good’ bacteria, resulting in the release of substances that can lower blood pressure. In the next 5 years, I will establish how these substances lower blood pressure and test their use to treat patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017383"^"http://purl.org/au-research/grants/nhmrc/2017383"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A comprehensive vaccine-based strategy to combat gonorrhoea,Investigator Grants"^"The sexually transmitted infection gonorrhoea has a significant impact on global health, with 100 million cases/year, many of which are associated with infertility and increased HIV transmission. Due to increasing antimicrobial resistance and the absence of a vaccine, the WHO has classified gonorrhoea an urgent threat to public health that requires immediate action. My research aims to develop a vaccine to prevent gonorrhoea from becoming an untreatable ‘superbug’ in the near future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017388"^"http://purl.org/au-research/grants/nhmrc/2017388"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sickly sweet: managing high blood glucose during and post critical illness,Investigator Grants"^"High blood sugar levels occur frequently during critical illness even in patients without a history of diabetes. High blood sugar levels are associated with increased mortality in ICU and an increased risk of developing diabetes in survivors. My research will; (i) determine the efficacy of a new drug to manage high sugar levels in the ICU, (ii) identify mechanisms of how high blood sugar levels in ICU lead to diabetes, and, (iii) determine whether this can be prevented with screening programs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017404"^"http://purl.org/au-research/grants/nhmrc/2017404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing microbiome-based interventions to improve vaccine immunogenicity,Investigator Grants"^"Effective vaccination is critical for combating infectious disease. However, vaccine immune responses are highly variable between individuals and populations (e.g. lower in the elderly). New evidence suggests bacteria in our gut microbiome may be responsible. This program of work will allow us to understand how gut bacteria modulate activity of the immune system in response to vaccination. This knowledge will be crucial to both future vaccine development and improving vaccines currently in use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017405"^"http://purl.org/au-research/grants/nhmrc/2017405"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Better health outcomes after road traffic injury,Investigator Grants"^"Chronic pain is the leading cause of disability worldwide with 30% caused by a road traffic injury. My research will produce new knowledge under three aims. To: 1) Gain new insights into the development of chronic pain, 2) Test novel early treatments to prevent chronic pain after road traffic injury and 3) Implement early risk-screening models of care in the clinical and injury compensation environments. The outcomes will drive change in the assessment and treatment of road traffic injury."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017417"^"http://purl.org/au-research/grants/nhmrc/2017417"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Applying communication and social science to improve vaccine confidence and uptake,Investigator Grants"^"COVID-19 has put vaccination in the spotlight like never before. It is more important than ever to understand why some people don't vaccinate and what to do about it. This research will: 1) Use surveys to understand access and acceptance barriers to vaccination, and 2) Provide tools and training for community leaders to use to advocate for vaccination. The outcome will be to help more people feel comfortable about getting routine and COVID-19 vaccines in Australia and the Western Pacific Region."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017420"^"http://purl.org/au-research/grants/nhmrc/2017420"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting T cell differentiation and function to treat cancer and chronic disease,Investigator Grants"^"Chronic diseases, including persistent viral infections and cancer, are major health burdens and among the most difficult to treat. T cells play a central role in disease control; however, their function is often impaired by a process termed ‘exhaustion’. Immunotherapies aimed at reinvigorating exhausted T cells have revolutionised cancer treatment. In this project, I will identify molecular pathways that control T cells with the goal to pave the way for new immunotherapies for chronic diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017436"^"http://purl.org/au-research/grants/nhmrc/2017436"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Addressing the threat of emerging zoonotic malaria in our region,Investigator Grants"^"The monkey malaria parasite P. knowlesi (Pk) increasingly infects humans across Southeast Asia. A multidisciplinary approach will evaluate why Pk cases are rising, improve laboratory detection methods, assess preventative treatments, and inform public health programs. Pk genetic analyses will explore causes of severe disease and geographical infection patterns. Evaluating human interaction with mosquitos, monkeys, and land-use, will generate regional Pk risk prediction maps for targeted control."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017438"^"http://purl.org/au-research/grants/nhmrc/2017438"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative interventions to reduce the personal and societal burden of food allergy,Investigator Grants"^"Food allergy causes severely reduced quality of life and psychological distress for allergic children and their families. My vision is to free children and families from the burdens of living with food allergy. This 5 year program of research will: (i) identify and evaluate new treatments that induce remission of allergy, bringing a long-term solution that will transform the lives of allergic children and families; (ii) deliver innovative tools that improve the way food allergy is managed now."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017450"^"http://purl.org/au-research/grants/nhmrc/2017450"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving equity, access, and quality of cardiac rehabilitation services,Investigator Grants"^"Cardiac rehabilitation (CR) enables people who have suffered a heart event to self-manage their condition and improve their quality of life.However, many eligible patients (70%) do not attend. Telehealth-delivered CR can reduce access barriers, is safe, effective and is well-liked by patients. However, there is a practice-gap in translating these findings into practice. This project aims to provide a major health system impact by supporting the expanded use of telehealth across CR services."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017461"^"http://purl.org/au-research/grants/nhmrc/2017461"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New Toxin Tools for Dissecting Pain,Investigator Grants"^"There is worldwide demand for new and creative pain treatment strategies. The aim of my research is to identify new pain-causing toxins from animal venoms and to use them as tools to improve our understanding and, ultimately treatment, of pain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017463"^"http://purl.org/au-research/grants/nhmrc/2017463"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel approaches to understand and treat human allergic diseases,Investigator Grants"^"Allergic diseases affect ~1 in 3 Australians and carry significant health and financial burdens. Primary immunodeficiencies (PIDs) result from damaging mutations in genes that affect the development and function of immune cells. In addition to life-threatening infections, PID patients often suffer from severe allergies. I will investigate immune cells from PID patients and patients with allergy to reveal mechanisms of disease and novel approaches to understand and treat these conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017476"^"http://purl.org/au-research/grants/nhmrc/2017476"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prolonging survival in glioblastoma through targeting of quiescent glioma stem cells.,Investigator Grants"^"Most people diagnosed with the brain cancer glioblastoma die within 15-months. The cancer is so deadly because of slowly dividing cancer stem cells that resist treatment and cause patient relapse. My strategy is to eliminate these resistant cells by focusing on unique features of their biology, for example, by targeting the fact that these cells have increased expression of surface proteins. This project will test targeted molecules to establish an evidence base for Phase 1 trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017477"^"http://purl.org/au-research/grants/nhmrc/2017477"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An immunogenomic approach to breast cancer in young women,Investigator Grants"^"Breast cancer causes the highest number of disease related deaths in adult women under the age of 45. It is a difficult problem that is also becoming more common. To understand this disease better, we need a comprehensive and detailed approach. Using samples taken from real patients, we will apply the most sophisticated technologies available to us for revealing how and why a cancer develops. This will ultimately lead to better ways to treat, detect and prevent breast cancer in young women."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017479"^"http://purl.org/au-research/grants/nhmrc/2017479"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming Outcomes for Pulmonary Fibrosis,Investigator Grants"^"Pulmonary Fibrosis (PF) is a group of devastating conditions with scarring of the lung tissue - the most common has a survival of only 2-5 years. This research program will develop new techniques to understand the causes of PF; improve early and accurate diagnosis; correctly identify patients whose PF is more likely to progress rapidly, and those most likely to respond to treatment; and optimise delivery of PF care across Australia. This will enable more personalised approaches to treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017481"^"http://purl.org/au-research/grants/nhmrc/2017481"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The impact of chronic viral infections on molecular ageing processes and associated clinical outcomes,Investigator Grants"^"Older people with certain chronic virus infections age more quickly and have more ageing-related medical problems than people without chronic virus infections. This research will study key chronic virus infections – HIV and cytomegalovirus (a very common virus) – to better understand the biological processes that increase the risk of ageing-related medical conditions. The aim of this research is to discover novel screening and prevention measures to promote healthy ageing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017485"^"http://purl.org/au-research/grants/nhmrc/2017485"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Eliminating Malaria in the Asia-Pacific,Investigator Grants"^"In the Asia-Pacific, more than two billion people are at risk of malaria, a parasitic disease transmitted by mosquitoes. I will work with malaria endemic partners to provide evidence for the most effective malaria prevention strategies and improve surveillance so that every last malaria infection is detected, treated and eliminated. My program aims to change policy and advance progress towards the goal of malaria elimination in the Asia-Pacific by 2030."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017498"^"http://purl.org/au-research/grants/nhmrc/2017498"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A program of substantive and methodological research and capacity building in biostatistics,Investigator Grants"^"Adaptive platform designs are revolutionising how clinical trials are conducted. The proposed program of biostatistical and substantive research and capacity building in these study designs will not only lead to advances in statistical methodology and child health, but will ensure that Australia has the biostatistical skills and understanding to support cutting-edge clinical and public health research into the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017499"^"http://purl.org/au-research/grants/nhmrc/2017499"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Single molecular antigen rapid test (SMART),Investigator Grants"^"This project aims to investigate the role of the spike protein of the COVID-19 virus in binding antibodies and host cells. The project will use new knowledge to develop a Single Molecular Antigen Rapid Test (SMART). Expected outcomes include a better understanding of virus functions and their structural correlation at the molecular level, being able to visualise spike-induced cellular interactions, and a device that can detect multiple virus antigens, sensitively and very efficiently."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017504"^"http://purl.org/au-research/grants/nhmrc/2017504"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel approaches to improve blood pressure control,Investigator Grants"^"High blood pressure (BP) is the top killer of people in Australia, but only 1 in 3 adults with high BP has it under control. My vision is to rapidly improve BP control using four novel scalable approaches. My program will evaluate the effectiveness of highly promising interventions to lower BP: a salt substitute; a BP awareness campaign in hardware stores; using wearable cuffless BP monitoring; and a simplified treatment model with single pill combination therapy in primary care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017506"^"http://purl.org/au-research/grants/nhmrc/2017506"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Protecting physical &amp; mental health of trauma-exposed populations,Investigator Grants"^"Traumatic experiences are a risk factor for poor physical and mental health. This research program will generate critical knowledge on how lifestyle factors (physical activity, diet and sleep) impact mental and physical health, in people exposed to trauma. This includes emergency service workers, veterans and people from refugee and asylum seeker backgrounds. Results will inform how lifestyle programs can be integrated into routine care of people exposed to trauma (with, and at risk of PTSD)."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017515"^"http://purl.org/au-research/grants/nhmrc/2017515"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Multi-omic landscape of platelet function in disease,Investigator Grants"^"Platelets enable blood clotting and would healing during vascular injury requiring high levels of energy to be maintained during circulation in preparation for activation. The energy centre of the cell is packaged within platelets but its function is not well defined. This project will uncover how dysfunction in the energy centre affects the platelets and how this can be translated to diagnosis and treatments for patients with excessive bleeding or clotting leading to stroke or heart attack."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017517"^"http://purl.org/au-research/grants/nhmrc/2017517"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New method to identify disease-associated drug targets,Investigator Grants"^"This project aims to develop mass spectrometry-based methods to identify or characterise new targets for drug discovery. The application of the methods in target identification will allow finding of unknown protein targets for bioactive compounds and will revolutionise and dramatically accelerate the drug discovery process. Furthermore, adapting to studying membrane proteins will result in finding novel therapeutic ligands that target MPs, the most important class of drug targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017521"^"http://purl.org/au-research/grants/nhmrc/2017521"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting anhedonia to improve clinical and functional outcomes in depression,Investigator Grants"^"Anhedonia (loss of pleasure) is a key driver of disability in people with depression because it impairs functioning and responds poorly to treatment. This research aims to improve our understanding of anhedonia’s underlying causes and will evaluate whether a novel intervention improves symptoms and functioning for people with anhedonic depression. By informing new treatment approaches for anhedonia, the findings would make significant progress toward reducing the global burden of depression."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017527"^"http://purl.org/au-research/grants/nhmrc/2017527"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Next Generation Therapeutic Brain Stimulation for Depression and beyond,Investigator Grants"^"With millions of people suffering from depression and other mental illnesses, there is an urgent need for more effective treatments. I aspire to make possible a future in which dysfunctional brain circuits are routinely delineated using a person’s brain scans and treated using innovative brain stimulation therapeutics. My program will fundamentally advance the brain stimulation personalisation technology that I have developed and accelerate its clinical translation to improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017537"^"http://purl.org/au-research/grants/nhmrc/2017537"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Averting suicide contagion and suicide clusters in young people,Investigator Grants"^"Suicide is the leading cause of death in young Australians. Young people who are exposed to suicide are at significant risk of suicide themselves. The proposed research will transform suicide prevention policy by building the evidence base identifying who is at risk of suicide contagion and clusters and building a suite of practical resources that can be implemented and utilised by stakeholders and decision makers to avert further deaths in communities impacted by multiple suicide losses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017538"^"http://purl.org/au-research/grants/nhmrc/2017538"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes after high-risk surgery,Investigator Grants"^"Complications after operations are common and can result in chronic health problems or death. In this project, a large clinical trial will test whether treatment with a local anaesthetic drug, lidocaine, reduces the development of chronic pain one year after high-risk breast cancer surgery. Parallel studies will also assess the impact of enhanced ward monitoring after all types of high-risk operations and the role of inflammation in driving poor surgical outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017575"^"http://purl.org/au-research/grants/nhmrc/2017575"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Scalable Survivorship Support after Cancer (CanSupport): Evaluation of a co-designed and automated eHealth intervention to support cancer survivors in primary care,Investigator Grants"^"After cancer treatment, survivors need ongoing health support but access is limited. As an emerging survivorship researcher, my vision is to improve survivors’ access to support and health. I will expand my earlier breast cancer work to co-design a new support program for prostate, colorectal and lung cancer survivors sent via text messages called CanSupport, test if it improves support access and health in a primary care clinical trial and collect information to inform national roll-out."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017578"^"http://purl.org/au-research/grants/nhmrc/2017578"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Structural biology and protein engineering to accelerate rational development of novel antipsychotics,Investigator Grants"^"Schizophrenia is a debilitating psychiatric disorder that affects ~1% of the population, with a projected global economic burden of ~US$6trillion by 2030. Unfortunately, most schizophrenia patients discontinue antipsychotic treatment within the initial months of starting due to two key reasons: debilitating side effects and lack of efficacy. My research program is focused on solving these major bottlenecks with cutting-edge techniques and platforms for drug discovery at both new and old targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017580"^"http://purl.org/au-research/grants/nhmrc/2017580"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving sepsis outcomes using precision medicine,Investigator Grants"^"Sepsis occurs when your body’s response to infection damages its own tissues and organs, if not prevented or treated promptly it may be fatal. It affects 55,000 Australians each year causing 7,000 deaths. Survivors commonly suffer long term health problems. My research focusses on improving the design and conduct of clinical trials that will match the right treatments to the right patients at the right time thus reducing death and disability from sepsis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017583"^"http://purl.org/au-research/grants/nhmrc/2017583"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fair resource allocation decisions in old age – enhancing the quality-adjusted life year (QALY) framework,Investigator Grants"^"People aged 65 years and over, a rapidly growing age group, are significant users of health and aged care services. Funding decisions for services are guided by cost-effectiveness evidence, using quality-adjusted life years (QALYs) as a measure of effectiveness. Yet the methods used to derive QALYs in older adults are flawed. My research will provide evidence on how to improve the estimation of QALYs in older adults, promoting fairer and socially accepted funding decisions for older adults."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017605"^"http://purl.org/au-research/grants/nhmrc/2017605"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Emergency Department Identification and Care for Children with Sepsis,Investigator Grants"^"Sepsis is a severe infection of major national concern due to its morbidity and mortality. Early identification and optimal management of children at risk of sepsis in emergency departments are yet to be determined. My program will develop methods to identify these children, expand our understanding of sepsis causes and identify the most efficacious intravenous fluid for management. The goal is to improve sepsis care for children by filling evidence gaps for national/international guidelines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017609"^"http://purl.org/au-research/grants/nhmrc/2017609"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integration of Pre-hospital and Hospital cardiac clinical registries to investigate novel therapeutics and systems of care in cardiac emergencies,Investigator Grants"^"The cardiac emergencies of cardiac arrest and heart attack continue to be a major challenge, with unacceptably high mortality and morbidity. Best outcomes are seen when systems of care integrating pre-hospital and hospital care are optimized. My research team involves the collaboration of Ambulance Victoria, with hospital based cardiac clinical registries, allowing for the unique opportunity to perform pragmatic clinical trials, to improve therapies in patients who currently have poor outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017628"^"http://purl.org/au-research/grants/nhmrc/2017628"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting death anxiety with an online intervention to improve outcomes in anxiety-related disorders,Investigator Grants"^"High rates of anxiety disorders are a global issue, with dire need for scalable treatment. Death anxiety has been shown to underpin many anxiety-related disorders, making it a vital treatment target. This research program will examine the world's first online evidence-based intervention for death anxiety. It will provide evidence of whether interventions targeting death anxiety improve existing mental health symptoms, reduce relapse, and prevent development of new disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017630"^"http://purl.org/au-research/grants/nhmrc/2017630"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative public health strategies for the elimination of malaria and lymphatic filariasis,Investigator Grants"^"My vision is to improve the health of communities that have a high, yet often unrecognised, burden of parasitic vector-borne diseases, particularly malaria and lymphatic filariasis. My collaborative program of research will reduce the burden of these chronic debilitating infections in low-income countries, especially Papua New Guinea, by developing and testing new public health strategies and directly informing policy to target these infections more accurately, efficiently and effectively."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017642"^"http://purl.org/au-research/grants/nhmrc/2017642"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Digital health to support behaviour change and chronic disease prevention in the community: What works, for whom, and in what context?,Investigator Grants"^"The use of technology like apps to support health care and lifestyle behaviours is becoming increasingly common. However, the research to date is either non-existent or unclear as to which ones work best to improve health outcomes. I will address this gap by synthesising existing research and evaluating novel technologies such as artificial intelligence to better understand how digital technologies can be best used to improve health behaviours and prevent chronic disease in the community."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017646"^"http://purl.org/au-research/grants/nhmrc/2017646"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel approaches to the treatment and monitoring of patients with incurable haematological cancers,Investigator Grants"^"This project will focus on 2 largely incurable forms of blood cancer; T cell lymphoma (TCL) and acute myeloid leukemia (AML). We will join international collaborators contributing to large databases to examine the causes and predictors of outcome of TCL. I will undertake completely novel clinical trials using non-chemotherapy therapies which will include the scale-up in our laboratory of genetically engineered human immune cells called CART cells specifically designed for treating TCL and AML."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017651"^"http://purl.org/au-research/grants/nhmrc/2017651"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating Epilepsy Genetics Advances into Improved Patient Care,Investigator Grants"^"Many epilepsies are now known to be genetic. The time has come to use this knowledge in the management of people with epilepsy to improve their treatment outcomes. I will develop a research program that will translate the progress in epilepsy genetics in the past 20 years into better patient care by using genetic data to accurately classify epilepsies of unknown type and guide epilepsy surgery. I will also set up a platform to study therapies targeting genetic abnormalities causing epilepsy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017661"^"http://purl.org/au-research/grants/nhmrc/2017661"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimised Outpatient Parenteral Antimicrobial Therapy,Investigator Grants"^"Treatment of many complicated infections can now occur in the community rather than hospital. The approach of giving antibiotics in the home setting is preferred by patients and health services. However, practical challenges impact on which antibiotics are available for use in the home setting. Further, as this is a relatively new field, research on the best possible treatments and strategies to overcome practical challenges to antibiotic administration in the home setting are urgently needed."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017679"^"http://purl.org/au-research/grants/nhmrc/2017679"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Platform Technologies for Antibiotic Resistance Diagnostics at Single-Cell Resolution,Investigator Grants"^"My research aims to advance our understanding of antibiotic resistance in bacterial populations at the single-cell level. Examining the differences between individual bacterial cells in response to antibiotics is essential to provide fundamental insights into heterogeneous resistance, an important player precipitating the antibiotic crisis. Expected outcomes include improved knowledge of bacterial heterogeneity, informing antibiotic usage, and a new tool for more accurate resistance testing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017694"^"http://purl.org/au-research/grants/nhmrc/2017694"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Design and evaluation of novel interventions for infectious diseases of global importance,Investigator Grants"^"I will set up a new centre to conduct studies on how to prevent sexually transmitted infections and neglected tropical diseases in the countries most affected by these conditions. I will trial novel uses and new agents for mass drug administration, which involves treating whole populations when disease rates are high, rather than trying to find those with the infection. I will also evaluate innovative methods for tracking the impact of programs and strategies aimed at control of these diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017719"^"http://purl.org/au-research/grants/nhmrc/2017719"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming Injury for Aboriginal and Torres Strait Islander Children through Innovative Knowledge Gain and Co-designed Intervention,Investigator Grants"^"Indigenous children have high rates of injury, these rates are not decreasing and create burden in the community. My research program will address this through collaborating with Indigenous communities in South Australia and working with Big Data to understand the injury burden for Indigenous children, detect areas for improvement, and co-design an injury intervention for Indigenous children to decrease injury and improve health and wellbeing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017734"^"http://purl.org/au-research/grants/nhmrc/2017734"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Lungs for life: a programme of clinical trials to improve respiratory outcomes for premature babies,Investigator Grants"^"Almost 1 in 10 babies in Australia are born early (preterm). They often need help to breathe at birth, and for days and weeks afterwards. Some will go on to have long-term problems with their lungs. My research looks at how we can improve the outlook for preterm babies, by finding better ways to support their breathing, right from their first breath. Improving how we care for preterm babies immediately after birth can improve their lung health, as newborns, as children and through to adulthood."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017742"^"http://purl.org/au-research/grants/nhmrc/2017742"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Large scale evidence, microsimulation and translation to address contemporary challenges in tobacco control and cardiovascular disease,Investigator Grants"^"Chronic diseases, including cardiovascular disease (CVD), cancer, dementia, chronic kidney disease and chronic lung disease, are highly preventable and threaten Australia's continuing improvements in life expectancy. The proposed research will generate and translate large-scale evidence to drive improvement in tobacco control, electronic cigarettes and CVD, for the general and Aboriginal and Torres Strait Islander populations, including through creation of an enduring CVD microsimulation model."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017774"^"http://purl.org/au-research/grants/nhmrc/2017774"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advanced intravascular optical imaging in vivo for future precise diagnosis and treatment therapies,Investigator Grants"^"This interdisciplinary project aims to develop a new optical imaging modality using the high-speed and focus-tunable micro-lenses I recently invented. The device will be small enough to be inserted into blood vessels to provide high-quality images with unprecedented resolution and image depth. Artificial intelligence will be implemented for high-speed and real-time image processing. This will help specialists better visualise and understand the causes of heart attacks and how to prevent them."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017798"^"http://purl.org/au-research/grants/nhmrc/2017798"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Managing the First Pillar for Atrial Fibrillation and Stroke,Investigator Grants"^"This program will develop and evaluate a standardised approach to the management of lifestyle/risk factors for atrial fibrillation (AF) and stroke. Management of AF is currently not standardised and therefore leads to highly variable patient outcomes. Advancing risk factor modification as the primary AF management pillar, this program seeks to establish a new paradigm of upstream interventions for the prevention and treatment of AF and stroke, and formulate optimal delivery strategies for care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017818"^"http://purl.org/au-research/grants/nhmrc/2017818"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A holistic approach to achieving best health outcomes through culturally appropriate self-determined pathways into employment for Aboriginal and Torres Strait Islander people,Investigator Grants"^"This project will achieve best health outcomes for Aboriginal and Torres Strait Islander peoples by developing holistic culturally appropriate pathways into self-determined employment. The longer people remain unemployed the more likely they suffer from a range of health problems and premature deaths. By improving employment outcomes, we will improve the set of circumstances that individuals, families, and communities are born, grow, live and work. This will promote good health and wellbeing."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017828"^"http://purl.org/au-research/grants/nhmrc/2017828"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Turning the tide: co-developing drowning prevention interventions,Investigator Grants"^"Drowning is a leading cause of injury deaths. In the last 30 years, we have developed a good understanding of how we can prevent drowning incidents and deaths, but we have not implemented our knowledge to its full potential. Using robust methods and through a consultative process, I will work with communities and policy stakeholders in Australia and India to develop and implement, evidence-led drowning prevention solutions for populations most susceptible to drowning."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017844"^"http://purl.org/au-research/grants/nhmrc/2017844"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding and reducing hip osteoarthritis burden in young adults and adolescents,Investigator Grants"^"Hip pain is common in young adults, causing substantial burden and representing early hip arthritis. My research program will reduce the burden of hip pain in younger adults at risk of/with early hip arthritis. I will capture the natural history of hip disease and develop effective interventions, determining how to best treat hip pain in younger adult, and identify who is at risk of hip arthritis to stop the progression of hip pain to hip osteoarthritis and the need for hip replacement."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017876"^"http://purl.org/au-research/grants/nhmrc/2017876"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing innovative digital technologies to enhance youth mental health care,Investigator Grants"^"There is a growing youth mental health crisis. Mental ill-health remains the leading cause of death in young people. Of the one in four who suffer, only a quarter receive adequate care. To overcome this crisis, more accessible and effective treatments need to be developed. My research program will develop, evaluate and implement a new generation of treatments that harness advanced digital technologies to provide better care to young people."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017877"^"http://purl.org/au-research/grants/nhmrc/2017877"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeted regulatory T cells to treat autoimmune diseases,Investigator Grants"^"Autoimmune diseases occur when the immune system attacks a person's own body. These diseases affect more than a million Australians and hundreds of millions worldwide. There are no cures and current treatments cause significant side effects. This novel research program will use genetic engineering to develop a potent cell-based therapy that specifically treats the cause of disease. This new therapy has the potential to cure autoimmune diseases and restore the lives of many patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017879"^"http://purl.org/au-research/grants/nhmrc/2017879"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for children with anxiety disorders,Investigator Grants"^"Children whose mental health difficulties are identified early, and effectively addressed, reap the benefits across their lifespan. This has profound benefits for the child and the child’s family as well as significant social benefits. We need to invest in improving outcomes for children with anxiety to make an enduring difference to the mental health of all Australians. This work will improve access to, and delivery of evidence-based care and will improve treatments for children with anxiety."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017897"^"http://purl.org/au-research/grants/nhmrc/2017897"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating new therapeutics and diagnostics for stillbirth and preeclampsia,Investigator Grants"^"Stillbirth and preeclampsia are terrible diseases of pregnancy that can claim the life of the mother, or her unborn baby. Here, I propose large programs of research that will avidly hunt for new treatments and diagnostics to tackle both conditions. We will develop a blood test that may save babies from stillbirth. We will find new drugs in the laboratory to treat preeclampsia and test them in successive international clinical trials - mainly South Africa where the disease is sadly rife."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017898"^"http://purl.org/au-research/grants/nhmrc/2017898"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel Therapeutic Strategies for Childhood Brain Cancer,Investigator Grants"^"Brain cancer is the single disease causing the most deaths in childhood, as well as significant disability and long-term health problems for survivors, warranting urgent improvement to treatments. My program seeks to improve outcomes for children with the most aggressive brain tumours by developing new targeted treatment strategies, investigating immunotherapies, and developing strategies to allow effective drugs to penetrate into the brain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017903"^"http://purl.org/au-research/grants/nhmrc/2017903"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing novel lymph-resident targets and lymph-specific therapeutics to fight inflammation,Investigator Grants"^"The mesenteric lymphatic system plays vital roles in regulating dietary lipid transport and immune activation. Lymphatic dysfunction impairs these processes, and is detrimental in both obesity-associated metabolic disease and inflammatory bowel disease. This proposal will uncover the mechanisms driving mesenteric lymphatic dysfunction and associated inflammation. This knowledge will be used to establish lymph-specific therapeutics to enhance treatment outcomes in chronic inflammation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017912"^"http://purl.org/au-research/grants/nhmrc/2017912"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Linking microbiome, inflammation, HIV target cells,Investigator Grants"^"New HIV infections are now clearly associated with an inflamed genital tract (in both females and males) and the microbiome of these sites. What is unclear is the immune cell constitution of these inflamed tissues that may be the main drivers of increased disease. I have developed in my lab techniques to isolate and interrogate immune cells from human genital tissue and how they interact with HIV. I will connect the immune cell environment with inflammation and the microbiome."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017916"^"http://purl.org/au-research/grants/nhmrc/2017916"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tumour-stroma crosstalk in breast cancer: Deciphering and disrupting communications between cancer cells and cancer-associated fibroblasts,Investigator Grants"^"Breast cancer can be described as a play with many acts and actors. For approx. 20% of women diagnosed with this disease, there are no targeted therapies and for many more, recurrence and metastasis are major obstacles. Whilst tumour cells take centre stage in the diagnosis and treatment of this disease, it is now understood that fibroblasts play an important supporting role. Using novel methods to view and study this disease, my work will help to define the next generation of cancer therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017929"^"http://purl.org/au-research/grants/nhmrc/2017929"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the interplay between cell death and inflammation in human diseases,Investigator Grants"^"Cell death is a mechanism that allows old cells to be replaced by new cells or occurs during tissue damage. In some contexts, dying cells release inflammatory molecules that can be beneficial or detrimental to the body. This proposal aims to study the complex interplay between cell death and inflammation. Understanding the involvement of these processes in cancer and inflammatory diseases is essential to identify novel treatment strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017942"^"http://purl.org/au-research/grants/nhmrc/2017942"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing and Applying Mendelian Randomization Methods to Facilitate Drug Discovery and Solve Intractable Problems in Medical Research,Investigator Grants"^"Mendelian randomization is a way of using genetic data to test whether particular environmental exposures, biological molecules or drug targets cause disease. The purpose of this Investigator Award is to create new statistical methods and software that use Mendelian randomization to facilitate drug discovery, and to use the Mendelian randomization paradigm to solve high value questions in medical research that have so far proven intractable to other research approaches."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017952"^"http://purl.org/au-research/grants/nhmrc/2017952"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovating pathways to embed novel RNA technologies into clinical practise,Investigator Grants"^"Genetic rare disorders affect 1 in 100 individuals. A precise genetic diagnosis is the key to personalised healthcare, disease prevention, and sometimes a cure or treatment. For the 50% of families undiagnosed after DNA testing, the answer can lie in their RNA. I will lead an evidence-based national strategy to embed RNA diagnostics in clinical practise, vastly improving diagnoses of families living with genetic rare disorders and revolutionising their personalised health care options."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017962"^"http://purl.org/au-research/grants/nhmrc/2017962"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying clinically relevant neurobiological markers of depression and suicidal behaviours,Investigator Grants"^"Depression and suicide have a devastating impact on lives and communities. To develop more effective treatments, we need to gain a better understanding of the biological mechanisms underlying depression and suicide. This research program aims to identify brain markers that can assist in the diagnosis of depression and suicidal thoughts and behaviours and predict who is at risk for poor clinical outcomes over time."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017971"^"http://purl.org/au-research/grants/nhmrc/2017971"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using advanced CRISPR tools to improve clinical therapies for poor prognostic lymphomas,Investigator Grants"^"Treatment outcomes for certain aggressive blood cancers have not improved in recent years. Many patients do not respond and novel treatments are desperately required. My program aims to fill this gap by using sophisticated lymphoma models and unique molecular tools to discover new treatments and therapy resistance factors, and to test a new drug for clinical application. Outcomes of this work could improve life quality and chances for a cure for blood cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017974"^"http://purl.org/au-research/grants/nhmrc/2017974"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fighting Cancer Relapse: Developing an Oral Cancer Vaccine Generating Memory T Cells,Investigator Grants"^"Colorectal cancer (CRC) is the world's second most fatal cancer with a high rate of relapse. This project aims to develop an oral vaccine for preventing CRC recurrence by boosting the local gut immune response, which is at the frontline in powerful anti-cancer defence. This oral vaccine is based on cutting-edge research in immunology and nanomaterials, enabling robust and persistent protection against CRC recurrence, and enables convenient oral intake for maximal patient acceptance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018015"^"http://purl.org/au-research/grants/nhmrc/2018015"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Increasing the impact of food policy research in Australia and globally,Investigator Grants"^"My research will identify the critical factors required to support adoption and implementation of food policies by governments in Australia and globally. It will inform strategies to support researchers to strengthen the impact of future food policy research. This will ensure that evidence-based policies are to improve diets are adopted and implemented reducing the health and economic burden of diet-related diseases and meaning government funding for food policy research is well spent."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018064"^"http://purl.org/au-research/grants/nhmrc/2018064"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing perinatal health in Australia through international randomised studies to reduce death and disability.,Investigator Grants"^"Clinical trials have made big advances in treatment in all areas in Australia and worldwide. However most trials for high-risk babies and their mothers are too small to find improvements in healthy survival as quickly as we would like. We will work with stakeholders across the world to create a new kind of trial that will run at least ten times larger and faster, at one tenth the cost, saving thousands more lives and millions more dollars in Australia and overseas"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018071"^"http://purl.org/au-research/grants/nhmrc/2018071"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Early intervention for therapeutic benefit in AML: a national program of clinical trials,Investigator Grants"^"AML is a lethal blood cancer capable of developing resistance to therapy. Relapsing disease is the major barrier to improving outcome. I will build on my success in delivering new AML therapies by developing a national program of trials using technologies to detect returning disease at its earliest stages complemented by novel drugs to target AML with precision intent. A multidisciplinary team will elucidate mechanisms of resistance and validate alternative approaches to extend patient survival."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018077"^"http://purl.org/au-research/grants/nhmrc/2018077"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Saving lives with better blood pressure measurement,Investigator Grants"^"The research program aims to address problems related to inaccurate measurement of blood pressure (BP). I will use advanced analysis techniques to develop a better way to measure BP. Other program elements include examining the accuracy of BP measurement in high-risk patients and promotion best practice measurement methods and devices through translational research. Overall, the aim of the program is to minimise the burden of preventable cardiovascular disease in Australia and globally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018081"^"http://purl.org/au-research/grants/nhmrc/2018081"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New therapies for skeletal dysplasia,Investigator Grants"^"Inherited disorders of the skeleton are common with significant health impacts. My research has enabled treatment of these conditions at their genetic source. This program will assess whether drug treatment of infants with achondroplasia will decrease the 50-fold higher risk of sudden death by relieving pressure on the spinal cord, and assess whether treatment of children with metaphyseal dysplasia will relieve pain, improve skeletal deformity and eliminate the need for invasive surgery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018082"^"http://purl.org/au-research/grants/nhmrc/2018082"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Estimating the health equity and productivity impacts of dietary salt reduction in people with chronic kidney disease in Australia,Investigator Grants"^"Excess salt intake increases blood pressure and puts persons at risk of complications like chronic kidney disease (CKD) that kills one in ten Australians. CKD contributes to health inequalities and has a major impact on quality of life and productivity, and the future impacts in Australia are unknown. This project will evaluate long-term impacts of strategies to reduce population salt intake on CKD burden, to guide policies that improve the quality of life of all Australians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018098"^"http://purl.org/au-research/grants/nhmrc/2018098"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding and exploiting A-to-I RNA editing,Investigator Grants"^"This project will determine how changes to a type of RNA modification, termed Adenosine-to-Inosine (A-to-I) RNA editing, cause disease. Reduced A-to-I editing causes development of autoimmune disease and brain diseases. Too much editing is seen in cancer. I will use animal models to understand how changes in A-to-I editing cause disease. This will be important to provide knowledge of how these diseases occur and identify new ways to treat them."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018101"^"http://purl.org/au-research/grants/nhmrc/2018101"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Scaling the effects of salt substitute on cardiovascular risk reduction population-wide,Investigator Grants"^"In a world-first trial, we showed that switching regular salt for a reduced-sodium, added-potassium ‘salt substitute’ can lower blood pressure and prevent premature death. ‘Salt substitutes’ are safe and low-cost but are not widely used. Over the next 5-years I will do the work required to upscale their use in Australia and around the world. I will do this by building tools that show governments the health gains, cost-benefits and practical ways they can scale national uptake of salt substitute."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018105"^"http://purl.org/au-research/grants/nhmrc/2018105"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Decoding the instructions for immune cell function,Investigator Grants"^"Each organ sends many different signals to its immune cells to instruct them in varied and critical functions that impact health and disease. These signals are complex and there is a lack of tools to study them, so how they act to instruct immune cell function remains largely unknown. I will combine cutting-edge molecular and imaging technologies to discover how the breast instructs its immune cells and reveal new ways to control breast cancer, treat inflammation and improve infant health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018108"^"http://purl.org/au-research/grants/nhmrc/2018108"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing big data to improve access to care and outcomes in REcent Migrants And Refugees diagnosed with Cancer (REMARC),Investigator Grants"^"Cancer is one of the leading causes of death in Australia. There have been 4.5 million migrants and refugees to Australia in the last 30 years. This research program uses big data to study whether recent migrants and refugees diagnosed with cancer access the right treatments and the impacts of a cancer diagnosis on these people’s lifespan and employment. Our research will highlight current gaps and the policy changes needed to improve the lives of people diagnosed with cancer in this population."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018114"^"http://purl.org/au-research/grants/nhmrc/2018114"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the epigenetic control of female-biased autoimmune disorders,Investigator Grants"^"Our immune system is a complex network of cells that defend us from infections. In 5-8% of people, the immune system goes awry and mistakenly attacks the body’s healthy tissues, leading to autoimmune disease. Remarkably, 80% of autoimmunity patients are women, however, the molecular mechanisms behind this bias remain unknown. Using cutting-edge technologies, I will define female-specific mechanisms leading to autoimmunity, which will provide tools for diagnostics and drug target prioritisation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018118"^"http://purl.org/au-research/grants/nhmrc/2018118"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Food, mood and microbes: Improving mental health through diet,Investigator Grants"^"Mental health conditions like depression are a major cause of reduced quality of life. Unfortunately, medications are suboptimal for many people with the condition. Research shows changing your diet can improve depression. A Mediterranean diet rich in wholegrain cereals, fruit, vegetables and olive oil is particularly beneficial. However, we do not know how this diet improves depression symptoms and we need to identify ways to provide clear information about it to the people who need it most."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018144"^"http://purl.org/au-research/grants/nhmrc/2018144"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Driving change in the health sector to reduce the impact of intergenerational trauma and family violence,Investigator Grants"^"Intergenerational trauma and family violence are global public health issues with major impacts on the health and wellbeing of children, families and communities. My research will provide robust evidence about lived experiences of intergenerational trauma and family violence in priority populations to inform early intervention and health system reform. Co-designed intervention studies will provide evidence about ways to embed culturally safe, trauma-informed approaches into practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018157"^"http://purl.org/au-research/grants/nhmrc/2018157"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing digital technologies to improve the quality of youth mental health services,Investigator Grants"^"Mental disorders are the leading cause of disability and death among young people. While youth mental health services have improved access to care, many challenges contribute to ongoing service inefficiencies and poor clinical outcomes at high costs to society. This research program aims to address these challenges by making use of modern digital technologies to provide services with decision-support tools designed to make youth mental health care more personalised, dynamic and proactive."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018163"^"http://purl.org/au-research/grants/nhmrc/2018163"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Atrial fibrillation: improving outcomes through lifestyle and ablation,Investigator Grants"^"Atrial fibrillation(AF) is the most common heart rhythm disorder and an epidemic of cardiovascular disease. AF is associated with stroke, mortality and heart failure. Ablation involves passing wires into the heart and delivering tiny burns to cure AF. Increasingly lifestyle factors such as weight loss and alcohol reduction have also been shown to reduce AF. The research plan explores yoga, medicated weight loss and new ablation techniques to improve outcomes in people with AF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018167"^"http://purl.org/au-research/grants/nhmrc/2018167"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting crosstalk in the tumour microenvironment for precision cancer therapy,Investigator Grants"^"Cancer spread remains very difficult to target therapeutically. My research focus has been modelling the cellular interactions that occur during cell spread to develop markers that predict the effectiveness of existing therapies and to uncover new biological targets for treating aggressive cancer types. I now aim to drive this research into the clinical setting by utilising unique humanised models and interrogating patient samples to enable science-guided therapies for cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018182"^"http://purl.org/au-research/grants/nhmrc/2018182"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Musculoskeletal pain: getting the right patient to the right treatment at the right time,Investigator Grants"^"Common painful conditions affecting the bones and joints such as low back pain and arthritis cause more disability than any other condition, and the scale of the problem is rising. Health care is struggling to meet the demand, commonly offering treatments of limited value to patients who don't need them, whilst not providing access to effective care for those who do. This program will reduce uncertainty about treatment effectiveness and ensure patients get access to the care they need."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018187"^"http://purl.org/au-research/grants/nhmrc/2018187"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging liver-derived extracellular vesicles to identify new therapies for type 2 diabetes,Investigator Grants"^"Type 2 diabetes is characterised by impairments in glycemic control, compromised insulin secretion, and insulin resistance. There is an urgent clinical need to develop new strategies to normalise blood glucose levels. This investigator grant aims to identify novel insulin-independent therapeutic targets that can improve glycemic control. This project will use preclinical models to validate the efficacy of these targets, setting the stage for the development of new treatments for type 2 diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018194"^"http://purl.org/au-research/grants/nhmrc/2018194"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative solutions towards reducing heart attacks- beyond classical risk factors,Investigator Grants"^"I am a cardiologist driven by the increasing number of heart attack patients who ask “why me?”. Fourteen-27% of patients with life-threatening heart attacks have no standard modifiable risk factors. By focussing on this growing group with no risk factors, I will discover and translate new biomarkers, develop new drugs to reduce heart attacks, derive new clinical pathways, and improve outcomes with broader benefits to all patients susceptible to coronary artery disease and heart attack."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018204"^"http://purl.org/au-research/grants/nhmrc/2018204"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing Refugee Mental Health,Investigator Grants"^"The number of refugees worldwide has reached unprecedented levels. Refugees show high rates of psychological disorders due to exposure to war, trauma and persecution. Despite this, many do not seek help or fail to respond to treatment. This research program proposes to increase knowledge about the factors contributing to PTSD and help-seeking. This will lead to the development of two new interventions to improve mental health outcomes in refugees."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018214"^"http://purl.org/au-research/grants/nhmrc/2018214"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reconstructing the megakaryocyte lipidome to control platelet production: Applications for thrombocytopenia or thrombocytosis,Investigator Grants"^"Platelets are cell fragments critical for blood clotting. Too few, results in bleeding disorders and too many, can block blood supply to organs. Both are life threatening. Current treatments are limited and have side effects. There is an urgent need to identify new ways to counteract both extreme conditions. We recently identified important lipids that are needed for platelet production. Here, we aim to increase or decrease these lipid levels to determine if we can control platelet production."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018220"^"http://purl.org/au-research/grants/nhmrc/2018220"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimizing strategies for control of neglected tropical diseases,Investigator Grants"^"My research program will optimize strategies for control of neglected tropical diseases which are closely associated with poverty, affecting 2 billion of people globally. The specific aims of this research program are: 1) optimising programs for control of intestinal worms; 2) integration of control programs to increase their impact and 3) defining the public health role of a new and promising medication, moxidectin. Findings will be used to inform policy makers and improve existing guidelines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018222"^"http://purl.org/au-research/grants/nhmrc/2018222"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pathogen Genomics Dual Utility to Deliver Personalised Medicine and Precision Public Health,Investigator Grants"^"Novel treatments for COVID-19 have rapidly been developed and are used to prevent severe SARS-CoV-2 infection in patients with underlying health conditions. The SARS-CoV-2 virus is evolving rapidly and this has led to variants that can reduce the effectiveness of novel antiviral treatments. This grant will develop genomic tools to predict the optimal SARS-CoV-2 therapeutic needed whilst monitoring for viral resistance in patients that fail antiviral therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018244"^"http://purl.org/au-research/grants/nhmrc/2018244"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Leveraging genomics to unravel tumour complexity and improve patient outcomes,Investigator Grants"^"Cancer is the cause of 1 in 8 deaths worldwide. Cancer occurs due to errors or mutations in the DNA of normal cells. I will identify the mutations in tumour cells to determine: i) How a tumour develops and how complex it is ii) How a tumour may be treated to kill the cancer The work studies a variety of cancer types including mesothelioma, melanoma, oesophageal and breast cancer. The overall vision is to apply some of the research findings or approaches into patient care to improve patient survival"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018256"^"http://purl.org/au-research/grants/nhmrc/2018256"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A rapid synthetic molecular evolution platform for novel antimicrobials against infections,Investigator Grants"^"Infections caused by antimicrobial resistant bacteria are rapidly increasing worldwide, with 106 million new cases annually. Antimicrobial peptides are a promising therapeutic to tackle the shortage of antibiotics. However, conventional development of antimicrobial peptides is limited by inadequate preparation of large parallel libraries and ineffective bioactivity tests. I will develop novel approaches via computational modelling and smart synthesis to identify therapeutic to combat infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018340"^"http://purl.org/au-research/grants/nhmrc/2018340"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Breakthrough research paving the way for the development of transformative immunotherapies for SLE.,Investigator Grants"^"Lupus is a debilitating autoimmune disease which is very hard to treat. Patients with lupus have a leaky gut but the role of this medical anomaly in driving disease is not known. Breakthrough data from our group showed that modifying the biology of immune cells in the gut, restores gut health and protects against lupus. We propose to harness the biological mechanisms underpinning this new therapeutic effect for the development of transformative and much needed new therapies for lupus."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018360"^"http://purl.org/au-research/grants/nhmrc/2018360"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the genetic diagnosis of cardiovascular disease,Investigator Grants"^"Cardiovascular disease (CVD) claims 17.9 million lives each year and has remained the leading cause of death globally for the last 20 years. Using genomic technologies and novel computational methodology, I will improve the rate of genetic diagnosis of cardiovascular disease and provide better understanding of the disease mechanism. This research program will enable personalised management and treatment, and improved risk assessment for CVD patients and their families."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018363"^"http://purl.org/au-research/grants/nhmrc/2018363"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RNA-level gene regulation,Investigator Grants"^"Genetic information resides in the DNA of our genome; however, to use this information it must be transcribed into chemically related RNA molecules, collectively known as the transcriptome. While different body cells carry the same genome, they differ widely in their transcriptome composition. To understand how cells properly utilise their transcriptomes, I will characterise the marks and binding partners found on RNA in the context of cardiac and cancer biology."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018376"^"http://purl.org/au-research/grants/nhmrc/2018376"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of novel ablation technologies for the treatment of ventricular tachycardia,Investigator Grants"^"Rhythm disorders from the main pumping chambers of the heart (ventricular arrhythmias, VA) cause 1 in4 of all deaths from heart disease. VA can be treated effectively by finding and destroying the circuits within heart scar tissue that perpetuate VA (ablation). The study innovates new technology and minimally invasive approaches to reduce the risk of VA for patients with heart disease, prolonging longevity and improving quality of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018383"^"http://purl.org/au-research/grants/nhmrc/2018383"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Simplified Immunotherapies for Global Oncology,Investigator Grants"^"Around 1 in 5 cancers worldwide are caused by infections. These are particularly important in the developing world, where they account for the majority of cancer cases and deaths, often in young people. This grant continues my world-leading work in developing drugs to treat and prevent cancers caused by infections, and in understanding their origins. I focus on simple but effective drugs that can be used in developing countries, to ensure my new treatments can be used by those in greatest need."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018391"^"http://purl.org/au-research/grants/nhmrc/2018391"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Addressing unmet needs in chronic disease through innovations in trial design and delivery,Investigator Grants"^"This program will utilise innovative designs and new digital capabilities to address some of the challenges in completing randomized trials in chronic disease. Trial designs will be informed by clinical practice and a good understanding of clinician and consumer attitudes to proposed trials. These approaches will facilitate large, simple randomized quality assurance studies and trials embedded in clinical practice, leading to improvements in clinical outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018420"^"http://purl.org/au-research/grants/nhmrc/2018420"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Expanding genetic causal inference analyses to evaluate cancer risk factors in diverse populations,Investigator Grants"^"My research studies the use of statistical models applied to large-scale genetic data to help us understand what causes diseases such as cancers. Using these models, I investigate whether the genetic background underlying cancers can give us clues about whether the observed relationship between a range of putatively modifiable risk factors and common cancers is causal in European populations. I am also investigating whether the same genetic relationship is present in other populations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018431"^"http://purl.org/au-research/grants/nhmrc/2018431"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards improved clinical outcomes for common brain disorders using large-scale statistical genomics,Investigator Grants"^"The social and economic costs of common brain disorders, such as autism spectrum disorder and Parkinson’s disease, are enormous. My research aims to generate new knowledge on these conditions by using advanced statistical methods to integrate large-scale genetics and genomics with deep clinical and lifestyle data. Ultimately, this is expected to underpin improved clinical outcomes and quality of life through prevention, earlier diagnosis, and safer evidence-based treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018432"^"http://purl.org/au-research/grants/nhmrc/2018432"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterisation of the genetic architecture of autoimmune disease at single-cell resolution,Investigator Grants"^"Autoimmune disorders represent a considerable burden for the healthcare system, affecting up to 9% of the human population. Genetic factors are the most significant contributors to autoimmune disease risk; however, their effects on individual immune cells remain unknown. My research seeks to characterise the functional impact of genetic factors in pathological cell states and their role in mediating autoimmunity to ultimately improve the treatment of autoimmune conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018440"^"http://purl.org/au-research/grants/nhmrc/2018440"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the cellular ecosystems and therapeutic vulnerabilities of breast cancer,Investigator Grants"^"Solid cancers are complex cellular ‘ecosystems’ in which the growth and drug response of the tumour is controlled by cell interactions. We will use single cell genomics to understand the nature and interactions of cells that make up breast cancers. This will help us to better understand the role of specific cell types in the development of cancers and find improved ways to treat cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018461"^"http://purl.org/au-research/grants/nhmrc/2018461"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineering protein diagnostics/therapeutics via next-generation enzymatic and genetic code expansion approaches,Investigator Grants"^"The use of protein conjugates for therapeutic or diagnostic applications is widespread. However, currently employed protein modifying technologies are largely non-specific and result in a mixture of conjugates. It is difficult to predict how such mixtures perform in a clinical setting and typically a substantial fraction underperforms. To address these issues, the proposed project aims to establish a platform for generating new types of highly defined protein conjugates."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018465"^"http://purl.org/au-research/grants/nhmrc/2018465"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Supporting healing and recovery for Aboriginal and Torres Strait Islander survivors of childhood sexual abuse,Investigator Grants"^"Child sexual abuse is a form of violence that occurs across nations and cultures worldwide. Collective efforts are being made to address this issue within Victorian Aboriginal and Torres Strait Islander communities. This research will generate new knowledge about survivors lived experiences of healing and recovery, identify current therapeutic practices, and build training and education resources that support Aboriginal organisations to better meet the healing and recovery needs of survivors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018477"^"http://purl.org/au-research/grants/nhmrc/2018477"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming Care and Outcomes for Patients with Pleural Effusion,Investigator Grants"^"My world-leading program brings together clinicians, scientists and allied health researchers to advance knowledge and care of pleural effusions (fluid build-up in the chest), a neglected condition that affects 60,000 Australians a year. Our consumer-driven research will use multicentre randomised trials, multidisciplinary (diet, exercise, psychology) approaches and cutting-edge laboratory techniques to improve diagnosis and treatment of pleural effusions esp those from cancer and infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018497"^"http://purl.org/au-research/grants/nhmrc/2018497"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Microvascular dysfunction in acute ischemic stroke: The next frontier in stroke reperfusion,Investigator Grants"^"Ischemic stroke is due to an abrupt blockage in a major brain artery. Over half of patients who receive acute treatment do not improve for unclear reasons. We will study how dysfunction of microcirculation (microscopic vessels in the brain) leads to complications and reduces treatment effectiveness. Ultimately, the aim is to develop a new therapy targeting the microvessels that can augment the benefit of reperfusion treatments in stroke."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018514"^"http://purl.org/au-research/grants/nhmrc/2018514"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Melanoma: Getting the Diagnosis and Treatment Right for Better Patient Outcomes,Investigator Grants"^"Melanoma is a major Australian health problem. Prevention, early diagnosis and appropriate treatment remain the linchpins of disease control. Over the past decade, new drug therapies have improved previously dismal outcomes for metastatic melanoma patients. This research proposal will integrate molecular and immune profiling with clinical and patient factors, and personalised treatment strategies, to transform melanoma diagnosis, risk prediction and treatment across all stages of the disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018534"^"http://purl.org/au-research/grants/nhmrc/2018534"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovation for global lung health,Investigator Grants"^"This program of work is dedicated to mitigating the global burden of ill-health due to lung disease. I have focused on the major respiratory diseases that are responsible for death and disability worldwide, noncommunicable chronic respiratory disease (asthma and COPD) and tuberculosis, and air pollution, a major environmental cause of ill-health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018537"^"http://purl.org/au-research/grants/nhmrc/2018537"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Innovative clinical trials: improving care and health outcomes,Investigator Grants"^"Ground-breaking clinical trials intended to advance care and improve health outcomes nationally and internationally will be undertaken. The focus will include trials and new methods in cardiovascular disease and diabetes particularly. Evidence synthesis for reliable guidelines and policy decisions will be conducted. Projects will link basic science research with clinical outcomes to improve our understanding of disease and treatment mechanisms."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015556"^"http://purl.org/au-research/grants/nhmrc/2015556"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hearing loss, the silent enemy of good health: Effectiveness, cost-effectiveness, and potential economic and social impact of interventions to promote treatment to facilitate improved hearing,Targeted Call for Research"^"Hearing loss impacts many adults of all ages, and 7 in 10 adults aged over 70 years. Despite significant associated health, well-being and financial costs, referrals for hearing care, hearing aid adoption and use are very low. This project will identify barriers to medical referral for hearing care and barriers to hearing aid uptake and use and will design and evaluate the feasibility and cost-effectiveness of interventions to address these, leading to improved health outcomes for Australians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015700"^"http://purl.org/au-research/grants/nhmrc/2015700"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving access to the hearing services program for people from culturally and linguistically diverse backgrounds,Targeted Call for Research"^"Hearing loss affects 1 in 5 people, impacting communication, quality of life, education and employment, social activities, and physical and mental health. People can get effective help for hearing loss. But people from culturally and linguistically diverse communities are less likely to get help. We will work with people from culturally and linguistically diverse communities to co-design accessible, equitable and culturally safe hearing services to preserve and protect hearing health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015711"^"http://purl.org/au-research/grants/nhmrc/2015711"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Implementation and Evaluation of a Co-designed Program Targeting the Psychosocial and Emotional Impacts of Hearing Conditions in Adults,Targeted Call for Research"^"Hearing conditions have many psychosocial consequences and the most common forms of management (e.g., hearing aids) do not appropriately address these concerns. This project will develop an online Hearing Wellbeing Program (HWP) to improve the psychological, social, and emotional wellbeing of people with hearing conditions. The project will test the feasibility of implementing the HWP and then assess the program for its effectiveness in improving the wellbeing of people with hearing conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015735"^"http://purl.org/au-research/grants/nhmrc/2015735"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building on newborn hearing screening success: towards national standards and data management,Targeted Call for Research"^"Australia’s universal newborn hearing screening enables early hearing loss identification, access to hearing devices and early intervention. But we do not know how hearing programs improve child outcomes, who do not access services, and whether postnatal screening occurs. We will establish the prerequisites of a national child hearing database to ensure screening/interventions improve child outcomes, ensure no deaf or hard-of-hearing child ‘falls through the cracks’, and facilitate research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015748"^"http://purl.org/au-research/grants/nhmrc/2015748"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Empowering adults with hearing loss by increasing informed choice, accessibility, and uptake of hearing healthcare,Targeted Call for Research"^"The problem. Four million Australians have hearing loss. Yet many do not seek help, and are unaware of the hearing healthcare options that are available. This leads to many people not obtaining the hearing healthcare they need. Our solution. We will co-create a tailored online decision aid to explain the pros and cons of available hearing health options. We anticipate this approach to decision-making will increase uptake of hearing healthcare and improve the lives of many adults with hearing loss."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015750"^"http://purl.org/au-research/grants/nhmrc/2015750"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prevalence of hearing loss in Aboriginal children caused by otitis media from birth to 5 years of age and evidence of the effectiveness of health promotion programs: evidence to inform national policy,Targeted Call for Research"^"This project will provide the first estimates of the number of Aboriginal children who have ear infections and hearing loss from 0 to 5 years of age and will demonstrate the feasibility of screening for ear infections and hearing loss from 2 months of age. It will also test, for the first time, the effectiveness of a health promotion intervention to resolve ear infections and prevent hearing loss without the need for surgery. If effective, this intervention can be implemented nationally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015793"^"http://purl.org/au-research/grants/nhmrc/2015793"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pathways For Aboriginal and Torres Strait Islander Hearing Health: The PATHWAY Project,Targeted Call for Research"^"All children have the right to hear well, but Aboriginal and Torres Strait Islander children have inequitable access to hearing healthcare. Multifaceted strategies are needed which consider people’s first-hand experiences in the co-design of solutions. This project will generate evidence of culturally appropriate methods to build a strategy which optimises the complex and difficult to navigate hearing health patient pathway experienced by Aboriginal and Torres Strait Islander children."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015794"^"http://purl.org/au-research/grants/nhmrc/2015794"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hearables and behavioural activation for mental distress and social isolation in hearing impaired older adults,Targeted Call for Research"^"Age-related hearing loss is common and may lead to depression, social isolation, loneliness, and reduced quality of life. Hearing aids are expensive and simpler, cost-effective hearing amplification devices (hearables) may offer an alternative treatment strategy. This trial will test if hearables in addition to a pragmatic psychological intervention (behavioural activation) improves mood, quality of life, mental distress and social isolation in older adults with mild to moderate hearing loss."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015803"^"http://purl.org/au-research/grants/nhmrc/2015803"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the psychosocial and emotional well-being of adults with hearing loss through co-designed evidence-based services: ACE2.0,Targeted Call for Research"^"Hearing loss affects a person’s ability to communicate and to socialise. Community members will partner with researchers to develop an innovative and contemporary education and support program to help adults with hearing loss and their family overcome the everyday communication, social, and emotional difficulties they experience. The solution will be rolled out and evaluated in hearing services across Australia and subsequently be made available to all Australians with hearing loss."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015740"^"http://purl.org/au-research/grants/nhmrc/2015740"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bridge to Better Health: A Cluster Randomised Controlled Trial for Capacity Building in Intellectual Disability Health for General Practice,Targeted Call for Research"^"We will improve preventive health outcomes for people with intellectual disability by supporting general practice nurses to do health assessments with their patients with intellectual disability. We will provide access to a specialist intellectual disability nurse, training on conducting a health assessment, intellectual disability health training and access to online resources. This intervention is designed to be able to be rolled out nationwide and will be evaluated using a randomised trial."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015753"^"http://purl.org/au-research/grants/nhmrc/2015753"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"GeneEQUAL: equitable and accessible genomic healthcare for people with intellectual disability,Targeted Call for Research"^"The GeneEQUAL team are: • self-advocates • researchers • clinicians. We will talk with: • people with intellectual disability • their families • their doctors. We will ask them about genomic health care. Genomic health care is genetic tests and genetic counselling. We will write guides and resources so that genomic healthcare will: • include everyone respectfully • help people make healthcare choices • help people understand about their health conditions • help people get the right treatments and support."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015902"^"http://purl.org/au-research/grants/nhmrc/2015902"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing potentially preventable hospitalisations and building health literacy for children and adolescents with intellectual disability,Targeted Call for Research"^"Children with intellectual disability have high health care needs but access to primary care services can be hampered by difficulties they and their carers face day to day, leading to potentially preventable hospitalisations. We will examine use of health services in hospital and primary care settings for these children, the enablers and barriers to using primary care services, and how health service use can be optimised for better care and be available across the community."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2015929"^"http://purl.org/au-research/grants/nhmrc/2015929"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Equitable access to health and disability services for Aboriginal and Torres Strait Islander children with intellectual disability,Targeted Call for Research"^"This project will improve the health and wellbeing of Indigenous children with intellectual disability (ID) by recommending effective models of care to ensure appropriate, timely diagnoses and access to high-quality health and disability services. National Disability Insurance Scheme data and interviews with families, adolescents with ID, and healthcare and disability services will be analysed to identify barriers and facilitators to meeting the healthcare needs of Indigenous children with ID."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021932"^"http://purl.org/au-research/grants/nhmrc/2021932"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Natural killer cell immunotherapy in paediatric sarcomas,Postgraduate Scholarships"^"Sarcomas account for 10% of childhood cancers. It is a group of cancers arising from the bone or soft tissue with less than 30% chance of cure when it has spread or comes back despite intensive and possibly mutilating therapies. Natural killer (NK) cells are a type of immune cells known for their ability to kill cancer cells. This project aims to prove that our immune cells can be used to treat sarcomas by selecting the appropriate NK cells for the patients based on their receptor expression."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021941"^"http://purl.org/au-research/grants/nhmrc/2021941"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Overweight and obesity in young adults with type 1 and type 2 diabetes: mortality, pregnancy outcomes, and novel glycaemic interventions,Postgraduate Scholarships"^"This project aims to explore the impact of overweight and obesity on long-term outcomes and pregnancy outcomes in young people with type 1 diabetes, and to make comparisons with young-onset type 2 diabetes. Furthermore, this project aims to produce highly novel randomised trial data on the efficacy of novel glycaemic and obesity interventions in people with overweight/obesity and type 1 dabetes/young-onset type 2 diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021945"^"http://purl.org/au-research/grants/nhmrc/2021945"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evaluation and diagnosis of cardiac allograft vasculopathy post heart transplant using novel Cardiac CT techniques.,Postgraduate Scholarships"^"Heart transplantation is reserved for patients with terminal heart failure. Cardiac allograft vasculopathy (CAV) is a leading cause of death post-transplant, due to progressive narrowing in the heart arteries. As CAV is often asymptomatic, screening with invasive coronary angiography (ICA) is required. Non-invasive testing with Cardiac CT may be a suitable alternative to ICA in this population, and newer techniques examining the effect of blockages on blood flow may improve its accuracy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021950"^"http://purl.org/au-research/grants/nhmrc/2021950"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The ZEUs (ZopiclonE for acUte low back pain) trial: A multi-site, double blind, randomised controlled trial of zopiclone for acute low back pain,Postgraduate Scholarships"^"Low back pain (LBP) is the leading cause of disability globally and all commonly prescribed medications for acute LBP are not effective or cause serious side effects. Effective treatments for acute LBP are urgently needed. Muscle relaxants medicines such as Zopiclone, a safe sleep drug, appear to be safe and effective for acute LBP, although considerable uncertainty remains. My study, ZEUs, will be the definitive, double-blind placebo controlled randomised trial testing Zopiclone in acute LBP."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021953"^"http://purl.org/au-research/grants/nhmrc/2021953"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Ethics of cancer trials phD,Postgraduate Scholarships"^"This project seeks to understand how recent changes to the manner in which cancer research is designed and undertaken may influence the way research results are interpreted and used across the modern cancer treatment landscape. Interviews and surveys will be undertaken with research experts, cancer doctors and patients about their views on this topic and analysed with respect to new implications which emerge of an ethical nature as well as the way in which research contributes to new knowledge."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021964"^"http://purl.org/au-research/grants/nhmrc/2021964"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes and experiences of Culturally and Linguistically Diverse patients affected by cancer participating in survivorship programs,Postgraduate Scholarships"^"Cancer survivors who have completed treatment are at risk of complications for several years. Although cancer survivorship clinics have been established around Australia, migrants of culturally and linguistically diverse (CALD) backgrounds, experience unique challenges in navigating local health systems in the survivorship setting. This research aims to highlight the substantial unmet needs specific to CALD populations that are yet to be addressed in the current Australian healthcare system."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021983"^"http://purl.org/au-research/grants/nhmrc/2021983"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Clonal determinants of immune evasion to allogeneic stem cell transplant in acute myeloid leukaemia,Postgraduate Scholarships"^"Patients with acute myeloid leukaemia (AML) who relapse after first line treatment have a very poor clinical outcome. A stem cell transplant offers the opportunity for cure, however up to half of patients receiving this cellular immunotherapy have disease resistance or recurrence. This project will use a cutting-edge barcoding technique to track the genetic and non-genetic changes in each leukaemia cell over time to determine the mechanisms of immune evasion by AML."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021986"^"http://purl.org/au-research/grants/nhmrc/2021986"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Immune Related Adverse Events of the Gastrointestinal System and Investigation of Novel diagnostics and Therapeutics,Postgraduate Scholarships"^"This research project will explore the utility of intestinal ultrasound as a diagnostic tool of immune checkpoint inhibitor colitis. It will also explore the utility of faecal microbiota transplant in the management of immune checkpoint inhibitor colitis. It is expected that intestinal ultrasound will prove to provide an accurate and non invasive way of diagnosing this condition. It is also expected that faecal transplant will be effective in managing difficult to treat cases of this condition."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021994"^"http://purl.org/au-research/grants/nhmrc/2021994"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Primary Aldosteronism: New Strategies for Diagnosis and Management,Postgraduate Scholarships"^"Primary aldosteronism (PA) is a common and curable form of high blood pressure, requiring multiple tests for diagnosis. Lack of capacity for testing has led to delayed diagnosis and suboptimal outcomes, especially among Indigenous Australians whose rate of PA is unknown. Treatment options for PA are also limited at present. My research will establish modern tools, efficient pathways and novel therapies to improve health outcomes for all Australians with PA."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022019"^"http://purl.org/au-research/grants/nhmrc/2022019"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterising the perinatal, neonatal and school-age childhood outcomes associated with diabetes in pregnancy,Postgraduate Scholarships"^"Diabetes in pregnancy is common and can lead to complications for mother and baby. Using population-based data from Victoria, this dissertation seeks firstly to assess the long-term developmental and educational outcomes for children born to diabetic mothers. Management of diabetes confers improved perinatal outcomes, and so this thesis will secondarily assess the efficacy of lesser used medications, such as metformin, with the view to improving treatment of diabetes in pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022072"^"http://purl.org/au-research/grants/nhmrc/2022072"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advanced magnetic resonance imaging (MRI) biomarkers for prediction of clinical outcomes after a first seizure,Postgraduate Scholarships"^"After someone has their first seizure, we are unable to accurately predict who will go on to have further seizures (e.g., epilepsy) despite routine investigations. Cognitive and social problems often predate the first seizure. This project will develop a prediction tool using MRI brain scan markers, that can be used in the clinic after someone experiences their first seizure. This may provide patients with a more accurate diagnosis, individualise treatment and prevent cognitive deterioration."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022097"^"http://purl.org/au-research/grants/nhmrc/2022097"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CD8+ T cell tolerance within the tumour draining lymph node as a novel immunotherapy target in colorectal cancer,Postgraduate Scholarships"^"Immunotherapy, a type of cancer treatment, achieves remarkable outcomes for some patients, though unfortunately not everyone benefits. An immune process called peripheral tolerance (PT) may be preventing the immune system from fighting cancer cells and reducing the benefit of immunotherapy. Our project aims to find out if PT is present in colorectal cancer and how it relates to patient outcomes. We will also define how to breach PT and explore new treatments in order to overcome this hurdle."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022099"^"http://purl.org/au-research/grants/nhmrc/2022099"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The impact of gender affirming hormone therapy on scalp hair pattern and distribution,Postgraduate Scholarships"^"Scalp hair loss in transgender individuals commencing testosterone for gender transition is poorly studied but has significant impacts on quality of life. Using novel artificial intelligence-assisted camera technology (HairMetrix), I will firstly document changes in scalp hair with gender affirming hormone therapy in trans men and in trans women. Following this, I will undertake the first randomised clinical trial to prevent hair loss in trans men starting testosterone therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022102"^"http://purl.org/au-research/grants/nhmrc/2022102"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining new therapeutic targets for ANCA-associated vasculitis,Postgraduate Scholarships"^"Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disease that causes inflammation of small blood vessels. It often leads to severe kidney and lung inflammation and kidney impairment. While experimental disease models have identified new therapeutic options, they have multiple limitations that are hindering therapeutic progress. This work will optimise new disease models, define key mechanisms and identify new therapeutic targets in ANCA-associated vasculitis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022109"^"http://purl.org/au-research/grants/nhmrc/2022109"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing precision therapies for epilepsy,Postgraduate Scholarships"^"Precision therapies targeting genetic abnormalities causing epilepsy may improve the outcomes of the medical treatment of epilepsy, which have remained unchanged for decades. My project will evaluate the existing information for precision therapies in epilepsy and study potential precision approaches in patients with two severe genetic epilepsies. The results of this project may provide a pathway to realising the promise of precision medicine, ultimately improving epilepsy treatment outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022116"^"http://purl.org/au-research/grants/nhmrc/2022116"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The impact of post-school transitions on the mental health of young people with developmental disabilities,Postgraduate Scholarships"^"Young people with developmental disabilities have poorer experiences of post-school transition and worse mental health compared to young people without disability. This PhD project will analyse survey data and conduct inclusive interviews with young people with development disabilities. The findings will provide evidence on the impact of post-school transitions on the mental health of young people with developmental disabilities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022137"^"http://purl.org/au-research/grants/nhmrc/2022137"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel approaches to transfusion to improve supportive care for patients with blood cancers,Postgraduate Scholarships"^"The burden of blood cancers is increasing with an ageing Australian population. With new treatments available, many older and more frail patients are accessing treatment for their disease. Transfusion is a mainstay of supportive care for people with blood cancers and one aspect of care that can be potentially be performed in the home. My research study involves the use of novel monitoring devices to monitor patients receiving transfusion, and to pilot a program to transfuse patients at home."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022142"^"http://purl.org/au-research/grants/nhmrc/2022142"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Cardiovascular risk reduction in stroke survivors,Postgraduate Scholarships"^"Many people who survive a stroke suffer heart disease in the next 10 years due to a high burden of vascular risk factors. Research in heart disease has identified effective ways to control these risk factors. Stroke survivors do not receive as much attention to these factors compared to heart attack survivors. The aim of our project is to implement a cardiologist-led clinic to reduce the risk of heart disease in stroke survivors. We will also classify risk in stroke survivors using new tools."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022150"^"http://purl.org/au-research/grants/nhmrc/2022150"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel Insights into Ischemia and No Obstructive Coronary Artery Disease,Postgraduate Scholarships"^"Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA) are under-diagnosed and under-treated in current clinical practice. These patients continue to experience recurrent angina, a poor quality of life and adverse cardiovascular outcomes. This project aims to improve our understanding of the burden of disease and the factors that drive its occurrence and progression. Our investigations will help inform future practice for INOCA patients, including a novel diagnostic pathway."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022155"^"http://purl.org/au-research/grants/nhmrc/2022155"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating methods to optimise and streamline transcatheter aortic valve implantation (TAVI),Postgraduate Scholarships"^"Transcatheter aortic valve implantation (TAVI) is a minimally invasive alternative to surgery for aortic valve narrowing. A common complication of TAVI is heart block (HB) requiring a pacemaker, which is hard to anticipate. This project investigates novel predictors of HB after TAVI, by monitoring patients for 2 years with an implantable heart monitor. Finally, we will evaluate the viability of safe &amp; early discharge in low risk patients, with aims to reduce length of stay, and streamline TAVI."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022156"^"http://purl.org/au-research/grants/nhmrc/2022156"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for children with complex communication needs,Postgraduate Scholarships"^"Speech &amp; language disorders impact literacy, social &amp; work outcomes. The investigation of human genes can help us to understand why some children have speech &amp; language disorders. My projects are: 1) Describe the speech &amp; language profile of 2 genetic disorders (Batten Disease &amp; Kleefstra Syndrome) 2) Complete a high-tech speech therapy trial in the genetic disorder Angelman's Syndrome 3) Create a high-tech therapy decision-making resource for speech pathologists."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022163"^"http://purl.org/au-research/grants/nhmrc/2022163"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Moving Towards Personalising Treatment for Patients with Pancreatic Cancer Using a Patient-Derived Tumour Explant Model,Postgraduate Scholarships"^"Patients with pancreatic cancer (PC) have a poor prognosis. Our team has developed a world-first laboratory model of PC which we can use to test different chemotherapy drugs on a sample of a patient's tumour ("explant") with results available within 3 weeks. The overall aim of my PhD is to show our model can be used as a reliable indicator of how a patient will respond to different drug treatments, and search for reasons why some patients have tumours that don't respond ("chemoresistance")."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022167"^"http://purl.org/au-research/grants/nhmrc/2022167"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Selective Serotonin Reuptake Inhibitors And Depression in Atrial Fibrillation: The SAD-AF randomised controlled trial,Postgraduate Scholarships"^"The SAD-AF study is trial of serotonin-based antidepressants in people with intermittent atrial fibrillation (AF) and at least moderate symptoms of depression, to improve AF-related quality of life. AF is an irregular rhythm arising from the upper chambers of the heart, and can cause symptoms of chest pain, breathlessness and feelings of depression or anxiety. We believe that commonly prescribed serotonin-based antidepressants may improve AF-related symptoms and reduce the time spent in AF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022178"^"http://purl.org/au-research/grants/nhmrc/2022178"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of the Gut Microbiome in Irritable Bowel Syndrome and its therapeutic potential,Postgraduate Scholarships"^"Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders. IBS patients have an altered gut microbiome, but the potential of targetting microbiome changes to treat IBS is unclear. This PhD will evaluate faecal microbiota transplantation as a novel method of restoring healthy gut bacteria in IBS treatment and the role of dietary modifications. It will also lead to the creation of Australia’s first microbiome bank for IBS patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022186"^"http://purl.org/au-research/grants/nhmrc/2022186"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the effectiveness of systems-oriented implementation research and partnerships in malaria-endemic settings,Postgraduate Scholarships"^"Malaria control interventions are falling short of impact and long-term sustainability as they lack systems integration and effective cross-program coordination. My research will provide evidence on; a) feasibility and acceptability of new vivax-specific tools, b) effectiveness of systems-oriented implementation research and c) impact of research partnerships in PNG. This research will be critical to embed the coordination and systems approach required to achieve malaria elimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022193"^"http://purl.org/au-research/grants/nhmrc/2022193"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Saving sight: Novel stratification instruments for glaucoma,Postgraduate Scholarships"^"Glaucoma is the leading cause of irreversible blindness globally. Predictors of disease progression remain poorly understood, and monitoring is time and resource intensive. This project seeks to create an innovative predictive risk calculator which can be used to identify individuals at the highest risk of vision loss. The outcomes of this project will directly address existing gaps in knowledge and clinical practice, and propose new approaches to glaucoma monitoring and resource allocation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022228"^"http://purl.org/au-research/grants/nhmrc/2022228"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Digital health to assist recovery after critical illness,Postgraduate Scholarships"^"People who survive an Intensive Care Unit (ICU) admission often have physical and mental complications and poor health outcomes. Previous ICU recovery research is limited to in-person follow-up. Digital solutions may be a powerful mediator of ICU recovery by improving access to specialised recovery programs. This research aims to understand acceptability of digital programs, and develop and test these. This research will improve outcomes for ICU survivors, and will inform larger-scale research."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022235"^"http://purl.org/au-research/grants/nhmrc/2022235"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Three-Dimensional (3D) Printing to Refine Cardiac Assessment and Procedures,Postgraduate Scholarships"^"3D printing in cardiovascular medicine is still in its infancy. There is great scope for clinical applications of this technology and its use in developing the field of personalised medicine. First, this technique needs to be refined and established. Studies to demonstrate effectiveness are required before this technology can become implemented into guidelines and widely adopted. The proposed research is expected to establish the optimal 3D printing strategy in cardiovascular medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022237"^"http://purl.org/au-research/grants/nhmrc/2022237"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the landscape of ANCA-associated vasculitides in Australia and providing a foundation for improved care,Postgraduate Scholarships"^"ANCA-associated vasculitis is caused by the body attacking itself in small blood vessels affecting multiple organs, leading to deaths and ill health. A registry is being established to capture more information about this condition in Australia, to gain insight into the extent of the disease locally and identify improvements to treatment. The plan is to link the data with an existing European registry to attain more meaningful results, to investigate how to better treat this condition worldwide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022238"^"http://purl.org/au-research/grants/nhmrc/2022238"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Nanoparticle and gene therapy approaches to HIV cure,Postgraduate Scholarships"^"Current treatment for HIV is able to suppress but not eradicate HIV infection. This is because HIV is able to infect long-lived immune cells and maintain a reservoir of latent infection. One promising approach to target this reservoir is a form of gene therapy using CRISPR/Cas9. CRIPSR is able to target sequences of DNA, including HIV. This project aims to develop a therapeutic approach using CRISPR/Cas9 and explore novel mechanisms for gene therapy delivery using nanoparticle technology."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022240"^"http://purl.org/au-research/grants/nhmrc/2022240"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Community, Country, and Cognition: A multi-jurisdictional assessment of dementia affecting Aboriginal and Torres Strait Islander Peoples,Postgraduate Scholarships"^"This study will be the first to evaluate nationwide dementia rates between Aboriginal and Torres Strait Islander and non-Aboriginal people. Guided by community-identified priorities, the study will evaluate risk factors for Aboriginal and non-Aboriginal Australians living with or developing dementia in NSW and Central Australia. This study will inform clinical practice and policy development to benefit dementia care for Aboriginal Australians across urban, regional, and remote settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022244"^"http://purl.org/au-research/grants/nhmrc/2022244"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Platelet biomarkers of thrombotic risk in type 2 diabetes,Postgraduate Scholarships"^"Patients with diabetes face an increased risk of diseases linked to abnormal blood clotting, such as heart attacks and strokes. Our initial studies show platelets from patients with diabetes, which are hyperactive, produce more inflammatory proteins such as CXCL3. This opens new opportunities for drugs to block platelet inflammation to prevent heart attacks, with potentially fewer bleeding side-effects compared to traditional treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022247"^"http://purl.org/au-research/grants/nhmrc/2022247"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Coronary artery mimicking blood clot test: A point-of-care prothrombotic prediction device for patient-specific diagnosis,Postgraduate Scholarships"^"This biomedical engineering program aims to develop a patient-specific biochip to diagnose and predict blood clot tendency at an earlier stage. The point-of-care prothrombotic prediction device will be suitable for patients with high blood clot risks such as diabetes and, more recently, the COVID-19. It also serves as a testing platform for new anti-platelet and anti-coagulant drugs, and as a way for surgeons to screen patients for anti-thrombotic before operating to avoid uncontrolled bleeding."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022273"^"http://purl.org/au-research/grants/nhmrc/2022273"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the phenotypic expression of early disease and genetics of cardiac amyloidosis,Postgraduate Scholarships"^"Cardiac amyloid is a multi-system disorder with poor survival that presents as heart failure, rhythm issues or strokes. New treatments improving survival are available but costly. The prevalence of genetic mutations, the best test and how to diagnose early disease is unclear. Cardiac amyloid patients and families will have genetic testing and cardiac imaging to identify the prevalence of mutations, the best and earliest diagnostic tests and better explain heart changes associated with strokes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022274"^"http://purl.org/au-research/grants/nhmrc/2022274"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predicting progression of intestinal metaplasia to gastric cancer,Postgraduate Scholarships"^"Stomach cancer is a rare type of cancer in Australia which is often diagnosed late and has a poor survival. Intestinal metaplasia is a change in the stomach which precedes cancer in some people. However, the best way to monitor patients with this condition is not known. This project will try to understand why some people develop stomach cancer, and how we should monitor patients with intestinal metaplasia. This will include developing a world-first model in the lab using cells from patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022279"^"http://purl.org/au-research/grants/nhmrc/2022279"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Generating the trial evidence end-users prefer: adding value to the analysis of a randomised controlled trial of patient-led surveillance for subsequent melanoma (MEL-SELF),Postgraduate Scholarships"^"Common ways of determining the success of new treatments for health problems do not always offer the most useful knowledge to patients and doctors. This research explores new ways of analysing research results. In doing so, it aims to enhance the benefits of new treatments to patients, doctors, and policy makers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022284"^"http://purl.org/au-research/grants/nhmrc/2022284"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding the interplay between eating disorders and weight management therapy,Postgraduate Scholarships"^"We need better evidence to make sure that weight management therapy for obesity does not lead to eating disorders development. We aim to (1) identify which persons are at risk of eating disorders (2) break down the building blocks of weight management therapies and compare if these ‘blocks’ increase eating disorder risk (3) describe what healthcare professionals and patients think about these issues (4) describe the pathway to eating disorder development during weight management therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022301"^"http://purl.org/au-research/grants/nhmrc/2022301"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards ending tuberculosis and leprosy in the Pacific – implementing the PEARL study in South Tarawa, Kiribati,Postgraduate Scholarships"^"South Tarawa, the capital of Kiribati, has the highest rates of tuberculosis (TB) and leprosy in the Pacific. My project will partner with the Kiribati government to offer community-based screening, treatment and prevention for TB and leprosy to the entire population. We will measure the impact of this intervention on incidence and transmission rates of TB and leprosy in South Tarawa, demonstrating a pathway for future disease elimination in the whole of Kiribati and other remote settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022307"^"http://purl.org/au-research/grants/nhmrc/2022307"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Precision diagnosis for children with hearing loss: optimising utilisation of imaging and genetic testing,Postgraduate Scholarships"^"Hearing loss (HL) is relatively common in Australian newborns. Early and accurate detection and diagnosis of hearing loss optimizes care and developmental outcomes. Over 50% of HL is genetic with &gt;120 genes known. Imaging findings and genetic testing can enhance our understanding of the cause, providing families with precise diagnoses and family planning information. Up to 12% of genetic HL is due to an inner ear abnormality associated with specific genes, but genetic testing is rarely offered."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022340"^"http://purl.org/au-research/grants/nhmrc/2022340"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel retinal imaging biomarkers for the assessment and prevention of diabetes complications,Postgraduate Scholarships"^"PREDICT is a major study of type 2 diabetes complications. Whilst diabetes management has improved tremendously, our ability to identify those at risk of the sight- and life-threatening complications of the disease has not. Our goal is to develop better ways of estimating the risk of complications. We will use the rich data collected in PREDICT to determine if simple eye scans can be used for improved prediction. We will test new eye scanning technology and artificial intelligence methods."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022345"^"http://purl.org/au-research/grants/nhmrc/2022345"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The effects of osteoanabolic pharmacotherapy and osteogenic exercise on bone and muscle outcomes in postmenopausal osteoporosis: exploring the bone/muscle interface,Postgraduate Scholarships"^"Bone fractures, particularly in women after menopause, result in significant health-related disability. We need to get more benefit from current therapies for osteoporosis (bone fragility). We will investigate the effects of combining exercise with bone-building medication on improving bone mass and whether bone-building medication can improve muscle and physical function, which may lend to reduction in falls. We are conducting a multi-centre study to help address these important questions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022346"^"http://purl.org/au-research/grants/nhmrc/2022346"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PhD Community Sentiment Tool,Postgraduate Scholarships"^"Widespread beliefs and opinions held by a community about a topic is known as "community sentiment". It is critical to understand community sentiment about public health measures as it will affect compliance. Artificial intelligence can be used to analyse sentences, phrases and words in open-source media and social media to measure community sentiment. This can be done in many languages and locations in real time to inform health policy. It can be adapted to any language, area or health issue."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022364"^"http://purl.org/au-research/grants/nhmrc/2022364"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Comparing the Efficacy and Acceptability of Genomic Testing and Skin Biopsy in Diagnosing Monogenic Skin Disease,Postgraduate Scholarships"^"A skin biopsy is currently the first-line diagnostic-investigation for individuals with suspected genetic skin diseases. It would be valuable to determine whether this invasive procedure could be replaced with a saliva sample and genomic testing. This proposal aims to measure the cost-effectiveness, diagnostic yield and clinical impact of these test modalities, in addition to examining the attitudes of relevant stakeholders – including patients, families and clinicians."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022368"^"http://purl.org/au-research/grants/nhmrc/2022368"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Assessing the cardiac arrhythmia profile of cancer therapeutics,Postgraduate Scholarships"^"Heart rhythm disorders or arrhythmias can result from cancer treatment. A lab-based study will assess the mechanisms of cancer-treatment induced long QT syndrome, which can result in fatal arrhythmias. A clinical study will recruit patients treated with medications that use the immune system to fight cancer. A side effect of these medications includes heart inflammation and arrhythmias. This study will develop methods to diagnose heart inflammation and markers that indicate arrhythmia risk."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022377"^"http://purl.org/au-research/grants/nhmrc/2022377"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Critical evaluation of the diagnostic utility of whole genome and transcriptome sequencing and the training of physicians in the deployment of frontier diagnostic technologies in healthcare,Postgraduate Scholarships"^"Rare diseases are largely uncommon but collectively, they result in significant morbidity. Most rare disease is genetic in origin and the majority of children with rare disease remain undiagnosed following genetic testing. This project focuses on increasing diagnoses in children with rare disease through novel testing strategies such as combined genome and RNA sequencing, as well as improving their overall care by upskilling and improving genomic literacy in medical specialists."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022380"^"http://purl.org/au-research/grants/nhmrc/2022380"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Prescription Drug Monitoring Program in New South Wales: A mixed methods study of implementation processes, stakeholder experiences, and program impact,Postgraduate Scholarships"^"Harm from high-risk prescription medicines including opioids is a public health concern. Prescription Drug Monitoring Programs (PDMP) are electronic systems that monitor these high-risk medicines and warn health care professionals when a patient is at risk. This research project will investigate how the NSW PDMP (SafeScript NSW) was implemented and will explore health care providers' and consumers' experiences and perceptions of the new PDMP tool in NSW."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022387"^"http://purl.org/au-research/grants/nhmrc/2022387"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Functional connectivity-guided transcranial magnetic stimulation (TMS) treatment for young people with major depression,Postgraduate Scholarships"^"Transcranial magnetic stimulation (TMS) is a Medicare-subsidised treatment for depression that normalises brain changes. However, neuroimaging studies of adolescent depression has generated inconsistent results, hindering the development of better TMS treatment for this age group. This study aims to establish a robust understanding of the neurobiology underlying adolescent depression and integrate this knowledge to improve TMS treatment efficacy for young people suffering from major depression."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022391"^"http://purl.org/au-research/grants/nhmrc/2022391"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Evidence Supporting Strategies for Coronary Artery Revascularisation,Postgraduate Scholarships"^"My PhD project examines the quality and safety of treatments for coronary artery disease (CAD) and seeks to demonstrates the outcomes from these in various patient groups including in women and indigenous populations. New techniques in Coronary Artery Bypass Surgery (CABG) have been refined, but the comparisons between these and stenting is limited. With the help of artificial intelligence and medical machine learning, this project will provide novel data to improve patient survival globally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022415"^"http://purl.org/au-research/grants/nhmrc/2022415"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predicting and preventing sepsis in patients with haematological malignancy,Postgraduate Scholarships"^"Sepsis is overwhelming reaction to severe infection. Patients with haematological malignancy (blood cancers) have reduced immunity to infection and many develop sepsis. The treatments available for blood cancers have improved in recent years, but the risk of dying from sepsis is still high. My research program will help understand which patients are at the highest risk of sepsis, and whether we can prevent sepsis with immunoglobulin (antibody) treatment or improved hospital hygiene strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022417"^"http://purl.org/au-research/grants/nhmrc/2022417"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Heart Failure Prevention in Cancer Survivors by Recognition and Treatment of Subclinical Disease,Postgraduate Scholarships"^"Cancer survivors have an increased risk of heart failure (HF) due to chemotherapy toxicity &amp; shared risks between cancer &amp; heart disease. Subclinical heart failure (SBHF) are changes in echocardiography occurring prior to symptoms, allowing initiation of cardioprotective therapies (medications, exercise) - reducing the risk of overt HF. We aim to detect SBHF in cancer survivors &amp; evaluate impact of early cardioprotection. We expect this will improve functional capacity &amp; delay/prevent overt HF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022424"^"http://purl.org/au-research/grants/nhmrc/2022424"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Detection of autoantibodies using novel bioluminescent systems,Postgraduate Scholarships"^"This research aims to develop new and improved laboratory tests to identify and measure antibodies and other markers in the bloodstream that are associated with autoimmune diseases, including a number of different neurological conditions. More accurate detection of these markers is important to allow early diagnosis and treatment of autoimmune diseases, and prevent their complications including long term disability."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022453"^"http://purl.org/au-research/grants/nhmrc/2022453"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising Biologics in Inflammatory Bowel Disease,Postgraduate Scholarships"^"There is no cure for inflammatory bowel disease (IBD), &amp; the underpinning mechanisms involved in disease development are poorly understood. Patients often progress on first line treatment and need ‘biologic’ therapy to control their disease, thereby keeping them healthy and improving their quality of life. My research aims to evaluate the clinical and cellular issues of IBD, and personalise treatments based on the individual which will help decide treatment strategies to keep patients healthy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022454"^"http://purl.org/au-research/grants/nhmrc/2022454"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel policy approaches to reduce the supply and availability of tobacco products,Postgraduate Scholarships"^"This research aims to reduce tobacco smoking in Australia. Tobacco is widely available to purchase, making it difficult for smokers to quit and easy for young people to start. I will find new options for reducing availability of tobacco by looking at models used in other countries for harmful products. I will develop new policy options for reducing tobacco supply and gain feedback from the public and other stakeholders, which I will use to make policy recommendations."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022463"^"http://purl.org/au-research/grants/nhmrc/2022463"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeted and stem cell therapeutics for Cystic Fibrosis sinus disease,Postgraduate Scholarships"^"Despite advances in treatment for Cystic Fibrosis, (CF) there is currently no cure. The sinonasal airway provides valuable insights into the lower airway. The impact of modulators on the sinonasal airway before and after treatment in the paediatric CF population will be studied. A rabbit sinus model will be developed to further define the essential preclinical steps to deliver rabbits own corrected airway stem-cells to renew the damaged cells within the sinus and lung."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022470"^"http://purl.org/au-research/grants/nhmrc/2022470"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating Novel Prevention and Treatment Strategies for for Gonococcal Control,Postgraduate Scholarships"^"Gonorrhoea infection can lead to long term health problems including infertility. Cases of gonorrhoea continue to increase and antibiotic-resistant strains have been reported, prompting WHO to declare an urgent need for new strategies to prevent the spread of untreatable gonorrhoea. My study focuses on this priority by generating new knowledge towards alternative strategies for gonococcal disease control including vaccine development and non-antibiotic strategies to treat gonorrhoea."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022471"^"http://purl.org/au-research/grants/nhmrc/2022471"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Human amnion epithelial cell derived novel therapeutics in inflammatory bowel disease,Postgraduate Scholarships"^"We will examine the potential therapeutic properties of extracellular vesicles, particles that carry messages between cells, that can be harvested from human amnion epithelial cells, a type of stem cell found in the amniotic membrane. We will then apply this as a treatment for perianal fistulising Crohn’s disease, a difficult to manage type of inflammatory bowel disease (IBD) with a higher risk of poor outcomes. Our goal is to establish a novel new therapy for patients suffering with IBD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022495"^"http://purl.org/au-research/grants/nhmrc/2022495"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Towards treatment of intellectual disability caused by errors in the chromatin machinery,Postgraduate Scholarships"^"Disorders that influence the expression of genes may be influenced by the metabolic environment in the cell. This research aims to characterise the metabolic environment and to see if there may be potential treatments for these metabolic disorders by supplementing deficient nutrients/substrates. In addition, we would be interested in characterising the biomarkers of these conditions to see if there are other chemicals that might be helpful to track treatment for these conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022510"^"http://purl.org/au-research/grants/nhmrc/2022510"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Vaccine Champions and Vaccine Communication program,Postgraduate Scholarships"^"The Vaccine Champions and Vaccine Communication (VCVC) program aims to increase the number of people getting the COVID-19 vaccine and to build confidence in vaccines by empowering healthcare providers, community, faith, and industry leaders to become vaccine “champions” within their communities, in three Western Pacific countries. Champions will run vaccine information sessions in the community, addressing concerns and misconceptions. This research will assess the impact of the VCVC program."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022517"^"http://purl.org/au-research/grants/nhmrc/2022517"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel bacteria as a therapy for inflammatory bowel disease,Postgraduate Scholarships"^"Inflammatory bowel disease (IBD) is an incurable disease, affecting 1 in 200 Australians and is thought to be related to an imbalance between protective and harmful bacteria in our gut. Despite years of research, a large proportion of these bacteria remain unknown or poorly understood. Our team has succeeded in identifying a vast number of new species. I will use novel techniques to further understand the relationship between these bacteria and IBD, and lead the development of a new treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022530"^"http://purl.org/au-research/grants/nhmrc/2022530"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Application of novel personalised medicine tools to understand treatment mechanisms in Primary Ciliary Dyskinesia,Postgraduate Scholarships"^"Primary Ciliary Dyskinesia (PCD) is a rare genetic condition mostly affecting the respiratory tract, causing recurrent respiratory infections eventually leading to scarred and dilated airways. Research on the best treatment for patients with PCD is scarce. This study will use medical imaging and mini airway organs created in a lab from cells collected from the nose of PCD patients to measure the impact of treatments in patients with PCD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022548"^"http://purl.org/au-research/grants/nhmrc/2022548"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Better Vision for Patients with Ocular Toxoplasmosis,Postgraduate Scholarships"^"Toxoplasma gondii is a parasite that causes the eye disease called ocular toxoplasmosis. There are no medications that can rid the body of the parasite, and there is no vaccine that prevents an infection. The goal of my research is to improve vision outcomes in patients with ocular toxoplasmosis. I will investigate a new treatment that targets inflammatory molecules to protect the eye tissues, and I will develop clinical algorithms to identify patients who would benefit most from treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022557"^"http://purl.org/au-research/grants/nhmrc/2022557"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Designing Bayesian clinical trials to enhance clinician- and consumer-directed decision-making,Postgraduate Scholarships"^"Clinical trials are designed to answer scientific research questions. It is therefore hard for clinicians and consumers to use the trial results for their own decision-making. This is because the research question does not consider their individual preferences and so may not be helpful to them. To change this, we need a better way to evaluate and report trial results to make decision-making easier. This project will use advanced statistics to design better clinical trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018592"^"http://purl.org/au-research/grants/nhmrc/2018592"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the impact of radiation on the heart for cancer and cardiac disease patients,Synergy Grants"^"This program will develop the integrated technology and perform datamining, animal and human studies to provide a comprehensive understanding on the response of substructures in the heart to radiation. This work will benefits patients receiving radiation therapy for cancer treatments where we aim to minimise cardiac complications post treatment. Our work will also benefit patients with advanced ventricular tachycardia where radiation is being used to reduce the number of painful ICD shocks."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018642"^"http://purl.org/au-research/grants/nhmrc/2018642"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving outcomes for high-risk child and adolescent cancer: from discovery to individualised treatment within a consumer partnership,Synergy Grants"^"Cancer is the commonest disease causing death in children. New anticancer drugs are developed against one adult cancer gene target. Anticancer drugs work best in combination to overcome resistance. Our network of scientists and doctors have developed a diagnostic platform to better match the drug to the gene target for high risk child cancer. We will develop effective child cancer-specific combination therapy, accurate diagnostics for resistance and integrate consumers in the research pathway."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018654"^"http://purl.org/au-research/grants/nhmrc/2018654"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Accelerating to zero: targeting roadblocks to achieve malaria elimination,Synergy Grants"^"This Synergy Grant addresses major knowledge and translation gaps that are key roadblocks to achieving malaria elimination. The new knowledge, tools, and strategies developed in this program through innovative and targeted research is responsive to global priorities and will directly inform policy and health practices, as well as driving future innovation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018668"^"http://purl.org/au-research/grants/nhmrc/2018668"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Synergise, Integrate and Enhance Sleep Research to Transform Brain Ageing (SIESTA),Synergy Grants"^"Modifiable risk factors account for up to 40% of dementia risk, and sleep disturbance (SD) has emerged as a viable new target. This project will assess SD, cognitive decline and dementia pathology using methods including novel blood-based biomarkers. This project will also develop scalable digital health solutions addressing SD, and assess the impact of interventions on SD and dementia biomarkers, in order to translate findings into clinical practice and substantially reduce dementia risk."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018970"^"http://purl.org/au-research/grants/nhmrc/2018970"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving Aboriginal health by understanding the influence of early life environments and contacts with health and social service systems over time and across generations,Synergy Grants"^"This project is a partnership between researchers, the Aboriginal community and government to provide evidence for policy and practice addressing high priority health conditions for Aboriginal children and families. It will use a longitudinal linked dataset based on a population representative sample of Aboriginal children and their families (the 2000/02 Western Australian Aboriginal Child Health Survey) and government data across health, education, child protection, and justice domains."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019056"^"http://purl.org/au-research/grants/nhmrc/2019056"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Advancing the treatment of brain cancer in children,Synergy Grants"^"Brain cancers are the number one cause of cancer related death in children. Treatment for this group of cancers is aggressive and includes chemotherapy, surgery and radiotherapy. This research will develop innovative nano-sized drug carriers to deliver therapies and imaging agents to detect and kill brain tumours. If successful, this work has the potential to markedly change treatment strategies to improve the survival of paediatric brain cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019247"^"http://purl.org/au-research/grants/nhmrc/2019247"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"How can health districts and networks cultivate anti-racist hospitals?,Synergy Grants"^"The aim of this research is to enable local health networks and districts in Australia to tackle systemic racism in hospitals. Specifically, this research will use tools and frameworks to improve quality of hospital care and reduce health inequities for Aboriginal and Torres Strait Islander people. This work will be undertaken by a team of researchers with expertise and skills across public health, social science and Indigenous ways of working."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019251"^"http://purl.org/au-research/grants/nhmrc/2019251"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using complex models of human trophoblast to study placental biology and disease,Synergy Grants"^"In this synergy grant, a multidisciplinary team of researchers in stem cell biology, placenta , epigenetics, embryonic implantation and computational science will work together to study the placenta using different artificial models. This will allow us to understand how early placenta is formed in humans, how it interacts with the cells of the uterus of the mother and unveil the genetic and toxicity insults that contribute to problems in pregnancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019252"^"http://purl.org/au-research/grants/nhmrc/2019252"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Interdisciplinary Tobacco Endgame Research Network (INTER-Net),Synergy Grants"^"Tobacco smoking remains the leading preventable cause of early death and disease globally. Australia has been a global leader in implementing policies that have reduced smoking to one of the lowest rates in the world. This multidisciplinary research program will examine promising new approaches to minimising smoking in Australia using methods from epidemiology and applied statistics, health policy, law, the social sciences, and economics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019260"^"http://purl.org/au-research/grants/nhmrc/2019260"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Rhythms and blues: Personalising care for body clock dysfunction in mood disorders,Synergy Grants"^"This project aims to improve our knowledge about how problems with “body clocks” might lead to mood disorders like depression and bipolar disorder. We expect this research will (1) lead to better ways to measure body clock function, (2) reveal more clearly how body clocks are affected in mood disorders, (3) help clinicians predict whose mood disorder will persist or get worse over time, and (4) guide clinicians about what treatments can help improve people’s body clocks and mental health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024704"^"http://purl.org/au-research/grants/nhmrc/2024704"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024700"^"http://purl.org/au-research/grants/nhmrc/2024700"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024693"^"http://purl.org/au-research/grants/nhmrc/2024693"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024706"^"http://purl.org/au-research/grants/nhmrc/2024706"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024696"^"http://purl.org/au-research/grants/nhmrc/2024696"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024689"^"http://purl.org/au-research/grants/nhmrc/2024689"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024690"^"http://purl.org/au-research/grants/nhmrc/2024690"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024710"^"http://purl.org/au-research/grants/nhmrc/2024710"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024709"^"http://purl.org/au-research/grants/nhmrc/2024709"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024708"^"http://purl.org/au-research/grants/nhmrc/2024708"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024707"^"http://purl.org/au-research/grants/nhmrc/2024707"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024688"^"http://purl.org/au-research/grants/nhmrc/2024688"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024705"^"http://purl.org/au-research/grants/nhmrc/2024705"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024703"^"http://purl.org/au-research/grants/nhmrc/2024703"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024702"^"http://purl.org/au-research/grants/nhmrc/2024702"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024701"^"http://purl.org/au-research/grants/nhmrc/2024701"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024699"^"http://purl.org/au-research/grants/nhmrc/2024699"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024698"^"http://purl.org/au-research/grants/nhmrc/2024698"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024697"^"http://purl.org/au-research/grants/nhmrc/2024697"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024695"^"http://purl.org/au-research/grants/nhmrc/2024695"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024694"^"http://purl.org/au-research/grants/nhmrc/2024694"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024692"^"http://purl.org/au-research/grants/nhmrc/2024692"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024691"^"http://purl.org/au-research/grants/nhmrc/2024691"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"IRIISS - 2022,Independent Research Institutes Infrastructure Support Scheme (IRIISS)"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024644"^"http://purl.org/au-research/grants/nhmrc/2024644"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024674"^"http://purl.org/au-research/grants/nhmrc/2024674"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024684"^"http://purl.org/au-research/grants/nhmrc/2024684"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024637"^"http://purl.org/au-research/grants/nhmrc/2024637"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024660"^"http://purl.org/au-research/grants/nhmrc/2024660"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024664"^"http://purl.org/au-research/grants/nhmrc/2024664"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024667"^"http://purl.org/au-research/grants/nhmrc/2024667"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024679"^"http://purl.org/au-research/grants/nhmrc/2024679"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024636"^"http://purl.org/au-research/grants/nhmrc/2024636"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024659"^"http://purl.org/au-research/grants/nhmrc/2024659"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024638"^"http://purl.org/au-research/grants/nhmrc/2024638"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024641"^"http://purl.org/au-research/grants/nhmrc/2024641"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024645"^"http://purl.org/au-research/grants/nhmrc/2024645"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024635"^"http://purl.org/au-research/grants/nhmrc/2024635"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024669"^"http://purl.org/au-research/grants/nhmrc/2024669"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024687"^"http://purl.org/au-research/grants/nhmrc/2024687"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024686"^"http://purl.org/au-research/grants/nhmrc/2024686"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024685"^"http://purl.org/au-research/grants/nhmrc/2024685"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024683"^"http://purl.org/au-research/grants/nhmrc/2024683"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024682"^"http://purl.org/au-research/grants/nhmrc/2024682"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024681"^"http://purl.org/au-research/grants/nhmrc/2024681"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024680"^"http://purl.org/au-research/grants/nhmrc/2024680"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024678"^"http://purl.org/au-research/grants/nhmrc/2024678"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024677"^"http://purl.org/au-research/grants/nhmrc/2024677"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024676"^"http://purl.org/au-research/grants/nhmrc/2024676"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024675"^"http://purl.org/au-research/grants/nhmrc/2024675"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024673"^"http://purl.org/au-research/grants/nhmrc/2024673"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024672"^"http://purl.org/au-research/grants/nhmrc/2024672"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024671"^"http://purl.org/au-research/grants/nhmrc/2024671"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024670"^"http://purl.org/au-research/grants/nhmrc/2024670"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024668"^"http://purl.org/au-research/grants/nhmrc/2024668"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024666"^"http://purl.org/au-research/grants/nhmrc/2024666"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024665"^"http://purl.org/au-research/grants/nhmrc/2024665"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024663"^"http://purl.org/au-research/grants/nhmrc/2024663"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024662"^"http://purl.org/au-research/grants/nhmrc/2024662"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024661"^"http://purl.org/au-research/grants/nhmrc/2024661"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024646"^"http://purl.org/au-research/grants/nhmrc/2024646"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024632"^"http://purl.org/au-research/grants/nhmrc/2024632"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024650"^"http://purl.org/au-research/grants/nhmrc/2024650"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024649"^"http://purl.org/au-research/grants/nhmrc/2024649"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024642"^"http://purl.org/au-research/grants/nhmrc/2024642"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024640"^"http://purl.org/au-research/grants/nhmrc/2024640"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024639"^"http://purl.org/au-research/grants/nhmrc/2024639"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2024634"^"http://purl.org/au-research/grants/nhmrc/2024634"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"2022 Equipment Grant,Equipment Grant"^"Not Applicable"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2016736"^"http://purl.org/au-research/grants/nhmrc/2016736"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dental health, mental health and economic productivity; a child longitudinal study,Partnership Projects"^"Working with partners across each State and Territory to ensure local tailoring and national implementation, we will undertake NCOHS-2 – oral epidemiological examinations and questionnaire data on approximately 32,000 Australian children aged 5 to 14 years – then compare against NCOHS-1 data to test, model, evaluate and disseminate evidence that will enable important questions around child oral health, social and emotional wellbeing, school performance and economic productivity to be answered."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017219"^"http://purl.org/au-research/grants/nhmrc/2017219"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving the health system’s response when patients are harmed: a mixed-methods study,Partnership Projects"^"When patients are harmed, it is imperative that health care organisations respond to and learn from them and prevent other patients suffering a similar incident. However, there is no evidence that systems for managing incidents reduce more incidents causing harm to patients. We will work closely with four jurisdiction's health systems to research current practices, test interventions that are occurring in health services, and undertake a world-first simulation trial using artificial intelligence."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2017496"^"http://purl.org/au-research/grants/nhmrc/2017496"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sleep for Strong Souls (3S): Multisectoral partnership and co-designed solutions to improve the sleep health of First Nations Adolescents,Partnership Projects"^"1 in 3 Aboriginal and Torres Strait Islander adolescents struggle with poor sleep, yet their sleep health needs remains unmet. In collaboration with community members, the project team and partner organisations are working together to co-design a sleep health program and resources, build local capacity, and embed culturally responsive and context responsive sleep health care in preventive programs and health system to meet the sleep health needs of First Nations adolescents."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018981"^"http://purl.org/au-research/grants/nhmrc/2018981"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"NAVICARE: Implementing, scaling up and sustaining a co-designed care navigation model to improve mental health service access in regional Australia,Partnership Projects"^"One in five Australians experience mental ill health each year. In regional Australia, mental health services are harder to access than in urban areas. We developed a new model of care with regional communities to address this. A local person assists people in navigating how to access the best mental health care, which has been shown to be beneficial. This project will evaluate the new model of care in multiple regional sites in Queensland and potential scaling up across Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019034"^"http://purl.org/au-research/grants/nhmrc/2019034"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Determining the impact of the Melbourne Supervised Injecting Rooms on health and social outcomess,Partnership Projects"^"The Melbourne Supervised Injecting Room opened in North Richmond in 2018 and has since become one of the busiest in the world. A second MSIR will open in Melbourne's Central Business District. By establishing SIRX, a prospective cohort of MSIR service users, this study will provide new highest-quality evidence about the effectiveness of the MSIRS to inform ongoing policy and practice around supervised injecting facilities over the coming decade."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019085"^"http://purl.org/au-research/grants/nhmrc/2019085"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Can an aftercare service reduce suicide risk in young people? An effectiveness-implementation evaluation,Partnership Projects"^"This project responds to rising rates of youth suicide. It will evaluate a youth aftercare service designed to support young people who have presented to the emergency department with suicide risk. The project will employ different methodologies to understand the acceptability and effectiveness of the service from the perspectives of young people, families and professionals. It represents a partnership between the University of Melbourne, Orygen and the Victorian Department of Health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019735"^"http://purl.org/au-research/grants/nhmrc/2019735"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Integrating mathematical modelling and public health surveillance to improve control of epidemic and pandemic respiratory infections in Australia,Partnership Projects"^"Australia has had a highly successful response to COVID-19 by global standards but this success relied on real-time development of public health responses including new surveillance of trends and interventions and analysis through newly developed models. We seek to embed efficient and relevant surveillance and real-time analysis within jurisdictional responses to COVID-19 and other important respiratory infections, through partnerships with NSW, ACT and QLD health departments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018793"^"http://purl.org/au-research/grants/nhmrc/2018793"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineered tumour-homing bacteria that safely turn up the heat on immunologically cold colorectal cancers,Ideas Grants"^"The most prevalent colorectal cancer subtype has a low mutational burden and does not respond well to immunotherapies. The immune agonist anti-CD40 can drive immune infiltration into this cancer subtype and can reduce tumour burden in a mouse model that faithfully recapitulates the disease, however induces severe toxicity. This project will determine if expressing CD40 agonists in probiotic bacteria can be used to reduce this toxicity and effectively suppress colorectal cancer growth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018797"^"http://purl.org/au-research/grants/nhmrc/2018797"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting the hepatitis B e antigen as a novel therapeutic approach,Ideas Grants"^"There is no cure for chronic hepatitis B virus disease. The secreted hepatitis B e antigen (HBeAg) is a major cause of chronic infection, and its removal by host immune responses improves patient health. Current antiviral therapy does not specifically target this protein. We have developed novel methods to reducing HBeAg levels in a mouse model of HBV persistence. This proposal will progress these findings towards a novel therapeutic approach to treat HBeAg-+ve chronic hepatitis B."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018825"^"http://purl.org/au-research/grants/nhmrc/2018825"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterization of the Germline Regulatory Landscape,Ideas Grants"^"Human fertility requires the generation of gametes (oocytes and sperm) that combine to produce an embryo. The aim of this research program is to identify genes and proteins that control gamete production. The biochemical pathways under study could be targeted by drugs. Therefore, new knowledge generated in this project has the potential to identify processes and pathways that are directly relevant to reproduction-related disease, infertility and in vitro fertilization."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018833"^"http://purl.org/au-research/grants/nhmrc/2018833"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Accelerating messenger RNA (mRNA) therapeutics by cracking the epitranscriptomic code,Ideas Grants"^"The remarkable efficacy of SARS-CoV-2 vaccines based on messenger RNA (mRNA) has highlighted the extraordinary potential of mRNA technologies and has secured the promise of mRNA as a therapeutic modality for multiple diseases. This research project builds on a recent breakthrough from my research that enables an unprecedented characterisation of the chemical composition of individual mRNA molecules to uphold this promise and accelerate mRNA exploration and design for therapeutic development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018835"^"http://purl.org/au-research/grants/nhmrc/2018835"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Molecular pathways that control platelet production,Ideas Grants"^"Platelets are small cells that circulate by the millions in the bloodstream and are primarily responsible for sealing a blood vessel when the vessel is damaged. The mechanisms controlling platelet production are not well understood. We have discovered that by inhibiting ribosomal biogenesis, we can rapidly increase platelet production. This will be of enormous benefit in clinical settings where platelets are low and catastrophic bleeding is likely."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018880"^"http://purl.org/au-research/grants/nhmrc/2018880"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the intracellular lifestyle of lethal Staphylococcus aureus,Ideas Grants"^"Staphylococcus aureus (golden staph) cause infection of the bloodstream, a serious condition with a high death toll in patients. Despite years of research, it is still unclear how these bacteria hide into human cells to escape our immune system and current antibiotics. Here, we propose a research programme to understand the molecular strategies used by golden staph to cause these serious infections. Our findings will help design new drugs to treat severe bacterial infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018888"^"http://purl.org/au-research/grants/nhmrc/2018888"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting molecular ageing pathways for the treatment of chronic pain,Ideas Grants"^"One in five Australians lives with chronic pain and this prevalence rises to one in three people over the age of 65. Available treatments for pain are often ineffective and associated with dose-limiting side effects. This project aims to explore a potential new avenue of pain research, and the knowledge gained is expected to provide a breakthrough understanding of the interplay between chronic pain and cellular ageing, and nonetheless will lay the groundwork for numerous applications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018895"^"http://purl.org/au-research/grants/nhmrc/2018895"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unmask HIV latency through disruption of HIV synapses,Ideas Grants"^"HIV synapses enable cell-cell transmission to overcome anti-retroviral therapeutics and broadly neutralising anti-HIV antibodies. Our ground-breaking report on the Ca2+-HIV synapse biology will: (i) improve efficiency of HIV therapeutics; and (ii) show how HIV latently infected cells can be sensitised for destruction. A cross-disciplinary approach involving molecular virology, cell biology, and machine learning will be used to accelerate our discovery for its application at the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018897"^"http://purl.org/au-research/grants/nhmrc/2018897"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preventing a nephron deficit in premature offspring,Ideas Grants"^"Many premature babies are born with a low number of functional units (nephrons) in their kidneys and an increased risk of developing chronic kidney disease. Strategies to prevent a nephron deficit in preterm offspring are required. We have found that manipulating maternal nutrition during lactation can rescue a nephron deficit. We will determine the multidimensional impact of dietary macronutrients on maternal milk composition and nephron endowment following premature birth."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018916"^"http://purl.org/au-research/grants/nhmrc/2018916"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Assessing benefits of extended genomic newborn screening at population scale in infants from Generation Victoria,Ideas Grants"^"There are over 7,000 rare diseases with the average age of diagnosis being 4 years. Newborn screening using genomics could identify these children at a younger age and deliver new therapies at birth to offer the most chance of health benefits. We will test effectiveness of a novel genomic workflow called EpiGNs to detect harmful changes to genes on the whole-of-state birth cohort (GenV) of 100,000 infants. This will enable its implementation as a new model for genomic newborn screening."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018919"^"http://purl.org/au-research/grants/nhmrc/2018919"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Regulators of Tau Pathology Induced by Exosomal and Vesicle-free Tau Seeds,Ideas Grants"^"In Alzheimer’s disease, misfolded forms of the protein tau known as seeds propagate from neuron to neuron allowing for spreading and progression of tau pathology. We discovered novel genes that regulate this process. We will dissect how these regulators enable the disease, and whether their manipulation can modulate or stop tau pathology in cells and in brains. We expect that by understanding how different tau seeds cause tau pathology, our research will also reveal novel therapeutic targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018947"^"http://purl.org/au-research/grants/nhmrc/2018947"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Personalising diagnosis and treatment of Pseudomonas aeruginosa infection,Ideas Grants"^"We will develop a novel blood test that measures the antibody glycocode and informs on the individual immune status of patients. This new test will improve and significantly accelerate personalised diagnosis and treatment of patients suffering from infection with Pseudomonas aeruginosa, a pathogen classified by the World Health Organisation at the highest threat level due to it becoming increasingly resistant to last resort antibiotics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018951"^"http://purl.org/au-research/grants/nhmrc/2018951"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New Approaches for Sensitising Metastatic Colorectal Cancer to Immunotherapy,Ideas Grants"^"Immunotherapy is an approach that takes advantage of the body’s own immune system to attack cancer cells. This therapy that has produced long term benefit for patients with many different types of advanced cancers, but has had limited benefit for patients with bowel cancer. In this application we are using cutting edge techniques to identify new ways to use immunotherapy to improve outcomes for patients with advanced bowel cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018980"^"http://purl.org/au-research/grants/nhmrc/2018980"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the roles of O-linked glycosylation on Burkholderia virulence,Ideas Grants"^"Burkholderia infections are associated with high mortality rates especially within immunocompromised individuals. Due to this there is an urgent need to identify bacterial factors which can be targeted to reduce the disease burden of these infections. Within this grant we aim to identify how a specific set of proteins, glycoproteins, contribute to Burkholderia virulence with the goal to identify next generation vaccines and anti-microbial targets."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018988"^"http://purl.org/au-research/grants/nhmrc/2018988"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel brain circuit inhibiting airway interoceptive processing,Ideas Grants"^"The air passages and lungs are exposed to the external environment through the air that is breathed. It is therefore important that they can sense danger signals present in air, such as toxins or irritants, that might compromise breathing. This sensory system is poorly described. We will investigate brain circuits regulating airway irritant detection when air quality is compromised by smoke arising from bush fires. The findings will inform the severe health impacts of environmental pollutants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018997"^"http://purl.org/au-research/grants/nhmrc/2018997"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel biomarkers and drug targets for pharmacoresistant epilepsy,Ideas Grants"^"In one-third of epilepsy patients, currently available antiepileptic drugs (AEDs) do not control seizures. Recurrent seizures threaten life and impair its quality; hence, there is a clear need to discover new AEDs. In addition, there is currently no way to accurately predict which and how individuals will respond to a specific or any AED. The proposed research aims identify new AED targets and predict the right (and wrong) drugs for an epilepsy patient from the outset."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019011"^"http://purl.org/au-research/grants/nhmrc/2019011"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Thalamic plasticity following cortical damage: recovery of vision,Ideas Grants"^"This project will investigate how neuroplasticity can contribute to vision recovery in adult brain, following damage to one of its key nodes. Normally, such lesions render the person blind, but some slight improvement occurs over time. We will test the extent to which newborn neurons can be integrated to other parts of this circuit in a manner that explains the partial recovery of vision, and whether a rehabilitation therapy can boost this process."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019014"^"http://purl.org/au-research/grants/nhmrc/2019014"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineering bone marrow-derived stromal cells to express anti-fibrotic cargo as a treatment for chronic kidney disease,Ideas Grants"^"Although a number of organs can repair themselves from mild injury, when subjected to persistent injury, they fail to do so. As a result, they undergo organ scarring (fibrosis) and a progressive loss of function. As current therapies fail to effectively stop this scarring process, we aim to engineer human bone marrow-derived stromal cells to express an anti-fibrotic agent (serelaxin), to deliver the therapeutic potential of this combination therapy as a treatment of chronic kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019024"^"http://purl.org/au-research/grants/nhmrc/2019024"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing and understanding Tr1 cells in inflammation,Ideas Grants"^"Inflammation that is inappropriately directed causes a range of important human diseases and current therapies for these diseases are limited. New methods or identification of new mechanisms that can be exploited to control persistent inflammation are therefore urgently required. In this project we will explore the biology of Type-I regulatory T cells (Tr1 cells), which appear to play an important role in the control of inflammation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019032"^"http://purl.org/au-research/grants/nhmrc/2019032"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Codon bias and the role of tRNA modifications in cancer,Ideas Grants"^"Cancer is characterised by high rate of cell growth and proliferation. Cancer cells need to increase their biomass to divide and this is dependent on the the synthesis of proteins. We have recently discovered that transfer RNAs, the small molecules carrying the building blocs required for protein synthesis, are chemicaly modified and that these modifications could be targeted to strongly inhibit tumour growth and progression in a wide array of cancers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019058"^"http://purl.org/au-research/grants/nhmrc/2019058"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"How does metabolic conditioning of the host environment enhance persistence of Haemophilus influenzae infections?,Ideas Grants"^"To thrive, bacterial pathogens infecting humans require access to high quality nutrients, but our understanding of pathogen nutrition is limited. We will examine how virulence of the respiratory pathogen Haemophilus influenzae (NTHi) is determined by nutrient availability in the human respiratory tract and how the presence of NTHi changes the way human cells detect infection. The project will identify targets for the development of novel types of antimicrobials that starve NTHi of key nutrients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019079"^"http://purl.org/au-research/grants/nhmrc/2019079"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Shedding new light on vagal nerve stimulation,Ideas Grants"^"Inflammation is a complex response to injury and overactivation of inflammation can lead to damage to the host. Stimulating the vagus nerve (VNS) is known to have powerful anti-inflammatory effects but the mechanisms are not well understood. We will use cutting-edge molecular tools in a pre-clinical model of inflammation to allow us to selectively target branches of the vagus nerve going to specific organs and will determine the contribution of each organ to the anti-inflammatory effect of VNS."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019087"^"http://purl.org/au-research/grants/nhmrc/2019087"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Interrupting suicides in public places: Using CCTV to understand, detect, and respond to behaviours prior to a suicide attempt,Ideas Grants"^"Suicide is a leading cause of death, and 30% of all suicides occur in public places. Despite this frequency, we lack an understanding of the key behaviours people exhibit prior to a suicide attempt in different public settings, and we lack the tools to identify these behaviours at the scale needed for those responsible for those public sites to meaningfully respond. This project will characterise, detect, and respond to behaviours which precede suicide attempts in public places in Australia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019093"^"http://purl.org/au-research/grants/nhmrc/2019093"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving estimates of antimalarial drug resistance,Ideas Grants"^"Antimalarial drugs are essential for the elimination of malaria. Resistance to all currently available antimalarials, including the pivotal artemisinin derivatives, has emerged and is spreading. This project aims to generate the first data-driven, predictive maps of the changing landscape of artemisinin resistance in Asia. These maps fill in the gaps where no information is available and can be used by health agencies to guide new polices about where and when the drug is appropriate to use."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019097"^"http://purl.org/au-research/grants/nhmrc/2019097"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A metabolic enzyme as a target for controlling tumourigenesis,Ideas Grants"^"Cancer is the leading cause of death in Australia and globally. The majority of cancers are associated with metabolic alterations in tumours. We have identified a key role for an enzyme involved in fatty acid metabolism which impairs immune responses involved in tumour-control and drives cancer. This research aims to investigate key mechanisms of how this enzyme promotes tumour progression and establish the development of inhibitors of this enzyme that can be applied to different cancers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019100"^"http://purl.org/au-research/grants/nhmrc/2019100"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Finding Biomarkers and Treatments for Vascular Dementia,Ideas Grants"^"Vascular dementia (VaD) occurs as a result of brain hypoperfusion and represents the second most common type of dementia after Alzheimer's disease. Currently, no specific treatments for VaD exist due to incomplete understanding of the underlying pathophysiology. We are studying inflammasomes as a new therapeutic target to treat VaD. In the next 5 years, this project expects to discover translatable preclinical targets and therapies to treat VaD, and novel biomarkers to diagnosis VaD in humans."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019101"^"http://purl.org/au-research/grants/nhmrc/2019101"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Combining genetics and genomics to tackle ovarian cancer.,Ideas Grants"^"Recent studies have identified DNA markers within the human genome that are associated with an increased risk of ovarian cancer. Most of these markers are located in noncoding regions, therefore the key genes driving risk are not known. This proposal will identify the target genes at all ovarian cancer risk regions and assess gene function in cancer development. Understanding how DNA variation contributes to ovarian cancer will provide new avenues for future prevention or treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019139"^"http://purl.org/au-research/grants/nhmrc/2019139"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Repurposing the in-clinic PCSK9 inhibitor evolocumab to enhance Gemcitabine/Abraxane chemotherapy in pancreatic cancer guided by single-cell intravital imaging,Ideas Grants"^"During pancreatic cancer development, cancer cells undergo metabolic rewiring in order to survive, grow and spread. This Ideas Grant will use advanced animal imaging and unique patient-derived pancreatic cancer specimens to explore targeting PCSK9 with drugs already in the clinic, in combination with chemotherapy. This new dual therapy could significantly improve treatment response in this devastating disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019152"^"http://purl.org/au-research/grants/nhmrc/2019152"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Multi-species malaria transmission modelling to inform policy decisions,Ideas Grants"^"Most malaria cases are caused by two parasite species. While many countries with malaria have both species, decisions about treatment and control of malaria rely on data and mathematical models on one species. Working with policy makers, we have built a novel model that includes both species. This model will explore how species interact and determine how to allocate money on strategies that will maximise health benefits, ensuring that we reach malaria elimination as quickly as possible."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019153"^"http://purl.org/au-research/grants/nhmrc/2019153"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The newly-discovered splenic Plasmodium reservoir as a target to reduce global malaria burden,Ideas Grants"^"We have recently discovered that the spleen is the major reservoir for malaria parasites in natural human malaria infections. There are significant concerns that this previously-unrecognised reservoir underlies the major challenges we face to eliminate this disease. We will use the world’s only collection of spleen and blood samples from untreated human infections, to study the splenic malaria reservoir, uncover its biology and identify new ways to improve malaria elimination strategies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019160"^"http://purl.org/au-research/grants/nhmrc/2019160"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pharmaceutical Development of Innovative "Trojan Horse" Anti-Cancer Agents that Inhibit Desmoplasia by Reprogramming Signalling,Ideas Grants"^"We discovered the new PPPT agents that reprogram Sonic Hedgehog Signalling to Inhibit Desmoplasia. Another breakthrough is that these agents totally prevent myoglobin (Mb) oxidation, which was an issue with our clinically trialled agent, DpC Underlining Innovation, no other drug currently available prevents deleterious Mb oxidation, targets the deadly "Triad of Death" (metastasis, Pgp resistance, primary tumour growth), and &amp; inhibits bidirectional oncogenic signalling that leads to desmoplasia"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019167"^"http://purl.org/au-research/grants/nhmrc/2019167"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Oxidised Cholesterols as Key Regulators of Host Immunity to Tuberculosis,Ideas Grants"^"Despite available antibiotics we have failed to eradicate TB. It is therefore critically important to elucidate the host immune factors that are required for effective containment of the bacteria that cause TB. We have identified that oxidised cholesterols play a critical role in attracting immune cells and containing the infection. This project will deliver further insights into this pathway which can ultimately be targeted with drugs to prevent the development of TB."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019196"^"http://purl.org/au-research/grants/nhmrc/2019196"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Mental Health Impact of Childhood SARS-CoV-2,Ideas Grants"^"Children have key differences in ACE2, the receptor by which SARS-CoV-2 enters host cells, that may make them especially vulnerable to lasting brain damage. We show that a single ACE2 inhibition in juvenile rats leads to lasting anxiety- and depressive-like behaviour and associated brain changes. We hypothesize these effects will be worse the younger COVID-19 occurs. We will reveal the potential for COVID-19 to critically impact children, changing the approach to child health in this pandemic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019231"^"http://purl.org/au-research/grants/nhmrc/2019231"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Firing up oncolytic vectors: viral based strategies to repurpose necroptosis,Ideas Grants"^"Necroptosis is an inflammatory form of cell death that could be harnessed to turn on the immune response and fight tumours. This research will study necroptosis signalling and adapt existing approved oncolytic viruses to deliver proteins that initiate necroptosis specifically within the tumour. Melanoma and colorectal cancer models will be used for proof-of-principle. These second-generation therapeutics could work in concert with existing immunotherapies to provide superior cancer control."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019254"^"http://purl.org/au-research/grants/nhmrc/2019254"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Size matters: ECM regulation in pregnancy success,Ideas Grants"^"Complications affect ~15% of pregnancies. Appropriate regulation of cellular environment is required for correct implantation and placental formation, but disease will occur if it is defective. To diagnose and treat pregnancy complications we must first understand how implantation and the placenta form. This project will investigate mouse models with abnormal implantation and placental development. It will determine how and why disease occurs and investigate potential therapeutic interventions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019264"^"http://purl.org/au-research/grants/nhmrc/2019264"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel Targeted Therapies for Chronic Pain,Ideas Grants"^"Using single cell sequencing technology, we have identified several drivers underlying spinal hyperexcitability in neuropathic pain. Here we will confirm our findings with new spatial technology that reconstructs the spinal anatomical map and assess the effectiveness of 1) boosting inhibition via cell transplants and 2) suppressing hyperexcitability via CRISPR. Our work leverages new functional genomic technologies to rapidly deliver new safe, effective pain management approaches to the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019271"^"http://purl.org/au-research/grants/nhmrc/2019271"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Neural circuits that control movement: from mice to humans,Ideas Grants"^"Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting nearly 1% of individuals older than 60, one of the fastest growing neurological disorders, generating a substantial burden patients, and caregivers, with the total cost to the community in excess of $10 billion / year. Many patients with PD develop Freezing of gait. This grant aim to understand what causes freezing of gait in PD and new ways treat the effects of PD on gait and movement."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019296"^"http://purl.org/au-research/grants/nhmrc/2019296"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An Achilles’ heel of ovarian cancer: targeting ARID1A mutant tumours,Ideas Grants"^"Five-year survival for most women with ovarian cancer is poor, with drug resistance a major problem, especially once relapsed. Outcomes are particularly dismal for the sub-type ovarian clear cell carcinoma that is particularly drug resistant. We are looking beyond the DNA to the “epigenome” to target factors involved in changing the landscape of DNA in order to identify new therapies to treat ovarian cancer, overcome chemoresistance and extend the lives of women with this malignancy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019329"^"http://purl.org/au-research/grants/nhmrc/2019329"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploiting the gene transfer synergies of AAV and LNP to achieve highly efficient genome editing in the human liver,Ideas Grants"^"Genome editing is set to revolutionise the face of modern medicine. This project will develop a cutting-edge genome editing treatment carefully designed for therapeutic readiness. The team will exploit privileged access to explanted patient and donor livers as well as elite gene delivery systems to advance an innovative approach that will provide the foundations for a future clinical trial in children with severe and potentially fatal urea cycle disorders without further preclinical studies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019352"^"http://purl.org/au-research/grants/nhmrc/2019352"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A therapeutic solution for respiratory RNA viruses that corrects the patient’s TLR7-dependent inflammatory response,Ideas Grants"^"Respiratory virus infections such as COVID-19 and influenza cause mild to severe complications in humans, often resulting in patient death. With limitations in current treatments, there is an urgent need for novel therapeutics to combat these and other viruses. We propose a drug strategy that attacks a critical point in the viral pathogenesis process. With the knowledge of this control point, we developed a drug and will evaluate its efficacy for treating COVID-19, influenza and the common cold."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019360"^"http://purl.org/au-research/grants/nhmrc/2019360"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Gene regulatory mechanisms by autoimmune risk loci in primary human cells,Ideas Grants"^"The genetic causes of autoimmune disease (where the immune system attacks our own body) are poorly understood. While many small changes in patient DNA are linked with autoimmunity, for more than 90% of these mutations we do not know which genes or cells are affected. We will discover the genes controlled by autoimmune-specific DNA changes and how they disrupt immune cell function. This will discover how autoimmune diseases develop and provide information needed to develop new treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019361"^"http://purl.org/au-research/grants/nhmrc/2019361"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Role of Salt in Obesity Development,Ideas Grants"^"Modern diets high in sugar and fat have contributed significantly to the prevalence of obesity. However, tackling obesity by lowering dietary fat content in our diets has not succeeded to the degree that we expected. As a result, obesity is on the rise. Recently, my team has discovered that high salt intake, often present in a high fat diet, could be a key and overlooked factor that potentially contributes to the development and progression of obesity, especially combined with high fat feeding."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019372"^"http://purl.org/au-research/grants/nhmrc/2019372"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing an in vitro human sleep system,Ideas Grants"^"This project aims to understand the formation of cells in the brain that are critical for controlling sleep. These sleep neurons are often affected in sleep disorders such as narcolepsy, a condition involving sudden attacks of sleep that affects 1/2,000 humans. By understanding how sleep neurons develop within the brain we will be able to generate sleep neurons from stem cells. This will pave the way for future bench-to-clinic transplantation experiments to alleviate narcolepsy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019383"^"http://purl.org/au-research/grants/nhmrc/2019383"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Stimulating Biomimetic Neuroplasticity to Develop New Cell Therapy for Blindness.,Ideas Grants"^"The loss of light-sensing photoreceptors is a leading cause of blindness. Severe cases have no treatments, and we thus aim to develop effective cell therapy by transplantation of photoreceptors to restore vision. We can generate millions of these cells from stem cell generated mini-retinas (organoids), but transplantation outcomes are still ineffective. Here we will test whether electrical stimulation improves photoreceptor transplantation in animal models to rescue sight and treat blindness."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019404"^"http://purl.org/au-research/grants/nhmrc/2019404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Microelectrode recordings from the vagus nerve in awake humans,Ideas Grants"^"The vagus nerve is an important nerve that controls the heart, lungs and gut. It exits the brain and travels with the carotid arteries and jugular veins in the neck. As such it has defied direct investigation in humans, but here we have developed a means of inserting metal microelectrodes into this nerve and recording signals going to and from the brain. This approach promises to provide much needed information on how the organ control provided by the vagus nerve is affected in disease states."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019416"^"http://purl.org/au-research/grants/nhmrc/2019416"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Neurokinin 3 Receptor is a New Target for the Treatment of Autism Spectrum Disorder.,Ideas Grants"^"No treatment has been shown to be effective in treating the core symptoms of autism spectrum disorder. We have discovered a molecule, named NK3R, which plays a key role in the development of autism. Studying how this molecule works in mouse models of autism will help us to better understand the disorder and enable us to identify the signs of abnormal brain function. The outcomes of this 4-year research will ultimately enable us to propose new strategies to treat the symptoms of autism."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019420"^"http://purl.org/au-research/grants/nhmrc/2019420"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Human anogenital mononuclear phagocytes in tranmission of HIV,Ideas Grants"^"Dendritic cells (DC) are the first cells to interact with HIV and the program has discovered three that transmit the virus. This proposal will define the receptors these DCs use to bind HIV and how they activate the immune system which is important information for vaccine design. Using new technologies that the research program has pioneered, the proposal will also define how HIV transmission occurs in human inflamed tissue for the first time which will lead to better prophylactic treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019437"^"http://purl.org/au-research/grants/nhmrc/2019437"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting phenotypic plasticity to treat chemotherapy-resistant cancer,Ideas Grants"^"Some cancer cells are very aggressive. Those cells are the reason why cancers become resistant to chemotherapy. If we can eradicate the aggressive cells we can improve survival outcomes for patients. We have identified a new target, SULF1, that is required for cancer cells to be aggressive and evade chemotherapy. We now aim to show that by targeting SULF1 we can stop cancers from spreading and make them susceptible to chemotherapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019442"^"http://purl.org/au-research/grants/nhmrc/2019442"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving parent and child emotion regulation in early childhood to reduce population rates of child mental illness,Ideas Grants"^"The project develops and trials a new smartphone intervention that will radically redesign models for parenting support and the prevention of child mental illness. We aim to engage both mothers and fathers of children 2-4 years, and will optimise parent and child outcomes: (a) tailoring parenting resources to be relevant to specific parenting situations; (b) including Indigenous-led, culturally-derived content; and (c) using machine learning to personalise the delivery of 3 types of support."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019447"^"http://purl.org/au-research/grants/nhmrc/2019447"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding clonal hierarchy and tissue reconstitution post injury,Ideas Grants"^"Millions of blood cells are made by the body every day in specialised organ compartments. T-cells are white blood cells and make up an important part of the immune system that fights infections and cancer. In this study, we aim to find out how blood stem cells turn into T-cells as they move through different organ compartments. We are trying to understand how the blood system is regenerated after damage from cancer therapies by stem cell transplants to improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019455"^"http://purl.org/au-research/grants/nhmrc/2019455"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the therapeutic potential of mesenchymal stromal cells by priming via surface microtopographies,Ideas Grants"^"Mesenchymal stromal cells (MSCs) promote tissue repair, but lose their beneficial properties during the production process outside the body. We have found that culturing MSCs on surfaces with microscale patterns alters their properties. We will investigate how these surfaces improve the therapeutic activity of MSCs and develop a technology to allow this to be done at a large scale. Our discoveries will enable higher quality MSCs to be produced for therapies for a wide range of diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019477"^"http://purl.org/au-research/grants/nhmrc/2019477"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing PKCepsilon-Degrading PROTACs as Dual-Action Agents to Treat Type 2 Diabetes,Ideas Grants"^"Type 2 diabetes (T2D) is reaching epidemic proportions worldwide, and involves poor insulin production and decreased insulin sensitivity. This collaboration between diabetes researchers and medicinal chemists will translate basic science, demonstrating that inhibiting one enzyme can improve both these defects, into the generation of lead compounds that block this target. We will test inhibitors in models of T2D, providing proof-of-principle for their further development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019488"^"http://purl.org/au-research/grants/nhmrc/2019488"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A calcium influx pathway regulates adaptive cancer drug tolerance,Ideas Grants"^"New drugs for the treatment of melanoma, lung and other cancers has revolutionised therapeutic approaches for many patients. However, in many cases, cancers become tolerant and eventually completely resistant to these new therapies. This project team has identified a specific new drug target that may hold the key to preventing or reversing the tolerance to these therapies. This grant will focus on defining the therapeutic opportunities that this new drug target offers."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019492"^"http://purl.org/au-research/grants/nhmrc/2019492"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hijacking enzymes that charge tRNAs: a new strategy for development of anti-malarials.,Ideas Grants"^"New drugs are desperately needed to treat drug-resistant pathogens. We have discovered a class of inhibitor molecules, called “nukes”, that target enzymes powered by the energy molecule, ATP. “Nukes” induce the enzymes to generate their own inhibitors, via a mechanism that we call “reaction hijacking”. This project will investigate the design principles for making bespoke “nukes”, which will have applications in curing malaria, as well as infections with antimicrobial resistant bacteria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019552"^"http://purl.org/au-research/grants/nhmrc/2019552"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unlocking the potential of cancer associated fibroblasts to defeat pancreatic cancer.,Ideas Grants"^"There are key knowledge gaps in understanding the complex metabolism of the pancreatic cancer tumour microenvironment and how this influences poor response to current therapies. My research will directly address this by characterizing how the pancreatic cancer tumour microenvironment evolves as cancer progresses and its response to current therapies. This will inform development of more effective treatment strategies that can overcome resistance and improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019558"^"http://purl.org/au-research/grants/nhmrc/2019558"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dysregulated lymphatic vasculature in the pathogenesis of bronchopulmonary dysplasia,Ideas Grants"^"Bronchopulmonary dysplasia is a severe lung disease that is a main cause of disability and death in premature infants and there is no cure. We have found that a factor that enhances the growth of lung lymphatic vessels, essential fluid channels, protects the lung from structural and functional damage. We will used advanced research methods to define the role of these vessels in this disease to turn our discovery into new treatments that can help these tiny lungs develop and function normally."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019572"^"http://purl.org/au-research/grants/nhmrc/2019572"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting pyroptosis to limit the severity of influenza virus infections,Ideas Grants"^"Highly pathogenic influenza A virus infections are associated with highly mortality rates. To facilitate the development of improved treatments for severe IAV infections, this project will advance our fundamental knowledge of the mechanisms by which the host and virus interact and elucidate how the host's immune system can be therapeutically modulated to limit disease severity. These studies are crucial to ensure we are better prepared for the next pandemic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019595"^"http://purl.org/au-research/grants/nhmrc/2019595"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of genetic compensation in modifying disease severity and potential therapeutic application,Ideas Grants"^"Harmful mutations in the genome have significant impacts on health and survival. Recent studies have identified individuals with mutations, that are expected to cause disease, yet they are remarkably asymptomatic. Growing evidence suggests this is due to compensatory activation of other genes, masking the effects of damaging mutations. This project examines the trigger for this compensation to determine its relevance in preventing disease and potential use in genetic therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019655"^"http://purl.org/au-research/grants/nhmrc/2019655"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tracking transcriptional evolution in breast cancer using circulating tumour DNA,Ideas Grants"^"Tumours shed small amounts of DNA into the patient’s bloodstream. Therefore, a simple blood test gives us a window to study the cancer, offering a non-invasive alternative to tissue biopsies. This project will use circulating tumour DNA in blood to study how cancer evolves and becomes resistant to treatment in advanced breast cancer where only 25% of patients survive beyond five years. Our method is generalisable across tumour types and has the potential to transform real-time cancer monitoring."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019670"^"http://purl.org/au-research/grants/nhmrc/2019670"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel methods to improve reporting and peer review of systematic reviews of health evidence,Ideas Grants"^"Systematic reviews focus on the totality of available evidence on a given question, and often underpin healthcare decision making. However, the reporting of many systematic reviews is suboptimal. This amounts to wasted research effort, and systematic reviews that cannot reliably inform clinical and public health guidelines. This proposal will develop guidance and web apps to help researchers produce systematic reviews that better meet the needs of stakeholders, hence improving health outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019689"^"http://purl.org/au-research/grants/nhmrc/2019689"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"On target and on time, advancing molecular diagnosis of complicated childhood pneumonia for better patient outcomes and vaccine strategies,Ideas Grants"^"During pleural infection fluid pools in the lung. Identifying the bacterial cause is important, so children can receive the right antibiotics. Our new laboratory test can better identify bacteria than traditional methods. We will use our test to determine which bacteria are causing pleural infection in Asian children and how our test will improve clinical care. We will apply other molecular methods to determine how many cases could be prevented by pneumococcal vaccines."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019722"^"http://purl.org/au-research/grants/nhmrc/2019722"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting Impaired Glucose Sensing in the Brain to Improve Glucose Homeostasis in T2D,Ideas Grants"^"New drugs working in novel ways are needed to treat type 2 diabetes, because current treatments fail to prevent the progression of the disease. We showed that an enzyme, PKCe, interferes with the the sensitivity of the brain to glucose, so that it fails to respond to rising glucose levels. We will investigate how this enzyme prevents the brain from controlling blood glucose levels, and will also test whether blocking PKCe is able to improve glucose sensing, paving the way for drug development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019729"^"http://purl.org/au-research/grants/nhmrc/2019729"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Determination of “actionable vaccine targets” for breast cancer immunotherapy,Ideas Grants"^"In recent years, immunotherapy brings hopes for treatment of incurable cancer. However, understanding the right target for immunotherapy is critical and challenging. We have developed new technologies and will explore new classes of antigens that can form targets of vaccines and immunotherapy in breast cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019765"^"http://purl.org/au-research/grants/nhmrc/2019765"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing metabolism to improve the outcomes of deadly fungal infections,Ideas Grants"^"Life-threatening infections are complications of surgery, chemotherapy and organ transplantations. Therapies are limited and mortality is high. This project studies how metabolic adaptations could be harnessed to provide energy for effective immune responses and maintaining the function of vital organs during life-threatening fungal infection. We expect that the knowledge gained in this project will inform therapeutic innovations aimed at improving patient survival of serious fungal infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019767"^"http://purl.org/au-research/grants/nhmrc/2019767"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterising a novel toxin regulatory mechanism from the new hypervirulent Streptococcal pyogenes M1uk lineage in Australia,Ideas Grants"^"Group A Streptococcus (GAS) is a strictly human pathogen that ranks among the top 10 infectious disease killers. A new variant of GAS expressing a novel set of bacterial toxins has emerged in the United Kingdom, known as M1UK. The M1UK lineage is associated with increases in invasive disease. We have now detected that this new GAS M1UK lineage has arrived in Australia. This proposal will define the disease mechanisms underlying this new health threat to Australian and global health."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019780"^"http://purl.org/au-research/grants/nhmrc/2019780"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"GABA-A receptor variants in developmental and epileptic encephalopathy: a bench to bedside approach.,Ideas Grants"^"Developmental epileptic encephalopathies (DEE) are a group of severe brain disorders characterised by childhood seizures that are often treatment resistant. We identified that hyperactivity in GABA-A receptors (the major inhibitory protein of the brain) caused by novel mutations are responsible for treatment resistant DEE. With a team of scientists, geneticists, and neurologists we aim to decipher the role of these receptors in brain networks and translate our discoveries to the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019804"^"http://purl.org/au-research/grants/nhmrc/2019804"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Testing a preventative strategy for sudden unexpected death in epilepsy (SUDEP) in mouse models based on human genetics,Ideas Grants"^"What causes sudden unexpected death in epilepsy (SUDEP) in unclear, although irregular heart rhythm is suspected to play a role. We recently found that genetic changes in the heart could help identify epilepsy patients who are at higher risk of SUDEP. By introducing these genetic changes in research models, we can understand how the heart responds in events leading up to SUDEP, and if improving heart function with currently available therapies can reduce SUDEP risk."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019818"^"http://purl.org/au-research/grants/nhmrc/2019818"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inspire the bright side of kidney fibroblasts to prevent and cure chronic kidney disease,Ideas Grants"^"Chronic kidney disease (CKD) is a worldwide public health problem. Current clinical strategies for CKD are largely ineffective. Kidney transplantation and dialysis are the only options for the management of end stage kidney disease (ESKD), which results in a significant personal and societal burden. This project will innovatively promote the good function but hinder the bad role of kidney fibroblasts thereby conferring renal protection in CKD through targeting En-1 gene function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019831"^"http://purl.org/au-research/grants/nhmrc/2019831"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Healing Spirit, Healing Minds: Co-designed healing program to promote social and emotional wellbeing of Aboriginal and Torres Strait Islander youth.,Ideas Grants"^"The Healing Spirits, Healing Minds project will co-design and evaluate a healing program under the leadership of First Nations youth that are most at risk of suffering from undetected and under-supported suicidal ideations and behaviours. The resulting program is anticipated to incorporate peer mentorship with activities focused on 1) promoting empowerment and wellbeing, 2) building social connections, 3) facilitating emotional regulation, and 4) encouraging help seeking behaviours."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019843"^"http://purl.org/au-research/grants/nhmrc/2019843"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting metastatic pancreatic cancer via selective inhibition of oncogenic JNK,Ideas Grants"^"Pancreatic cancer is one of the most lethal forms of human cancer. The current standard-of-care chemotherapies are known to be largely ineffective against advanced disease and new treatment options are urgently needed. We have developed a novel drug (K12) that selectively inhibits the metastatic function of JNK in breast cancer, and shown that this oncogenic pathway is conserved in pancreatic cancer. We will now test the utility of our novel drug as a treatment for metastatic pancreatic cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019853"^"http://purl.org/au-research/grants/nhmrc/2019853"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing novel therapeutic strategies and predictive biomarkers in Pancreatic Cancer,Ideas Grants"^"Pancreatic cancers are frequent and have extremely poor outcomes. Very few treatments are available for patients with this disease. Candidate drugs have recently emerged to block specific genetic modifications found in this cancer, but tumour cells can often evade these treatments. Here, we will combine innovative genetic and cellular analyses to design specific drug combinations preventing the ability of pancreatic cancers to escape treatment and thus improving the treatment of this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019859"^"http://purl.org/au-research/grants/nhmrc/2019859"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying modifiable health and social determinants of 'deaths of despair': learning from the past to shape new interventions,Ideas Grants"^"Deaths of despair (due to alcohol, other substances, and suicide) have risen dramatically in Australia and globally over the last 20 years. These are avoidable deaths given timely and targeted intervention. Using population-based data linkage, novel machine learning methods, and mathematical modelling, we will examine risk factors, and model the impact of potential interventions to reduce deaths of despair to inform targeted strategies and policies to prevent these premature deaths occurring."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019867"^"http://purl.org/au-research/grants/nhmrc/2019867"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new brain circuit of GPR75 to regulate metabolism,Ideas Grants"^"The increasing prevalence of obesity represents a major public health crisis worldwide. In Australia, almost two-thirds of adults are overweight or obese. GPR75 is a gene recently identified to play an important role in body weight regulation. Indeed, humans and mice carrying loss-of-function mutations of GPR75 are protected from obesity. This proposal will determine the specific site of action, and underlying mechanism of GPR75-induced protection against obesity, and its related hypertension."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019871"^"http://purl.org/au-research/grants/nhmrc/2019871"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel regulation of a fundamental host defence pathway by human herpesviruses,Ideas Grants"^"Human cytomegalovirus (HCMV) and herpes simplex virus (HSV) often cause serious disease. Eg, HCMV is the leading infectious cause of birth defects and a major complication in transplant patients, and HSV causes cold sores that can be life-threatening in those with a compromised immune system. We have identified a novel way that these viruses can control the host response to infection. This research proposal will investigate this control to identify potential ways to control viral disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019889"^"http://purl.org/au-research/grants/nhmrc/2019889"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel therapeutic target for obesity: Salt-inducible kinase 3 (SIK3),Ideas Grants"^"The overconsumption of high calorie foods together with sedentary lifestyle are key reasons for the obesity epidemic. The brain plays an important role in controlling the amount of energy intake and expenditure. However, how the brain controls these physiological processes remain poorly understood. In this proposal, we aim to study a new molecule in the brain to control appetite and body weight and establish this molecule as a potential new therapeutic target for the treatment of obesity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019904"^"http://purl.org/au-research/grants/nhmrc/2019904"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Endothelial origin of left ventricular non compaction,Ideas Grants"^"Primary cardiac myopathies refers to inheritable heart diseases, characterised by weak heart muscles. A common form of these disorders is left ventricular non-compaction (LVNC). By enlarge our understanding of the cellular origin of these cardiac defects is still unknown. This proposal will investigate how defects in blood vessel formation during embryogenesis is a cause of LVNC. This work will help to risk-stratify patients with LVNC cardiac disease to better manage adverse outcome."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019912"^"http://purl.org/au-research/grants/nhmrc/2019912"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding how platelets prevent fetal and neonatal stroke,Ideas Grants"^"Stroke is caused by either abnormal clotting or by unchecked bleeding; both result in devastating damage to the brain, causing death or life-long disability. Newborn children with low platelet numbers are at high risk of bleeding-associated stroke, yet we do not understand why. We hypothesize that the cause is rooted in early development. We will identify when these problems arise and define therapeutic strategies for the prevention or amelioration of neonatal stroke."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019920"^"http://purl.org/au-research/grants/nhmrc/2019920"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Uncovering and detecting placental dysfunction in late-onset preeclampsia,Ideas Grants"^"Preeclampsia is a life-threatening disease of pregnancy with grave immediate and life-long consequences for the mother and baby. The root cause of preeclampsia is an unhealthy placenta which releases toxins into the maternal blood causing maternal organ damage. This project will identify early pregnancy biomarkers to detect women who are at risk of developing preeclampsia and discover the key molecular mechanisms which drive preeclampsia, leading to new preventative treatment options."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019925"^"http://purl.org/au-research/grants/nhmrc/2019925"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Metformin, gut epithelium and microbiome in the prevention of colorectal cancer,Ideas Grants"^"Prevention of colorectal cancer (CRC) saves lives. Metformin, a safe drug clinically used as an anti-diabetic therapy, has been shown to suppress cancer. Yet, its successful implementation as a CRC preventative is limited by a lack of knowledge on how metformin elicits these anti-cancer effects. Our project will provide a holistic understanding of how metformin impacts the colon lining, its microbiome and CRC development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019931"^"http://purl.org/au-research/grants/nhmrc/2019931"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The first tool to quantify brain copper during life,Ideas Grants"^"Copper is essential for brain health but serious diseases result from either too much, or too little, copper in the brain. Unfortunately we do not have a method to measure brain copper levels. This limits our ability to understand the role of copper in these disorders and to deliver safe, effective treatments to patients. We are developing a technology to directly measure brain copper levels during life to solve these important problems."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019934"^"http://purl.org/au-research/grants/nhmrc/2019934"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Novel determinants of male fertility carried by seminal fluid extracellular vesicles,Ideas Grants"^"A father's influence over reproductive outcome goes beyond the provision of sperm. Our research has shown that signals carried by seminal fluid influence the likelihood of conception and pregnancy, but the identity and regulation of these signals is unknown. This research will define novel drivers of fertility and expand our understanding of the biological events at conception. Ultimately, these findings will inform the development of therapeutics that address the rising burden of infertility."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019948"^"http://purl.org/au-research/grants/nhmrc/2019948"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing a native corticosteroid-binding globulin to treat life-threatening septic shock,Ideas Grants"^"Septic shock is a maladaptive response to overwhelming infection that leads to organ failure and death. Corticosteroid-binding globulin (CBG) is a blood protein with unique properties to deliver the body’s natural anti-inflammatory hormone, glucocorticoid, to threatened organs - but its excessive depletion in septic shock triples the risk of dying. Our experiments in mouse models of sepsis are important next steps towards the use of CGB therapy to prevent deterioration and death in patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019968"^"http://purl.org/au-research/grants/nhmrc/2019968"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing Therapeutic Engineered Virus-Like Particles to Target Genetic Diseases of the Retina,Ideas Grants"^"Inherited retinal disease is a leading cause of blindness among working-aged adults. Advances in diagnosis have identified mutations in genes which can cause these diseases. The project aims to develop and construct personalised gene therapy treatments for patients with inherited retinal diseases. The team will combine customised gene editing tools to fix their particular gene mutation together with a delivery system that specifically target the affected cell type."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019970"^"http://purl.org/au-research/grants/nhmrc/2019970"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The neural bases of inhibitory learning and disorders of action control,Ideas Grants"^"Several mental disorders including Tourette syndrome and obsessive-compulsive disorder, share a common feature, that is, the repeated urge to engage in behavioural sequences that are counterproductive or damaging. This proposal will study the neural bases of naturally-occurring processes for behaviour change by which subjects learn to inhibit maladaptive actions. The findings will help develop effective therapeutic interventions that promote inhibitory learning in affected individuals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019988"^"http://purl.org/au-research/grants/nhmrc/2019988"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A human experimental model to assess whether the gut microbiota regulates specific and non-specific immune responses to vaccination,Ideas Grants"^"Our hypothesis is that the gut microbiota is a critical and targetable factor regulating specific and non-specific immune responses to vaccination. To assess this, we will investigate the impact of depleting the human gut microbiota on protection mediated by the BCG vaccine against microbes specifically targeted by the vaccine and unrelated infections. This study will lead to new interventions to maximise vaccine mediated protection in vulnerable populations worldwide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019991"^"http://purl.org/au-research/grants/nhmrc/2019991"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Transforming the management of perinatal depression through precision medicine to improve outcomes for women and children,Ideas Grants"^"Pharmacogenetics have increasingly been shown to be relevant to the understanding of outcomes associated with antidepressants. By using a study of 862 women, including 158 taking antidepressants in pregnancy, we propose to use a new novel approach to elucidate how better to manage depression in pregnancy for women and also predict vulnerability to adverse impacts for the infant following antidepressant exposure and whether this can be attributed to variation in pharmacogenetics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2019993"^"http://purl.org/au-research/grants/nhmrc/2019993"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Tuning mitophagy in mitochondrial diseases,Ideas Grants"^"The accumulation of damaged mitochondria is detrimental to cells and results in diseases. This fundamental research addresses how cells maintain a healthy mitochondrial population. We have discovered a pathway that maintains healthy mitochondrial numbers in cells. This pathway does not function properly in a devastating disease called mitochondrial DNA depletion disease. In this proposal, we seek to determine strategies to restore mitochondrial function in this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020010"^"http://purl.org/au-research/grants/nhmrc/2020010"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Let there be light- Modified Serpin as a Dual Function Therapeutic Agent in Glaucoma,Ideas Grants"^"Glaucoma causes blindness and despite our best treatment many patients continue to progress. A new and innovative approach is needed to protect the cells that die in the retina. We have engineered a protease inhibitor – neuroserpin – a protein that is deactivated in the disease. We aim to deliver this molecule to retinal cells using an “artificial virus” approach and determine its usefulness as a novel and innovative therapy in glaucoma."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020020"^"http://purl.org/au-research/grants/nhmrc/2020020"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel approach to reducing the psychosocial burden of infertility treatment,Ideas Grants"^"One in six Australian couples experience infertility. Up to 75% of patients will report anxiety or depression during reproductive treatment, but less than 20% will receive mental health support. This research will generate new evidence on how coping, social support and mood change across an in vitro fertilization cycle (IVF). It will produce an online coping intervention for patients and information resources for partners and families, leading to better mental health outcomes after IVF."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020035"^"http://purl.org/au-research/grants/nhmrc/2020035"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Computational analysis and Artificial Intelligence in brain tumour imaging: towards the augmented diagnostics of the future,Ideas Grants"^"This work will apply computer models, including Artificial Intelligence techniques, to augment expert diagnosis of brain tumours with the aim of better predicting patients’ prognosis, optimising their treatment and thereby improving their outcomes. By the end of this research, a new diagnostic paradigm will be in place: computers will help clinicians and surgeons in their decision-making to ensure the best treatment of patients affected by brain tumours, throughout their journey."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020050"^"http://purl.org/au-research/grants/nhmrc/2020050"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Fat Chance for Melanoma,Ideas Grants"^"Recently a study in melanoma patients showed that overweight patients did much better on treatment than normal weight patients. This project aims to understand how body fat makes melanoma patients more responsive to therapy. By understanding the biological basis for this association, we can design new therapeutic strategies that will improve the outcomes for melanoma patients and not lead to adverse health effects associated with being overweight."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020077"^"http://purl.org/au-research/grants/nhmrc/2020077"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using genomic signatures of natural selection to elucidate the genetic architecture of multiple sclerosis,Ideas Grants"^"Multiple sclerosis (MS) is more common in people of European descent, and more common further from the equator. It is likely that this pattern has been shaped by natural selection. Identifying genes that increase MS risk and have experienced natural selection will improve our understanding of what causes the disease. We will identify specific genes that are under local selection in response to environmental factors, helping to better target therapies aimed at these risk factors."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020078"^"http://purl.org/au-research/grants/nhmrc/2020078"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New ways to treat fatty liver disease: a focus on lipid metabolism,Ideas Grants"^"Individuals with obesity have increased risk of developing other metabolic diseases including non-alcoholic fatty liver disease and diabetes. This is partially due to impairments in the capacity to burn fat and excessive accumulation of fat in most tissues of the body. We have identified a new pathway by which cells of the body regulate fat breakdown. In this project, we aim to test whether activating this pathway is effective in slowing the development of fatty liver and diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020097"^"http://purl.org/au-research/grants/nhmrc/2020097"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unlocking the Therapeutic Potential of a New ‘Dual-Action’ Target for Bone and Joint Diseases,Ideas Grants"^"Diseases affecting the bones and joints are devastating to physical function and human health and often feature bone destruction by osteoclasts, giant bone dissolving cells. However, treatments for these diseases remain inadequate. We have discovered a new molecule that blocks osteoclast function and helps build new bone when inhibited. This proposal evaluates the utility of this promising target for the development of new bone preserving drugs for the treatment of bone and joint diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020111"^"http://purl.org/au-research/grants/nhmrc/2020111"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predict, prevent and treat bone metastases in prostate cancer,Ideas Grants"^"Bone metastases are a fear development of prostate cancer that cannot be predicted and for which there is no effective treatment. In this translational and multidisciplinary project, we will develop an innovative strategy to predict, prevent and treat bone metastases. Our idea is based on cancer neurosciences and the targeting of nerves in prostate cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020113"^"http://purl.org/au-research/grants/nhmrc/2020113"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Network level decoding of touch and pain in the spinal cord,Ideas Grants"^"Understanding how touch and pain signals pass through the spinal cord is critical in pain treatment, especially for touch-evoked pain. Our current understanding focuses on small circuits of spinal nerve cells, even though we know touch and pain activate much larger networks to produce signals that reach our brain. This project will decode network-level signalling of touch and pain in the spinal cord by studying activity in large nerve cell networks using imaging and complex systems analysis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020121"^"http://purl.org/au-research/grants/nhmrc/2020121"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Test often, treat early: Are major changes in policy and practice needed to eliminate hepatitis C among people with HIV?,Ideas Grants"^"Hepatitis C treatment is highly effective, preventing liver-related morbidity and mortality for individuals, as well as onward transmission of hepatitis. However, current limitations on the number of tests per year and restrictions on treatment until chronic hepatitis C infection has been confirmed, mean that treatment is usually delayed for over a year after diagnosis. This proposal aims to estimate potential benefits from allowing more frequent testing and earlier treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020137"^"http://purl.org/au-research/grants/nhmrc/2020137"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"In vivo genetic engineering of T-cells for cancer treatment using novel exosome mimetic nanoparticles,Ideas Grants"^"Despite the promise of using genetically engineered T-cells for treatment of a variety of immune-mediated diseases, current methods are expensive, labour-intensive, result in significant side effects, and have limited availability. In this proposal, we will re-engineer naturally occurring vesicles that are present in our body to allow them to redirect T-cells to specific danger signals. We will examine the therapeutic efficacy of this novel nanotechnology in cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020149"^"http://purl.org/au-research/grants/nhmrc/2020149"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Spatial analysis to investigate cancer evolution as a complex ecosystem of interacting tumour populations,Ideas Grants"^"Cancer is a disease where cells grow rapidly, creating tumours. However, all tumour cells are not the same. There can be multiple cell types within a single tumour. These are likely interacting, helping each other grow. We aim to understand which tumour cells are cooperating with each other in prostate cancer that has spread using computational methods. With this, we hope to develop a new type of treatment that works by disrupting how tumour cells talk with each other and thus kill tumours."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020151"^"http://purl.org/au-research/grants/nhmrc/2020151"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of new treatment options for post-sepsis acute lung injury (ALI).,Ideas Grants"^"Acute lung injury (ALI) occurs due to uncontrolled inflammation and is a major cause of death in Australia because there are no treatments. We recently found treatment with a new protein called A3 protects mice from this condition. In this project, we will develop A3 into a new class of anti-inflammatory drug and test it in mouse models of ALI that resemble human ALI and validate our results in human cells. This invention will address one of the most important unmet clinical needs worldwide."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020152"^"http://purl.org/au-research/grants/nhmrc/2020152"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Autoimmunity; Finding the key to chronic atherosclerotic inflammation and plaque rupture,Ideas Grants"^"Heart disease is the leading cause of death globally, and ~1/3 of all deaths in Australia. Inflammation has been identified as a major cause of heart disease. However, what drives inflammation in heart diseases is not well known. Our research will explore how T cells, a common white blood cell, might cause heart attacks and strokes. By doing so, we will identify new ways in which we can treat inflammation and thereby prevent the massive numbers of deaths caused by heart disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020164"^"http://purl.org/au-research/grants/nhmrc/2020164"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Assessment and modulation of cortical sensorimotor control for recovery after stroke,Ideas Grants"^"Our goal is to promote the recovery of motor function after stroke. We will create a computational model of the effects of stroke on the motor control system throughout rehabilitation. We will determine whether electrical stimulation can enhance the effect of movement-based therapy on recovery after stroke. We will also adjust our stimulation based on ongoing brain activity. We hypothesise that feedback mediated rehabilitation is a more robust mechanism to activate affected areas."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020169"^"http://purl.org/au-research/grants/nhmrc/2020169"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Protecting vitamin D levels to prevent chemotherapy-induced gastrointestinal mucositis,Ideas Grants"^"Vitamin D deficiency is common in cancer patients, and is linked to the incidence of many cancers. Maintaining vitamin D levels is key for maximising therapeutic outcomes and preventing chemotherapy- induced mucositis. We will identify cancer patients as ‘at risk’ for vitamin D deficiency, leading to higher incidence and severity of chemotherapy-induced mucositis. We will investigate therapeutic options for maintaining vitamin D levels and preventing chemotherapy-induced mucositis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020173"^"http://purl.org/au-research/grants/nhmrc/2020173"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bacteriophages: a new paradigm in caring for infected wounds.,Ideas Grants"^"We will develop wound dressings carrying bacteriophages (viruses that kill bacteria) as a safe, effective way to treat wound infections. This will have great impact on treatment of diabetic foot ulcer infections, which currently often lead to amputation, which carries extremely high mortality. This work will lead to a new paradigm in wound care and will dramatically improve the lives of people with diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020185"^"http://purl.org/au-research/grants/nhmrc/2020185"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"An accessible chronic pain therapeutic target in peripheral sensory nerves,Ideas Grants"^"Chronic pain is hugely debilitating and its prevention remains an area of unmet clinical need. Nerve injuries result in exaggerated responses to painful, and even mild, stimuli. In pre-clinical models, we have discovered that removing a single protein from neurons, either throughout the nervous system or only in the peripheral nervous system, significantly diminishes injury-induced pain. This research aims to find a way to interfere with the development of chronic pain by targeting this protein."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020192"^"http://purl.org/au-research/grants/nhmrc/2020192"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Using Big Data to Engineer Highly Immunogenic Hepatitis C Virus Envelopes for the Induction of Broad Neutralising Antibodies,Ideas Grants"^"There is an urgent need to develop a preventative vaccine against hepatitis C, a virus that causes chronic life-threatening disease in millions of people globally. This project will bring together intelligent big data design methods and innovative experimental models to engineer panels of viral antigens for eliciting antibodies capable of neutralising diverse virus strains. The findings can be used to design new hepatitis C vaccines aimed at preventing virus infection and chronic disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020197"^"http://purl.org/au-research/grants/nhmrc/2020197"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Bioengineered Model of Calcific Aortic Valve Disease,Ideas Grants"^"Calcific aortic valve disease is a common cause of mortality and morbidity in the elderly. Our limited knowledge of the mechanisms that drive the progression of aortic stenosis is a major obstacle in developing medical treatments for this disease. This project utilises a bioengineered aortic valve model that mimics features found in the early and late stages of this disease. It enables the systematic study of the complex pathology of this disease and serves as a platform for screening drugs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020226"^"http://purl.org/au-research/grants/nhmrc/2020226"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding neurodegeneration caused by oligodendroglial dysfunction,Ideas Grants"^"Globular glial tauopathy (GGT) is a recently described frontotemporal dementia, a debilitating early-onset neurodegenerative disorder. GGT is characterised by abnormal tau protein in oligodendroglia, the main neuron support cell. Previous research has focused on neurons, which cause neurodegeneration and clinical symptoms with little consideration of oligodendroglia. This study will investigate how dysfunction in oligodendroglia causes neurodegeneration in human and preclinical disease models."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020234"^"http://purl.org/au-research/grants/nhmrc/2020234"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Community driven communication and engagement during health crisis periods: co-designing enhanced and transferable strategies,Ideas Grants"^"Communicating crisis information with “hard-to-reach” culturally and linguistically diverse (CALD) communities is a significant challenge. Leveraging existing networks and actors can ensure that information reaches CaLD communities. We will fill a key gap via developing a: (1) communication and engagement strategy that outlines best practices around the identification and support of information intermediaries and (2) a training program that focuses on capacity building with CaLD communities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020251"^"http://purl.org/au-research/grants/nhmrc/2020251"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Systems Genetics Approach to Defining the Sexual Dimorphism in Exercise-Induced Cardioprotection,Ideas Grants"^"Men and women differ in their risk and development of cardiovascular disease (CVD) and their response to the protective effects of exercise; however, we do not fully understand the mechanisms underlying these differences. We propose to generate a cutting-edge research tool that characterises the changes in the heart at rest and in response to exercise in male and females. Using this tool, we will identify novel targets that we will test for their ability to treat CVD in a personalised manner"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020253"^"http://purl.org/au-research/grants/nhmrc/2020253"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Burning Question – how safe is sun exposure at low-dose and intensity?,Ideas Grants"^"Skin cancers are more common in Australia than all other cancers combined. To reduce their burden, Australians are advised to protect their skin when the sun is strong, but not when the sun is weak. We will test whether low-intensity sunlight is ‘harmless’ by exposing the skin of volunteers to non-burning doses of UV radiation, and then assessing the effects on their skin cells. The information from these experiments will inform sun protection policies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020285"^"http://purl.org/au-research/grants/nhmrc/2020285"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New approaches to enhance immunotherapy for brain tumours,Ideas Grants"^"Primary brain tumours and brain metastases arising from other tumours both have extremely poor patient outcomes. Immunotherapy offers great promise for brain tumour therapy, but is currently limited due to brain tumour-induced immunosuppression. This proposal aims to overcome this problem to improve the potency of brain tumour immunotherapies. Successful outcomes in this work have the potential to dramatically improve the survival outcomes for glioblastoma patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020289"^"http://purl.org/au-research/grants/nhmrc/2020289"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modulation of the M4 muscarinic receptor for the treatment of schizophrenia,Ideas Grants"^"The M4 muscarinic receptor is a promising drug target for treating schizophrenia, with therapeutic outcomes above and beyond any current antipsychotics. Recently, two M4-targeting drugs, xanomeline and emraclidine, have progressed to advanced stages in clinical trials. This project aims to explore the pharmacological outcomes of xanomeline and emraclidine as a novel, first-in-class, dual therapy to ultimately assist in designing more effective and safer drugs for treating schizophrenia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020303"^"http://purl.org/au-research/grants/nhmrc/2020303"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploiting GPX2 deficiency to enhance radiation response in gastrointestinal cancers,Ideas Grants"^"Bowel cancer is a major global health problem. Here, we will investigate how loss of protein called GPX2 can on the one hand contribute to the development of this disease, but make cancers sensitive to radiotherapy on the other. By studying the role of this critical protein, this project will deliver important new knowledge into how colorectal cancers arise, enable us to identify patients most likely to benefit from radiotherapy, and to develop a new way to improve response to this treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020305"^"http://purl.org/au-research/grants/nhmrc/2020305"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"HARNESSING TUMOUR SPECIFIC HOMING AND EVOLUTION OF PROBIOTIC BACTERIA TO ENGINEER NEXT-GENERATION BOWEL CANCER TREATMENTS,Ideas Grants"^"Bowel cancer kills over 5000 Australians each year. This failure of current treatments shows that a very different approach is needed. We are investigating the use of probiotics engineered to selectively release drugs direct to tumours. This research will help us understand why the probiotics home to tumours and how they change once in the tumour, so that we can better design probiotic treatments to treat bowel cancer in the future."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020315"^"http://purl.org/au-research/grants/nhmrc/2020315"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel algorithm for accurate and efficient alignment of long DNA and RNA sequencing reads,Ideas Grants"^"Long-read sequencing is a new development in DNA/RNA sequencing. It helps to find mutations and other genomic features that can never be found before. Mapping read sequences to the genome is usually the first step in the analysis. We will use many novel concepts to develop a new tool for long-read mapping. Because of its high efficiency and accuracy compared with the current tools, it can strongly enhance the value of long-read sequencing in both research and clinical settings."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020316"^"http://purl.org/au-research/grants/nhmrc/2020316"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the role of group 2 innate lymphoid cells in gastric cancer,Ideas Grants"^"Gastric inflammation and early gastric cancer (GC) development elicits a rapid expansion of specialised immune cells (ILC2) in the stomach and their dissemination into the bloodstream. This project aims to uncover the impact of the systemic spread of ILC2s on metastatic niche formation and metastatic cancer growth in the context of aggressive GC and to investigate the utility of circulatory ILC2 as diagnostic biomarker for GC in order to achieve better health outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020334"^"http://purl.org/au-research/grants/nhmrc/2020334"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Functional impact of CTCF binding site mutations in 3D cancer genome regulation,Ideas Grants"^"Understanding what regulates gene expression in normal cells and how this goes wrong in cancer is still one of the biggest challenges in modern biology. This grant is focused on investigating two classes of non-coding somatic mutations in breast and prostate cancer, which we hypothesise disrupt binding of an important DNA regulator (CTCF) and results in deregulation of specific regions of gene expression. Unravelling mechanisms underpinning CTCF site mutations may lead to new cancer treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020371"^"http://purl.org/au-research/grants/nhmrc/2020371"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel molecular test to determine if a pathogen is alive or dead - a tool to transform infectious disease management and reduce the threat of antimicrobial resistance,Ideas Grants"^"Antimicrobial resistance is threatening our ability to treat infections globally. Current molecular tests for infectious disease detect both living and dead pathogens contributing to overdiagnosis and treatment. We will use a novel real time molecular assay, adaptable across pathogens, to determine what proportion of sexually transmitted infections are viable as an exemplar. This study could transform our entire public health approach to infectious disease diagnosis and antimicrobial stewardship"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020376"^"http://purl.org/au-research/grants/nhmrc/2020376"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving therapeutic responses in oesophageal cancer by overcoming resistance to ferroptosis,Ideas Grants"^"Compared to normal tissues, oesophageal cancers increase their consumption of nutrients from the surrounding environment and change the way they use these nutrients in order to survive, grow, spread to other organs and resist treatments. This project will identify which nutrients oesophageal cancers depend on to survive, and develop strategies to exploit these dependencies and improve the efficacy of treatments used to combat this disease, thereby improving cure rates and long term outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020377"^"http://purl.org/au-research/grants/nhmrc/2020377"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Elucidating the signalling functions of Transmembrane Pseudokinases as a strategy to develop novel therapeutics modalities,Ideas Grants"^"Cells require highly coordinated communication signals to grow and divide. Any improper signalling responses can lead to conditions, such as cancer and inflammation. Pseudokinases have recently been discovered to play a vital role in the coordination of signals that can lead to cancer. This program aims to elucidate how transmembrane receptor pseudokinases contribute to “out of control” signalling, which will provide novel therapeutic strategies to counteract pseudokinase-driven diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020421"^"http://purl.org/au-research/grants/nhmrc/2020421"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Overcoming antiseptic and disinfectant resistance in staphylococci,Ideas Grants"^"Strains of Staphylococcus aureus (Golden Staph), resistant to almost all available anti-staphylococcal agents, are responsible for serious infections among patients. Resistance has emerged to all classes of antimicrobial agents, including antiseptics and disinfectants. We will increase our understanding of proteins that confer resistance by pumping multiple compounds out of the cell to ultimately be able to block their action."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020423"^"http://purl.org/au-research/grants/nhmrc/2020423"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing the protective effects of Interferon epsilon as a therapeutic for endometriosis,Ideas Grants"^"Endometriosis is a chronic, debilitating condition that affects 1 in 9 menstruators. People with the disease have limited treatment options and there is no cure. A defective immune response is one of the causes of the disease. This project aims to investigate a new immunomodulator, interferon epsilon (IFNe), which may exert protective effects against the development of endometriosis. We will investigate whether IFNe can be used as an innovative treatment for endometriosis."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020434"^"http://purl.org/au-research/grants/nhmrc/2020434"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A human brain organoid model of acute prenatal hypoxia enables biomarker discovery and drug screening for hypoxic-ischemic encephalopathy.,Ideas Grants"^"A lack of oxygen supply to the baby before and during birth has devastating immediate and long term consequences for brain development. Quantifiying the severity of birth asphyxia in newborns is difficult, little is known about the molecular and cellular processes involved, and effective treatments beyond cooling the newborn do not exist. Here we will use innovative human brain organoid models to address and overcome each of these knowledge and capability gaps."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020443"^"http://purl.org/au-research/grants/nhmrc/2020443"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Engineered Amphiregulin: A Novel Growth Factor to Promote Tissue Regeneration,Ideas Grants"^"Tissue regeneration is facilitated by key proteins that are released by immune cells in injured tissues. These proteins include growth factors, which are promising drugs for regenerative medicine. However, growth factors have found limited clinical success due to poor efficacy and/or side effects. We have developed a novel engineered growth factor that shows significant promise in promoting tissue healing. This project will confirm its safety and efficacy for regenerative medicine applications."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020452"^"http://purl.org/au-research/grants/nhmrc/2020452"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting interleukin-18-mediated inflammation to treat advanced kidney disease,Ideas Grants"^"Kidney failure is a leading cause of death and morbidity worldwide. This project will use state-of-the-art technologies to characterise the role of a newly identified molecule (interleukin-18) that contributes to the pathological remodelling that precedes kidney failure. The therapeutic potential of interleukin-18 inhibition will also be tested. This research will define an entirely new mechanism of kidney disease and validate interleukin-18 as a target for new therapies."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020453"^"http://purl.org/au-research/grants/nhmrc/2020453"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Nuclear mechanobiology in cell migration and metastasis,Ideas Grants"^"Preventing, diagnosing, and treating metastasis (the appearance of secondary tumors within the body) is the key to reducing death in breast cancer patients. Yet we still do not know exactly how cancer cells leave their tumors and invade into blood vessels to metastasise. Here we will test a new idea that invading breast cancer cells control their genes differently to normal cells, by the cell sensing its environment. This new understanding will help develop new drugs and diagnostic tools."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020454"^"http://purl.org/au-research/grants/nhmrc/2020454"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Stratifying low-calorie sweeteners for diabetes risk,Ideas Grants"^"Low calorie sweeteners are not inert sugar supplements. Rather, they are emerging as a risk factor for the development of diabetes. They can enhance sugar absorption from the gut and disrupt bacteria that live there, which can raise blood sugar levels. However, sweeteners are all distinct and are likely to affect blood sugar differently. We will test these differences in innovative human and animal studies to identify which sweeteners are safer options, in an effort to prevent type 2 diabetes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020455"^"http://purl.org/au-research/grants/nhmrc/2020455"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"CRACing the role of the Flavivirus NS1 protein,Ideas Grants"^"In this proposal, we will investigate the mechanisms by which various forms of the dengue viral protein, NS1 physically interacts with lipids and cholesterol. This is a critically important interaction for efficient viral replication and so understanding the ways in which NS1 engages with these host cell components should provide important clues as to how we can disrupt this interaction and so design potential anti-viral strategies not only for dengue, but also other flaviviruses."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020482"^"http://purl.org/au-research/grants/nhmrc/2020482"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Viral modulation of the host cell: The STAT3 Interface,Ideas Grants"^"This project will examine how viruses that cause major human diseases are able to interact with and control the cells that they infect, specifically through targeting of a central cellular regulator protein called STAT3. We will examine precisely how viruses selectively regulate STAT3 to control multiple processes in our cells that support viral infection and spread, and hence disease. By understanding how viruses do this, the project will identify new potential strategies to combat infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020483"^"http://purl.org/au-research/grants/nhmrc/2020483"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Discovery of eosinophil-derived thermogenic beiging factors to combat obesity,Ideas Grants"^"Obesity is a global problem. We study the signals that control the switch between the accumulation and the burning of fat. A new type of fat, beige fat, is important in burning rather than storing fuel. Our data show that signals from a specialised immune cell – the eosinophil – convert normal fat into beige fat. By identifying the signaling molecules eosinophils produce in mouse and human tissue, we seek to mimic their action, and therapeutically stimulate beige fat to combat obesity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020501"^"http://purl.org/au-research/grants/nhmrc/2020501"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Comparative human functional genomics of Island Southeast Asia,Ideas Grants"^"To date nearly all studies of how DNA variants impact genes have been carried out in people of European descent. But insights gained from them do not always translate to other populations. By combining measurements of gene expression obtained at a single cell level with samples from Island Southeast Asia, this project will be the first to characterise the genetic differences that impact immune response in these populations, with implications for disease progression and personalised medicine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020517"^"http://purl.org/au-research/grants/nhmrc/2020517"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Examining the ‘how’ and ‘why’ of blood cell gene regulation at loci relevant to autoimmune disease,Ideas Grants"^"Every person has a distinct DNA code, which is why some people get certain diseases and some don’t. This code is complex and we currently only understand a fraction of what it does. Our research aims to understand which bits of DNA code are important for causing autoimmune diseases. We will do this using new technologies, like subtly changing the DNA code and looking at the effect this has. Understanding how these changes influence disease can benefit clinical diagnosis and drug development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020532"^"http://purl.org/au-research/grants/nhmrc/2020532"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New pooled CRISPR screening approaches to study pain and painful venoms,Ideas Grants"^"It is time to develop new, effective, and non-addictive ways to manage pain, but this can only come from a better basic understanding of pain biology. Here, we develop and apply new pooled CRISPR screening technologies to map the human genome for factors that control pain. Our work here will yield the first genome-scale basic understanding of human pain regulation, and will provide a foundation for rational new painkillers for the 21st century."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020540"^"http://purl.org/au-research/grants/nhmrc/2020540"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hypothermic machine perfusion of circulatory death hearts for transplantation,Ideas Grants"^"Novel technology has been developed to mitigate injury associated with heart preservation during heart transplantation. Preliminary studies show this technology is effective, but its beneficial effects are poorly understood. This project will investigate at a functional and cellular level how this technology improves heart function during heart transplantation. Increasing use of this technology will increase the donor heart pool, and decrease the risk of death following heart transplantation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020543"^"http://purl.org/au-research/grants/nhmrc/2020543"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Characterising a novel molecular pathway to reduce penicillin failure for Strep throat,Ideas Grants"^"Strep throat is a common bacterial infection caused by Group A Streptococcus (GAS). While GAS is sensitive to penicillin in vitro, 10-20% of infections recur after treatment. We have identified that some GAS strains can replicate in a penicillin-resistant intracellular niche. This project will define this mechanism of resistance to penicillin and other antibiotics, and develop a prototype test to detect resistant infections at the point of care. This will lead to better treatment outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020555"^"http://purl.org/au-research/grants/nhmrc/2020555"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"HORIZONTAL GENE TRANSFER TO DETECT MUTATION AND REACT TO COLONIC NEOPLASIA,Ideas Grants"^"Bowel cancer is common and is defined by changes to our genetic material (DNA). In this project we will answer whether bacteria that naturally live in the bowel can be coerced to take up cancer DNA through cutting-edge synthetic design; and whether bacteria could, in the future, detect and then react to bowel polyps and cancer and thus facilitate the detection, prevention and treatment of bowel cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020562"^"http://purl.org/au-research/grants/nhmrc/2020562"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"PRC-1 regulation of mature CD8+ T cell effector and memory responses,Ideas Grants"^"The programming of effective killer T cell immunity is associated requires appropriate gene regulation that ensures acquisition of the specific functions necessary for control of infection and cancer, as well as the establishment of effective immunity. This study will examine how a key factor called PRC1 regulates the induction of optimal protective virus and tumour T responses. This knowledge will contribute to the development of novel treatments for infection, cancer and autoimmune disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020563"^"http://purl.org/au-research/grants/nhmrc/2020563"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The influence of genetic variation on foetal alcohol spectrum disorder,Ideas Grants"^"Drinking alcohol during pregnancy is the most common cause of environmentally induced human birth defects. But there is not a simple linear relationship between the amount of alcohol ingested and the consequence for the unborn child. In this research we will examine how the genetic makeup of an unborn child influences the consequence of maternal alcohol consumption."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020565"^"http://purl.org/au-research/grants/nhmrc/2020565"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Therapeutic targeting of TLR7 in autoimmunity,Ideas Grants"^"Autoimmune diseases, which are driven by self-reactive autoantibodies, affect approximately 5% of all Australians. While treatments are available to limit disease progression and morbidity, these are non-curative and can have numerous harmful side-effects. Here, we propose an innovative approach to thwart autoimmune disease by targeting how autoantibodies are generated. We have developed a new class of specific therapeutics that have the potential to help treat diverse autoimmune conditions."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020567"^"http://purl.org/au-research/grants/nhmrc/2020567"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reverse translation of a rodent cognitive flexibility task,Ideas Grants"^"Cognitive dysfunction is prominent in patients with neuropsychiatric and neurodegenerative disorders, yet current treatments have little effect on these symptoms. We need better treatments, but this requires better testing protocols. The goal is to provide a novel cognitive flexibility task for cognitive research in rodents that will help to develop initiatives to prevent, treat and rehabilitate patients with cognitive impairment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020569"^"http://purl.org/au-research/grants/nhmrc/2020569"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Liver metastases: a niche of resistance and of therapeutic opportunities for all cancers.,Ideas Grants"^"Drugs that stimulate immune cells to fight cancer (immunotherapy) have been used in melanoma and other cancers. The majority of melanoma patients resistant to immunotherapy have their melanoma spread to the liver; and we will study the effect of the presence of liver metastases on the immune response, in order to unveil novel mechanisms of resistance and therapeutic targets. Given the global finding across other cancers, our work has potential for impacting a broad range of cancer patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020579"^"http://purl.org/au-research/grants/nhmrc/2020579"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel pharmaco-genetic treatment for auto-immune kidney disease,Ideas Grants"^"There is mounting evidence that the enzyme DNase I is a novel non-toxic therapeutic for autoimmunity, an appealing alternative to long-term use of current sub-optimal immunosuppressive drugs that carry significant toxicities. This project will build the translational bridge for application of a “one shot” DNase I therapy in humans with autoimmune kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020587"^"http://purl.org/au-research/grants/nhmrc/2020587"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel proinflammatory mechanism reveals an innovative therapeutic strategy to treat hepatic inflammation in chronic liver disease.,Ideas Grants"^"We have generated considerable evidence for a role for tissue ferritin as a mediator of inflammation associated with liver fibrosis (scarring). These highly novel and innovative studies will identify the mechanisms associated with H-Ferritin-regulated liver inflammation in hepatic stellate cells (scar-forming cells in the liver) in chronic liver disease, which we will use to develop novel anti-inflammatory therapeutics to inhibit inflammation and fibrosis associated with chronic liver disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020590"^"http://purl.org/au-research/grants/nhmrc/2020590"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Incubation of craving for alcohol: Is exercise a viable intervention?,Ideas Grants"^"Environmental cues elicit strong craving in people with alcohol use disorder. These cravings increase over longer periods of abstinence, in many cases prompting relapse. In a preclinical model, we have found that increased compulsion to seek alcohol across abstinence can be prevented with voluntary exercise. In this project we will identify the neural changes responsible for both the increase in craving and the restorative effect of exercise, and test the longevity of exercise benefits."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020606"^"http://purl.org/au-research/grants/nhmrc/2020606"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Monoclonal antibodies to placental malaria antigen VAR2CSA,Ideas Grants"^"Placental malaria parasites express VAR2CSA protein on the red blood cell surface. From the blood of pregnant women with strong antibody to VAR2CSA, we will isolate antibody-producing B cells. We will test the antibodies produced by the B cells to find antibodies which can block placental infection, can clear or kill infected cells, and react with many strains. The best ones will be tweaked to further improve activity. Optimised monoclonal antibody to VAR2CSA may prevent placental malaria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020613"^"http://purl.org/au-research/grants/nhmrc/2020613"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the regulatory mechanisms controlling antigen processing and presentation in dendritic cells,Ideas Grants"^"Dendritic cells of the immune system utilise specific receptors to sense danger signals from their environment. We identified a DC danger receptor, Clec9A, which recognizes and induces immunity to “dangerous” dead cells eg. infected cells. We will investigate how dendritic cells regulate their responses to “dangerous” dead cells, and the checkpoints that control immune responses. We will use this knowledge to develop novel approaches for vaccines and immunotherapies for improved health outcomes"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020624"^"http://purl.org/au-research/grants/nhmrc/2020624"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Inhibition failure in Alzheimer’s disease,Ideas Grants"^"Dementia is a leading cause of death in Australia with a huge socioeconomic burden. Network of the brains executive cells, the neurons, are critical for the normal function of the brain. We hypothesize that distinct populations of neurons are compromised or lost in dementia brains, resulting initially in mild cognitive impairment and progressing to severe dementia. This project aims at understanding how these network fail and will test novel way to prevent or treat the resulting deficits."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020626"^"http://purl.org/au-research/grants/nhmrc/2020626"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Co-designing a consumer-focused digital health system to improve adverse drug event (ADE) detection, management and reporting,Ideas Grants"^"Medicines have many benefits, but can also cause harm. Currently the effects of medicines and any potential harms are not monitored for the majority of people taking medicines. This project will develop a new digital health system that enables consumers and health professionals to actively detect medicine harms, and to report the harms to the medicine regulatory authority in Australia. We will also develop new tools to better communicate medicine safety issues to the public."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020633"^"http://purl.org/au-research/grants/nhmrc/2020633"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The use of Pro-apoptotic Drugs to Eliminate HIV in the Brain,Ideas Grants"^"HIV affects &gt;37 M people worldwide and no scalable cure exists. Current approaches to cure HIV utilises drugs that are designed to target and kill HIV-infected cells in the blood. However, the efficacy and possible toxicity of these compounds in the brain is unclear. Our study will use novel animal cohorts and human brain cells to determine the ability of these drugs to target and kill HIV-infected cells in the brain, thus, informing on the suitability of these drugs in people with HIV."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020636"^"http://purl.org/au-research/grants/nhmrc/2020636"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"What Matters to First Nations Kids: Co-designing a wellbeing measure for First Nations children aged 5-11 years (WM2K Project),Ideas Grants"^"This project gives First Nations Australian children the chance to have a say about what is important to their wellbeing. The project team will engage First Nations children and their primary carers from across the country to co-design a new wellbeing measure that asks questions about what makes a good life for them. The measure will be widely available for use by decision makers to better understand the real impacts of policies and programs to improve the lives of all First Nations children."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020646"^"http://purl.org/au-research/grants/nhmrc/2020646"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Molecular mechanisms underlying NF1 dysfunction in tumour growth and disease,Ideas Grants"^"Mutations of the neurofibromin tumour suppressor gene cause the common genetic disease neurofibromatosis type 1 and drive numerous cancers including melanoma, breast and brain cancer. We will apply new breakthrough technologies to uncover how the neurofibromin protein is dysregulated at the atomic level and inside the cell. This project will discover new pathways for therapeutic intervention for Australians living with NF1-linked disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020732"^"http://purl.org/au-research/grants/nhmrc/2020732"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Next generation technology for paediatric blood pressure monitoring,Ideas Grants"^"Blood pressure (BP) monitoring is critically important in hospitalised children and in those with hypertension, but is impeded by low tolerance to repeated cuff inflation. In this project, a novel cuffless BP device suitable for children will be developed and tested in real clinical settings. The device will overcome the distress and sleep disturbance caused by current devices, enabling more reliable and timely identification of high or low BP levels that can cause permanent brain/kidney damage."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020737"^"http://purl.org/au-research/grants/nhmrc/2020737"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting Bromodomain and Extra-Terminal (BET) Proteins for Preventing Preterm Birth,Ideas Grants"^"Preterm birth is the biggest contributing factor to death and disease among newborns. This application explores the physiological mechanism that controls pregnancy length and is disrupted in preterm birth. We focus on the involvement of key regulatory proteins that can be targeted by drugs and will determine the potential of these drugs to block preterm parturition."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020743"^"http://purl.org/au-research/grants/nhmrc/2020743"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"How is immunogenic double-stranded RNA regulated in cells?,Ideas Grants"^"Fundamental to a functional immune system is the ability to correctly distinguish between material from our own cells and from a virus. Failure to do so results in auto-inflammation. We have identified three new genes that are important for regulating virus-like RNA in our own cells, to prevent inflammation. Understanding these genes provides crucial insights and potential new therapeutic targets for diverse settings from auto-inflammatory disease to cancer, viral immunity and RNA therapeutics"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020750"^"http://purl.org/au-research/grants/nhmrc/2020750"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Translating and field-validating an epigenetic blood test to predict TB infection and disease risk,Ideas Grants"^"We will deliver a validated DNA blood test which can be used to identify asymptomatic individuals in at-risk communities who are infected with the tuberculosis bacteria and at risk of developing symptomatic disease over 3 years. Community screening asymptomatic individuals with this test has the potential to have the greatest impact on reducing TB cases, by allowing us to better target preventative therapy to those most in need, before they develop disease and transmit the bacteria to others."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020757"^"http://purl.org/au-research/grants/nhmrc/2020757"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting hepatic amino acid transport to combat cardiometabolic disease,Ideas Grants"^"The overarching idea of this proposal is to find a way to mimic the health benefits of dietary protein restriction while avoiding negative health consequences. To this end, we have invented a way to internally mimic a protein restricted state, and preliminary data have shown that such a strategy can reduce cardiometabolic disease biomarkers. This proposal seeks to thoroughly understand and to provide key evidence of the effectiveness of this novel drug target against cardiometabolic disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020758"^"http://purl.org/au-research/grants/nhmrc/2020758"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A novel dual therapy approach to treatment of multidrug-resistant Gram-negative infections,Ideas Grants"^"This project will use multiple advanced approaches to pinpoint how new derivatives of the anticoccidial drug robenidine kill and exert their specific activities against different superbugs. This study is of utmost significance in the current era of inexorable rise in multidrug resistance. The project will generate critical data that will promote targeted and responsible use of new antimicrobials, in alignment with similar global approaches towards eliminating multidrug resistance development."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020762"^"http://purl.org/au-research/grants/nhmrc/2020762"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Striatal population involvement in OCD symptom domains,Ideas Grants"^"Obsessive compulsive disorder (OCD) is associated with disturbances in different areas of flexible behaviour, including flexible actions (compulsions), threat responses (obsessions) and decision making. The striatum is a brain region that is critical for flexible behaviour, and that is also over active in OCD. The current proposal will determine how the two distinct functional neural populations in the striatum contribute to different disturbances in flexible behaviour relevant to OCD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020768"^"http://purl.org/au-research/grants/nhmrc/2020768"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A new mechanism for targeting stress-related mental health disorders,Ideas Grants"^"Australians have faced significant emotional trauma over the past two years. Unfortunately, treatments for stress-induced psychiatric illness remain poor. By establishing a causal role of hypothalamic PVN-CRH cells in stress-induced psychopathology independent of the stress hormones, these studies will significantly shift the current dogma in psychiatry, leading to new studies and therapeutic opportunities for the treatment of stress-related disorders including depression and PTSD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020780"^"http://purl.org/au-research/grants/nhmrc/2020780"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Does finite slowing of feeding cause artemisinin resistance in malaria?,Ideas Grants"^"Drug resistance to the frontline antimalarial artemisinin is a major challenge to addressing the global burden of malaria. Deteriorating artemisinin resistance could lead to this drug becoming unusable, or could be manageable if drug resistance doesn't worsen and spread. We have determined the mechanism that underlies resistance and will test whether this is a finite and manageable process or instead is an escalating system that likely presages worsening prospects for global artemisinin use"^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020782"^"http://purl.org/au-research/grants/nhmrc/2020782"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising sleep quality inside insecticide treated mosquito nets in hot overnight environments,Ideas Grants"^"Nine-five percent of all Malaria transmission occurs within the African region, causing approximately 600 000 deaths per year. Insecticide-treated bed nets are one of the primary interventions used to stop the spread of malaria. However, sensations of feeling too hot to sleep comfortably is the primary reason for not using bed nets. By simulating real-world conditions, this project will determine how fans can be used to improve thermal comfort and sleep quality within the bed net enclosure."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020814"^"http://purl.org/au-research/grants/nhmrc/2020814"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identification and functional characterisation of genomic enhancers in the human brain: a steppingstone to clinical translation of genetic data for brain disorders.,Ideas Grants"^"The genetic basis of brain disorders is incompletely understood. An important discovery over the last decade was that genetic variants associated with brain disorders are likely to impact gene expression regulation. The proposed project studies enhancers, the key regulatory elements of the genome that turn genes on and off. The project aims to identify enhancers that play functional roles in brain cells, thereby uncovering how genetic changes lead to brain disorders."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020822"^"http://purl.org/au-research/grants/nhmrc/2020822"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"4D molecular characterisation of C-RIP proteins required for malaria host-cell entry,Ideas Grants"^"We have identified proteins that control the dynamic release of essential antigens required for malaria parasite infection of host red blood cells and will identify druggable interactions between these proteins that can be targeted to kill malaria."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020851"^"http://purl.org/au-research/grants/nhmrc/2020851"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting sympathetic nerves to treat metastatic triple negative breast cancer,Ideas Grants"^"Survival from metastatic triple negative breast cancer is terrible. Our new findings suggest that nerves within cancers undermine the beneficial effects of current treatments. This project investigates how blocking nerves improves response to treatment, and will determine how to optimally apply these findings so cancer patients benefit."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020861"^"http://purl.org/au-research/grants/nhmrc/2020861"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"New approaches to treating hemoglobinopathies,Ideas Grants"^"The genetic disorders ß-thalassemia and sickle cell disease are caused by mutations in the adult globin gene. Fortunately, humans have a second globin gene, the fetal globin gene, which is expressed in utero but turned off after birth. Re-activating expression of this fetal globin gene can alleviate the symptoms of ß-thalassemia and sickle cell disease. We are using new strategies, including sophisticated gene editing, to boost fetal globin output to treat this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020900"^"http://purl.org/au-research/grants/nhmrc/2020900"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"RNA-mediated regulation of chromatin compaction in development and disease,Ideas Grants"^"Polycomb repressive complexes are enzymatic complexes that safeguard the genome by preventing repressed genes from becoming active. The proposed study aimed at identifying how RNA regulate certain types of polycomb repressive complexes to maintain genes in a compacted state that prevent their expression. The project aims to determine how RNA regulates the formation of compact chromatin structure and to visualize this process in high resolution."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020902"^"http://purl.org/au-research/grants/nhmrc/2020902"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Designing novel blood and MRI-based predictive tools to understand disease mechanisms, improve recovery and guide targeted interventions following neonatal arterial ischaemic stroke,Ideas Grants"^"Around 120 Australian babies suffer a stroke every year but causes are unknown. Almost half experience long-term problems such as cerebral palsy, speech, learning or behavioural difficulties. The study aims to answer the two most important questions that parents ask their doctors: why did my baby have a stroke and how will the stroke affect my baby’s future development? We will do this by looking at blood signatures and use advanced MRI imaging to study brain networks in 50 babies with stroke."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020911"^"http://purl.org/au-research/grants/nhmrc/2020911"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting the 4Ms in cancer treatment – matrix, mechanics, microenvironment, metabolism,Ideas Grants"^"This project addresses a clinical problem with an innovative approach. Pancreatic cancer is one of the deadliest cancers and only 10% of patients survive 5 years after diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between different cell types. We will develop a controllable platform for modelling the human disease in the laboratory. We will use our new platform to discover better ways of treating the disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020950"^"http://purl.org/au-research/grants/nhmrc/2020950"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"High-throughput ex vivo screening of human retinal cell specific delivery nanoparticles for gene therapy,Ideas Grants"^"Using nanoparticles as carriers of therapeutic payloads is one promising way to treat retinal diseases. They can carry significantly larger payloads than viruses. The project combine single-cell RNA sequencing with a barcoded library to perform high-throughput screening for the nanoparticles that will cell-specifically deliver genes. These identified carriers will be used as vectors to introduce the gene constructs or drugs specifically into the target retinal cells to treat retinal diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020961"^"http://purl.org/au-research/grants/nhmrc/2020961"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting IL-6 trans-signalling in brain injury,Ideas Grants"^"Acquired brain injury is a leading cause of ongoing disability worldwide. Although the damage caused by the primary insult is irreversible, a series of secondary events cause further nerve cell death and exacerbate brain dysfunction. My laboratory has recently uncovered a way to prevent these secondary events by targeting the brain’s immune cells - microglia. Here we will dissect as to how microglia can be manipulated to promote repair following brain injury."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020984"^"http://purl.org/au-research/grants/nhmrc/2020984"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Identifying endometriosis risk and disease variability by mapping endometrial stem cell maturation,Ideas Grants"^"Endometriosis is a poorly categorised disease. Diagnosis is via surgery and patient outcomes are varied. Identifying markers for disease risk and sub grouping would greatly improve treatment for individual patients. Endometriosis grows from endometrial stem cells that enter the peritoneal cavity. We identified altered differentiation increases endometriosis risk and propose to identify factors that cause altered differentiation and the biological signatures that result to improve treatment."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020999"^"http://purl.org/au-research/grants/nhmrc/2020999"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Neuroprotective benefit and safety of preterm neonatal sulphate supplementation,Ideas Grants"^"Preterm babies become sulphate deficient after birth, increasing the risk of cerebral palsy. Any intervention that prevents cerebral palsy in preterm infants, particularly a simple, low-risk, low-cost intervention would have considerable personal and economic benefits. In this study, we will investigate the impact of sulphate supplementation on brain development in preterm piglets, which will help develop future sulphate therapies in human preterm infants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021009"^"http://purl.org/au-research/grants/nhmrc/2021009"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting desmoglein-2 to reinvigorate anti-tumour immunity,Ideas Grants"^"Pancreatic cancer and melanoma are amongst the deadliest forms of cancer which continue to rise in prevalence. Despite clinical advances, once metastasised, cancer from any organ is universally fatal. The growth and spread of solid tumours requires access to the blood supply as well as control of the immune response. Our work on tumour vasculature, in these most difficult to treat tumours, has identified an adhesion protein on the cancer cells that may help fight this deadly disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021010"^"http://purl.org/au-research/grants/nhmrc/2021010"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Muscle-directed gene therapy as an adjuvant to neuroprotection: Targeting both ends of the dysfunctional nerve-muscle axis to treat motor neurone disease,Ideas Grants"^"Amyotrophic lateral sclerosis involves nerve cell death and deterioration of the muscles that the nerves control. Effective treatments are lacking. Capitalising on our team’s complementary expertise in neuroscience and muscle physiology, we are developing a multimodal treatment strategy designed to protect nerves and promote muscle re-growth. Targeting both ends of the ‘nerve-muscle axis’ will prevent premature death of people with this disease and stimulate functional recovery."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021029"^"http://purl.org/au-research/grants/nhmrc/2021029"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Enabling remote screening of childhood hearing loss using artificial intelligence,Ideas Grants"^"Children born in Australia are tested to check if they have a hearing loss. This newborn screening doesn't pick up some forms of hearing loss and can't detect a hearing loss that only appears later in life. This project will create a smartphone app parents can use to record their child speaking to check if they may have a hearing loss. The app will provide a simple way for parents, health workers, and teachers to help make sure all children with hearing loss are diagnosed as soon as possible."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021041"^"http://purl.org/au-research/grants/nhmrc/2021041"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploiting sex differences in androgen action to advance a novel treatment for breast cancer.,Ideas Grants"^"We have recently discovered that activation of the androgen receptor (AR) can redirect the cancer-promoting activity of the estrogen receptor (ER) to halt rather than promote breast cancer growth. The current study will establish if AR activating drugs influence the immune system to inhibit growth of ER-driven breast cancers to establish androgen therapy as a more effective treatment strategy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021055"^"http://purl.org/au-research/grants/nhmrc/2021055"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reducing the burden of respiratory distress after caesarean delivery.,Ideas Grants"^"Compared with vaginally born babies, babies born at term by caesarean section have a higher risk of needing intensive care due to breathing problems soon after birth. We have recently made a major break-through in understanding why and this project will provide the additional information required to identify effective treatments for these otherwise healthy newborns. Ultimately this research will identify approaches and treatments that will reduce the risk or severity of this breathing problem."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021057"^"http://purl.org/au-research/grants/nhmrc/2021057"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"SETDB1 Epigenetic checkpoint blockade: A new approach to enhance immune-mediated control,Ideas Grants"^"SETDB1 is a novel drug target that mediates immunotherapy resistance. We have shown that the nuclear form of SETDB1 is enriched in tissue and blood samples from immunotherapy-resistant metastatic cancers. We have designed a new drug targeting nuclear SETDB1 (MSETC) that targets both cancer cells and simultaneously re-invigorates the immune system. In this project, we will undertake critical molecular pre-clinical studies towards advancing our prototypic drug (MSETC) to the clinic."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021063"^"http://purl.org/au-research/grants/nhmrc/2021063"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding and targeting self-renewal in aggressive blood cancers,Ideas Grants"^"The epigenetic protein Menin, is critical for the ability of leukaemia cells to divide indefinitely. Therapies that target this protein are currently in clinical trials, however it is unclear how they work. By studying how resistance to these therapies emerges, we have unexpectedly discovered that they work differently to what was previously thought. This proposal will use new tools to elucidate these findings in order to develop ways to overcome resistance and improve their efficacy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021074"^"http://purl.org/au-research/grants/nhmrc/2021074"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Organ Transplantation as a Model of Reversible Frailty,Ideas Grants"^"People with end-stage kidney failure often have low energy and muscle weakness. Clinically, they are “frail”. Since health status improves significantly post-transplant, organ transplantation is a model of reversible frailty. In this study, we’ll measure frailty and biological data in 3 groups: (1) people before and after a kidney transplant (2) people with kidney failure who don’t receive a transplant (3) older people who are frail. This will provide new insights into the causes of frailty."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021082"^"http://purl.org/au-research/grants/nhmrc/2021082"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the features of atypical T cell responses in Human Immunodeficiency Virus (HIV) controllers,Ideas Grants"^"Human immunodeficiency virus (HIV) directly attacks our immune system, impairing our natural defence against infection and disease. HIV has infected ~76 million individuals worldwide, leading to a long-lasting pandemic with no vaccine or cure currently available. However, there are rare individuals able to control HIV infection. Our work focuses on understanding how these individuals’ immune system can control HIV, thereby aiding the design of novel treatments or potential vaccines against HIV."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021085"^"http://purl.org/au-research/grants/nhmrc/2021085"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modelling of mitochondrial disease in specific cell lineages to understand pathomechanisms and develop effective targeted therapies,Ideas Grants"^"Mitochondrial disorders are a group of inherited diseases that can cause severe, life-limiting disease in at least 60 children born in Australia each year. These disorders impact on the brain, heart and other organ systems and we lack effective treatments, partly because we don’t understand the disease mechanisms. We will use human cell model systems, including stem cells differentiated into heart cells, to study disease mechanisms and trial new treatment approaches."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021126"^"http://purl.org/au-research/grants/nhmrc/2021126"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Reversing Neurofibrosis: A New Way to Treat Type-2 Diabetes,Ideas Grants"^"We aim to discover new treatments for type-2 diabetes (T2D), a national and global health priority. Brain cells that maintain blood glucose levels within a safe range, are encased within a specialised extracellular matrix. We have discovered that this matrix becomes augmented and defective in T2D, a process termed neurofibrosis. Neurofibrosis makes neurons insulin resistant, which results in high blood sugar levels. We will pioneer the very first drugs targeting neurofibrosis to treat T2D."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021130"^"http://purl.org/au-research/grants/nhmrc/2021130"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving HPV vaccine rates for Aboriginal young people through social media,Ideas Grants"^"Human papillomavirus (HPV) is a common sexually transmitted infection that can lead to HPV-related cancers. HPV rarely produces symptoms and cannot be cured or treated; therefore, vaccination is essential to protect against HPV and HPV-related diseases. This project aims to improve HPV vaccination rates amongst young Aboriginal people. Our project will combine health messages co-created by young people and implemented by micro-Influencers to improve HPV vaccination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021155"^"http://purl.org/au-research/grants/nhmrc/2021155"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the morphological and molecular origin of non-compaction cardiomyopathy,Ideas Grants"^"Every year, 1 in 100 Australian babies are born with heart malformations of a genetic origin stressing the need for further research. In this project, we will investigate one of the most recently classified genetic cardiac condition and therefore, one of the least understood. Our expert team will apply innovative approaches to better understand the condition and provide crucial insights to design customized genetic screening panels and treatments for patients suffering from this disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021163"^"http://purl.org/au-research/grants/nhmrc/2021163"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting Endosomal Receptor Signalling for Superior Pain Relief,Ideas Grants"^"G protein-coupled receptors (GPCRs) are important drug targets. A key feature of GPCR function is their ability to internalise when stimulated, and it is now appreciated that this can promote signalling events that are uniquely associated with diseases of global relevance, including chronic pain. This project will define signalling processes mediated from internalised GPCRs, and develop nanomedicines for targeted delivery of drugs to specific sites inside cells for superior pain relief."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021172"^"http://purl.org/au-research/grants/nhmrc/2021172"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Indigenous telomere-2-telomere human reference genomes to enable discovery, translation and innovations,Ideas Grants"^"Our project will use the latest DNA sequencing technologies to generate, for the first time, indigenous telomere-2-telomere reference genomes. These genomes will account for ancestral diversity and underpin the implementation of precision medicine, enable discoveries and drive innovations using genomics. Critically, the project will foster existing and create new partnerships with Indigenous communities through mutually agreed benefits of the genomics revolution."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021176"^"http://purl.org/au-research/grants/nhmrc/2021176"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The neuroprotective potential of exercise in individuals with motor neuron disease - a paradigm-changing idea,Ideas Grants"^"Every day two Australians die from motor neuron disease (MND) - an incurable neurodegenerative disease. This project aims to discover if exercise can slow neurodegeneration in MND. Thanks to the interdisciplinary expertise of our international consortium, we will investigate the neuroprotective potential of exercise on the brain, spinal cord, and muscle of patients with MND. This research has the potential to change the role of exercise in the treatment of MND."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021181"^"http://purl.org/au-research/grants/nhmrc/2021181"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unravelling tumour plasticity via parallels with tissue regeneration,Ideas Grants"^"Development of resistance to chemotherapy is a major challenge in the treatment of bowel cancer. We are exploring whether a new cell type that is produced when the lining of the gut is injured, is also produced as bowel cancers acquire drug resistance. We will characterise these cells and examine if approaches directed at targeting these cells are capable of eliminating bowel cancers. This work could provide a rational basis for the design of new combination treatments for bowel cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021182"^"http://purl.org/au-research/grants/nhmrc/2021182"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unravelling the brain-lung communication pathway as a novel way of improving stroke outcome,Ideas Grants"^"Lung infection is highly prevalent and often deadly in patients with stroke, raising the possibility of weakened antibacterial responses in the lung after stroke. The focus of this project is to investigate the mechanisms underlying impaired lung immunity following stroke onset. We will also assess the potential of exosome content as biomarkers to identify high-risk stroke patients who will require antibacterial therapy to limit infection development and improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021183"^"http://purl.org/au-research/grants/nhmrc/2021183"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Fluent Mobility for the Blind Individual Using Multimodal Auditory Sensory Augmentation,Ideas Grants"^"Fluency in blind users' mobility arises from access to an appropriate flow of sensory information, subtle control over the sensory information flow, and natural interaction. Any unimodal sensory augmentation system will fail to provide sufficient fluency, therefore we propose a multimodal sensory augmentation system using smart glasses and gesture control to improve fluency in mobility and orientation for blind individuals."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021186"^"http://purl.org/au-research/grants/nhmrc/2021186"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing and applying a world-first alcohol market monitoring system,Ideas Grants"^"The alcohol market is evolving rapidly, with new products being brought to market and creative marketing strategies being implemented, often targeting younger drinkers. This project will deliver a world-first system of monitoring marketplace changes and providing timely data to policy makers to enable them to implement effective policy responses. A sustainable system of product monitoring and data reporting will be delivered to assist with alcohol harm-reduction strategies long term."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021208"^"http://purl.org/au-research/grants/nhmrc/2021208"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"UNIVERSAL NEUROPHOTONIC INTERFACE: A REVOLUTION IN MEDICAL BIONICS,Ideas Grants"^"This project aims to deliver the proof-of-concept of a universal nerve interface, which eventually will bidirectionally connect any bionic device to the peripheral nervous system. This would allow the brain to directly control any bionic device and also to receive sensory feedback, i.e. to “feel”. We will achieve this by combining permanently photoactive neurons, located on pre-determined areas on a photonic chip and addressed by light. Their axon will form a nerve-like structure."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021218"^"http://purl.org/au-research/grants/nhmrc/2021218"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A Faster Cure for Tuberculosis: Revealing Adjunctive Antimicrobial Solutions,Ideas Grants"^"The world urgently needs effective solutions for TB, a bacterial infection that claims more lives than any other. We have identified a "weak link" in the defences of the bacteria responsible and aim to find ALL such vulnerabilities, enabling the development of the next generation of therapy for TB. We will identify ways to weaken these bacterial defences, enhancing potency of existing antibiotics, and rescuing antimicrobial resistance, delaying the need for development of new TB antibiotics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021228"^"http://purl.org/au-research/grants/nhmrc/2021228"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Making next-generation dendritic cell vaccines a reality,Ideas Grants"^"Dendritic cells (DCs) kickstart the immune response to fight infections and cancer. Considering their power, they are also being harnessed for immunotherapy for use as ‘DC vaccines’ for the treatment of solid cancers and other immune disorders. We have found a novel way to make DCs in a petri dish in the large amounts required for such an approach. If we can demonstrate this approach is feasible in mice, it will provide the impetus to seek translational studies for use in humans."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021247"^"http://purl.org/au-research/grants/nhmrc/2021247"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding non-genetic inheritance in health and disease,Ideas Grants"^"Eggs provide genetic and non-genetic (epigenetic) information that is critical for offspring development. While we understand how genes transmit instructions that regulate offspring development, epigenetic inheritance is poorly understood. This project will determine how an essential epigenetic mechanism acting in eggs controls formation of tissues in offspring and grand-offspring and how dysregulation of this mechanism results in disease. Outcomes will help understand disease inheritance."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021260"^"http://purl.org/au-research/grants/nhmrc/2021260"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Investigating the application of targeted therapeutics for the treatment of complex lymphatic vascular anomalies,Ideas Grants"^"Complex lymphatic anomalies arise due to defects in the development of lymphatic vessels during embryogenesis and result in stillbirth or chronic disease. We have identified pathogenic variants in the MDFIC gene underlying a complex lymphatic anomaly termed CCLA. Here, we will investigate the signalling pathways affected by pathogenic MDFIC variants and determine whether small molecule inhibitors of these signalling pathways might provide novel therapeutics able to effectively treat CCLA."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021267"^"http://purl.org/au-research/grants/nhmrc/2021267"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Antibody based therapeutic development for coronaviruses,Ideas Grants"^"The first human coronavirus was isolated from individuals suffering from the common cold in the 1960’s. Since then, three highly pathogenic human coronaviruses have arisen in the last two decades; SARS in 2002, MERS in 2012 and the devastating COVID-19 pandemic. It is critical we understand how current and emerging coronaviruses infect humans and more importantly, develop therapeutic agents to tackle current disease, resist future SARS-CoV-2 variants and new coronavirus-origin pandemics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021271"^"http://purl.org/au-research/grants/nhmrc/2021271"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Structurally informed vaccines and therapies to resist and counter JEV emergence,Ideas Grants"^"Flaviviruses such as JEV are arthropod-borne human pathogens that infect over 200 million annually. The current JEV vaccines are based on &gt;50 year old strains, raising the question of whether these are still optimal against modern emerging strains including the recent Australian outbreak. In this project we will reveal the molecular differences that define JEV strains. This will provide framework for a new generation of JEV vaccines as well as identify new antivirals to treat JEV infection."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021272"^"http://purl.org/au-research/grants/nhmrc/2021272"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Dissecting the mechanisms of flavivirus neuro-pathogenesis using the systems biology approach,Ideas Grants"^"Flaviviruses are important pathogens that Include West Nile, Japanese encephalitis and Zika viruses. They can infect human brain causing severe neurological diseases. This project is aimed to identify the cells in the brain vulnerable to viral infection and elucidate the molecular processes affected by the viruses in the brain. This will explain why flaviviruses cause neurological disease and identify the molecules that can be targeted to prevent or mitigate infection in the brain."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021286"^"http://purl.org/au-research/grants/nhmrc/2021286"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Medulloblastoma plasticity, persistence, relapse and resistance,Ideas Grants"^"Childhood cancer is devastating. For young children with medulloblastoma the outlook is bleak and if the cancer comes back after treatment it is lethal. We will identify cancer cells that survive treatment with a new drug, Palbociclib, and show how they lead to relapse. We will find out if the presence of these cells predicts relapse in patients, and develop a map of how cells develop tolerance to the drug that will help us to identify ways we might target these cells to prevent relapse."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021290"^"http://purl.org/au-research/grants/nhmrc/2021290"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Functional genetic screen of osteoclasts targeted to risk loci for osteoporosis,Ideas Grants"^"Numerous genetic risk variants for osteoporosis, which have been identified through genome-wide association studies and are specifically relevant to osteoclast function, have been partially characterised by our group. We will now use targeted Perturb-seq, which involves pooled CRISPR screens that couple targeted genetic perturbations relevant to the risk loci, with single-cell transcriptomics of the osteoclasts to definitively delineate the mechanism of effect of the variants."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021292"^"http://purl.org/au-research/grants/nhmrc/2021292"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Selective Modulation Of Brain Circuits In Obsessive-Compulsive Disorder,Ideas Grants"^"Obsessive-compulsive disorder (OCD) is a mental illness that can be very difficult to treat and causes significant disability and suffering. In this research, we plan to understand how focussed electricity delivered through permanent stimulating electrodes (deep brain stimulation) works in the brain to treat OCD and how we can translate this knowledge into new therapies that can be used without the requirement for surgery - thereby increasing acceptability and accessibility for more people."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021305"^"http://purl.org/au-research/grants/nhmrc/2021305"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Bioengineering of next-generation adeno-associated viral vectors for gene therapy clinical applications using whole human liver explant preclinical model,Ideas Grants"^"The recent exciting advancements in gene therapies targeting genetic conditions of the liver, eye and brain rely on viral vectors that enable delivery of the therapeutic cargo to the targeted cells. Unfortunately, vector utilised for therapeutic delivery to human liver lack in efficacy, which increases therapeutic cost and lowers safety. Most advanced preclinical model of human liver, the human liver itself, will be used to develop the next generation of vectors for clinical implementation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021307"^"http://purl.org/au-research/grants/nhmrc/2021307"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Modulators of T cell signaling: mechanism of pathogen virulence factors and design of synthetic immunomodulatory constructs,Ideas Grants"^"T cells are immune cells critical for clearing infections and fighting cancer. They can distinguish healthy from infected or cancerous cells by sensing cues in their environment and encoding this information into networks of biochemical reactions, which are integrated into a functional decision. We will use cutting edge microscopy techniques to decode this information processing mechanism so that we may better intervene when T cells make incorrect decisions and fail to perform their function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021322"^"http://purl.org/au-research/grants/nhmrc/2021322"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Improving CNS copper availability to mitigate permanent neurological disability in progressive cases of multiple sclerosis,Ideas Grants"^"The accumulation of permanent neurological disability in progressive cases of multiple sclerosis represents a major, unmet medical need. New treatment options are required, but their production to date has been limited by incomplete knowledge of the underpinning biological factors and events. This application presents our discovery of a treatable feature of progressive multiple sclerosis and outlines our plan to develop novel compounds that can produce life-changing outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021360"^"http://purl.org/au-research/grants/nhmrc/2021360"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A gut feeling about new therapies for glioma treatment: lessons from the enteric nervous system,Ideas Grants"^"Gliomas are the most aggressive form of brain cancer. Gliomas come from glial cells, a type of support cell in the nervous system. Glial cells are found in the brain and also in the enteric nervous system, which is located in the gut. However, gliomas are rarely found in the gut and are generally benign. In this study, we aim to identify factors that protect enteric glial cells from forming aggressive cancers in order to develop new treatments for brain cancer."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021380"^"http://purl.org/au-research/grants/nhmrc/2021380"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Protecting hearts from trastuzumab-induced cardiomyopathy,Ideas Grants"^"Heart failure is a serious side-effect of an antibody-based therapy for breast cancer. The antibody targets a growth receptor called HER2, which is also present in hearts cells where it is critical for normal cardiac structure/function. We propose to mutate the HER2 receptor so it is no longer recognised by antibody, but where it retains functionality. In a mouse model of Herceptin-based cardiac toxicity, we will use viruses to deliver the resistant HER2 receptor to heart and rescue function."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021396"^"http://purl.org/au-research/grants/nhmrc/2021396"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genomic Autopsy of Pregnancy loss Study (GAPS): genomic investigations to help solve unexplained pregnancy loss at all gestations.,Ideas Grants"^"Despite scientific and medical advances, the rate of miscarriage and stillbirth has not declined in Australia over the past 20 years. Our project aims to better understand the underlying causes of pregnancy loss across all gestations. We will use novel genomic techniques and for the first time study variation in the placenta that may contribute to pregnancy loss. Accurate diagnosis is essential for counselling, and offers families reproductive choices to avoid future recurrence."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021404"^"http://purl.org/au-research/grants/nhmrc/2021404"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pregnancy and early life virome dynamics: contribution to chronic diseases,Ideas Grants"^"Viral infections during pregnancy and early life can majorly impact on maternal and infant health, and cause lifelong health issues, especially among those at risk of chronic disease. However, little is known about the early life virome of Australians, and whether it is a risk factor for pregnancy complications and chronic diseases. We will use the most comprehensive, sensitive and unbiased methods to assess pregnancy/early exposure to all viruses and their association with chronic diseases."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021463"^"http://purl.org/au-research/grants/nhmrc/2021463"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Targeting novel cellular protagonists of cardiac fibrosis,Ideas Grants"^"Heart failure is a leading cause of death. We have recently discovered two new heart cell types that emerge after cardiac stress to drive fibrosis—a key precursor for the development of heart failure. This project aims to determine what genes support the development of these cells and whether targeting these cells prevents the development of fibrosis after cardiac stress. This project may reveal novel approaches to prevent or treat heart failure by targeting these new fibrosis-promoting cells."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021475"^"http://purl.org/au-research/grants/nhmrc/2021475"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Understanding novel ways that bacteria drive virulence by subverting metal ion intoxication,Ideas Grants"^"The pathogen Group B streptococcus (GBS) is a significant risk to human health, an ageing Australian population and is a major cause of severe infections in babies. This project will define fundamental aspects of streptococcal biology, revealing how bacteria survive in the human body. The outcomes will highlight novel strategies for disease prevention and treatment. Ultimately, this work could reduce the economic and social burdens imposed by GBS infections on our healthcare."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021495"^"http://purl.org/au-research/grants/nhmrc/2021495"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A neural metabolic memory of diet restriction influences rebound weight gain,Ideas Grants"^"The overconsumption of high calorie foods in today’s society is a primary reason for the obesity epidemic. In this proposal we argue that periods of repetitive hunger program a metabolic memory of food shortage, which exacerbates feeding responses, motivation and food reward, especially high energy foods. A strong metabolic memory of food shortage may precipitate compulsive overeating, which is a major cause of obesity in today’s society."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021510"^"http://purl.org/au-research/grants/nhmrc/2021510"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Exploring the anti-apoptotic and apoptosis-unrelated functions of MCL-1 during embryonic and blood cell development to advance MCL-1 inhibitors in clinical trials for cancer,Ideas Grants"^"In a healthy organism damaged or autoreactive cells kill themselves by a controlled cell death program, called apoptosis. Pro-survival proteins (e.g. MCL-1) block apoptosis, and their enhanced expression causes cancer. Some pro-survival inhibitory drugs (e.g. Venetoclax) are effective and well tolerated, whereas the highly effective MCL-1 inhibitors cause intolerable side effects in clinical trials. This project aims to determine the differences of these proteins to improve cancer therapy."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021525"^"http://purl.org/au-research/grants/nhmrc/2021525"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Defining the mechanisms that underpin the environmental contribution to Parkinson’s disease,Ideas Grants"^"The number of people with Parkinson’s disease (PD) is doubling every 20 years as a consequence of exposure to environmental stressors from an industrialised world. These stressors increase the risk of developing PD, however, the underlying biology is poorly understood limiting our ability to intervene. We will characterise the link in this pathway and its association with PD. This knowledge will enable us to develop new intervention strategies that can attenuate the rising incidence of disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021560"^"http://purl.org/au-research/grants/nhmrc/2021560"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Predicting disease progression in patients with myeloid neoplasms to enable early intervention,Ideas Grants"^"Myelodysplastic and myeloproliferative neoplasms (MDS/MPN) are blood cancers with multiple genetic mistakes that have a risk of progressing to acute myeloid leukaemia (AML), a rapid and fatal disease. There are no reliable approaches to predict who is going to develop AML. Based on the idea that a skewed hormone receptor is the cause of the problem we propose to identify its genetic fingerprint that can predict when MDS and MPN will transform to AML to enable faster and better treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021564"^"http://purl.org/au-research/grants/nhmrc/2021564"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Unveiling the modulators of scarless wound healing,Ideas Grants"^"Aberrant wound healing, scarring and fibrosis results in a tremendous burden on public health to treat or have them surgically removed. After injury a fibrin clot forms, this project aims to understand the properties of fibrin clots, that drive scarless, as observed in foetuses, or positive wound healing outcomes. Then engineer these key properties into smart fibrin biomaterials to improve the management of injuries to promote scarless wound healing to improve patient outcomes."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021586"^"http://purl.org/au-research/grants/nhmrc/2021586"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Optimising treatment of Hepatitis B with novel predictive biomarkers,Ideas Grants"^"Hepatitis B is treatable but most people have to take medicine for life. Some people can safely stop treatment after a few years but it is difficult to predict for each person whether or not the virus will come back. We have developed a new test to measure different forms of virus in the liver. This test should identify people who can safely stop treatment and those who need to continue. In this grant we will study how to use our test to improve quality of life for people living with hepatitis B."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021587"^"http://purl.org/au-research/grants/nhmrc/2021587"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Combining multi-omic causal-prediction networks from large patient datasets with a human intestinal organoid pipeline to identify new therapies for IBD,Ideas Grants"^"Inflammatory Bowel Diseases are an increasingly prevalent cause of morbidity worldwide. Therapies that induce mucosal healing are a key unmet clinical need required to improve disease remission. Using a form of artificial intelligence on genomic networks from large patient datasets we have identified novel drug targets in the intestinal epithelium. In this project we will use human 'mini-guts' to investigate the potential of these drug targets to improve healing and reduce disease severity."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021595"^"http://purl.org/au-research/grants/nhmrc/2021595"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sleep Disruption and Alzheimer’s Disease Pathology – Investigating Mechanisms via Acoustic Stimulation of Slow Wave Sleep,Ideas Grants"^"A change in the sleep-wake system, particularly reduced deep sleep, is associated with impaired memory and cognition, and other aspects of brain health in later life. We will use exciting new technology and never-before-used ways of understanding the brain to reveal the causal role of deep sleep in brain and cognitive health. This will provide critical evidence for the use of sleep therapeutics which increase deep sleep to enhance brain health and promote cognition in older adults."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021623"^"http://purl.org/au-research/grants/nhmrc/2021623"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Sensitivity to BH3 mimetics identified by BCL2 family interactions,Ideas Grants"^"BH3 mimetics are small molecule therapeutics which have resulted in paradigm shifts in the management of several cancers, although they are not curative and patients inevitably develop resistance. The mimetics bind to prosurvival BCL2 family members and displace proapoptotic members, indicating that sensitivity can be predicted by measuring complexes formed by BCL2 members. This project will develop the first antibodies to those complexes to measure responses of cancer cells to BH3 mimetics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021638"^"http://purl.org/au-research/grants/nhmrc/2021638"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"A genomics-powered ultrahigh-throughput pipeline for rapid antibiotic discovery,Ideas Grants"^"Antibiotic resistant bacterial infections are becoming increasingly common in both hospitals and the community. A key strategy to overcome resistant bacteria is to identify new antibiotics. However, we must do this faster and more creatively or we risk rediscovering already known antibiotics. This project will miniaturise and accelerate the antibiotic discovery process, allowing us to investigate previously unseen bacteria and find antibiotics to combat multi-drug resistant infections."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021644"^"http://purl.org/au-research/grants/nhmrc/2021644"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Genomic medicine for Indigenous Australians,Ideas Grants"^"Whole genome sequencing of individuals from four remote Indigenous communities uncovered genomic patterns that suggest why previous studies failed to identify the genetic basis of two important diseases. We will use this information to develop a novel approach to find the causes of chronic kidney disease in people from the Tiwi Islands. These genetic patterns also allow us to recommend guidelines that increase the chance of success for future mapping projects in other Indigenous communities."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021675"^"http://purl.org/au-research/grants/nhmrc/2021675"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Harnessing Endogenous Opioids to Treat Gut Motility Disorders and Pain,Ideas Grants"^"Opioids are highly effective pain killers and anti-diarrheal drugs, but their use can be severely limited by serious side-effects. An alternative therapeutic strategy that largely avoids these side-effects is to harness the actions of opioids produced by the body. This project explores a new approach to enhance the effects of these opioids to provide natural pain relief and a new approach to regulate the movement of contents through the intestine."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021687"^"http://purl.org/au-research/grants/nhmrc/2021687"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Blocking harmful lung damage during acute exacerbations of chronic obstructive pulmonary disease (COPD) caused by infections,Ideas Grants"^"Chronic obstructive pulmonary disease (COPD) affects over 2 million Australians and acute attacks, triggered by viruses or bacteria, can be fatal. Standard treatment with steroids is highly damaging to the lungs and safer treatments are urgently needed. Our team of leading clinical and basic science COPD researchers has identified a new drug with the potential to improve patient outcomes. Our pioneering studies will break the connection between COPD attacks, infections, lung damage and death."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021704"^"http://purl.org/au-research/grants/nhmrc/2021704"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mechanisms of regulatory T cell function,Ideas Grants"^"Normal regulation of the immune system is vital to human health, especially after bone marrow transplantation, but we still do yet not know exactly how it is achieved. In this project we will study one of the most important molecules used to regulate immune responses, CTLA-4. We aim to show that secreted CTLA-4, rather than CTLA-4 on the surface of immune cells, is responsible for immune regulation. Secreted CTLA-4 may hold promise as a new therapy for graft-versus host disease after transplant."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021732"^"http://purl.org/au-research/grants/nhmrc/2021732"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The Development of splice-switching oligonucleotides for the management of kidney disease,Ideas Grants"^"RNA can now be used to treat human diseases. It can be used as a template to make a new protein, such as in mRNA vaccines. But RNA can also be used change how coding elements are spliced together and the protein that results from them. This strategy has been used to great effect in difficult-to-treat diseases like muscular dystrophy and spinomuscular atrophy. We will apply this same technology to target pathways critically involved in the development and progression of chronic kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021749"^"http://purl.org/au-research/grants/nhmrc/2021749"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Pre-emptive targeted therapy to optimise high-risk neuroblastoma treatment,Ideas Grants"^"Despite intensive and prolonged treatment, half of all children diagnosed with high-risk neuroblastoma either do not respond, or subsequently relapse. There are no curative therapies for these patients. Current approaches are clearly inadequate for these children, and experimental therapies are being introduced too late. This study aims to change this paradigm through comprehensive pre-clinical evidence supporting earlier intervention with targeted agents."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021763"^"http://purl.org/au-research/grants/nhmrc/2021763"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"What codes the development of asthma in children?,Ideas Grants"^"Wheezing in children is very common. At present, we cannot predict which young children who wheeze will progress to develop the lung disease asthma. Thus, we cannot prevent asthma and treatment for asthma is broadly the same for everyone. We will analyse skin cells from inside the nose and blood cells from children who wheeze. Changes in these cells will help predict who will go on to develop asthma. Better, more specific treatments can also be developed."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021811"^"http://purl.org/au-research/grants/nhmrc/2021811"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Wnt Signalling in Oligodendroglia: A missing link in MS neuroinflammation,Ideas Grants"^"Multiple Sclerosis (MS) is a disease in which a person’s immune system incorrectly attacks a specific group of cells within the central nervous system (CNS) called oligodendroglia. Destruction of these cells causes neurodegeneration that leads to devastating functional deficits. Oligodendrogila have the capacity for regeneration, but it is insufficient. We aim identify new therapeutic targets that boost the ability of oligodendroglia to regenerate and thus limit the neurodegneration in MS."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2021864"^"http://purl.org/au-research/grants/nhmrc/2021864"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Establishing caffeine as a potential new treatment option for circadian misalignment,Ideas Grants"^"The aim of this project is to examine the effects of caffeine on the human internal body clock. In particular, we will assess the extent to which a moderate amount of caffeine, equivalent to a double-shot espresso, can shift the timing of the body clock. The results of this project will enable practitioners to use caffeine to treat disorders and behaviours that seriously disrupt the body clocks of 20% of Australian adults (e.g., delayed sleep onset, night work, international flight)."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022034"^"http://purl.org/au-research/grants/nhmrc/2022034"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of bivalent degraders targeting Aurora kinase A for the treatment of polycystic kidney disease,Development Grants"^"Autosomal dominant polycystic kidney disease (ADPKD) affects &gt;1:1000 people and is a leading cause of kidney failure. There are no useful treatments. We have shown this disease is driven by a protein called AURKA. We have discovered a drug candidate that potently degrades this disease-driving protein in cells. This grant will support development of potency and selectivity to give a patented drug candidate for a potential safe and effective treatment for ADPKD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022040"^"http://purl.org/au-research/grants/nhmrc/2022040"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a New Class of Formyl Peptide Receptor 1 (FPR1) Biased Agonists for the Treatment of Myocardial Infarction,Development Grants"^"Cardiovascular disease is the leading cause of death, accounting for 30% of all global deaths. We have discovered a highly potent and novel compound that is unique in boosting a particular signalling pathway in heart tissue that can greatly improve recovery from heart attack, but this compound needs further optimization of properties that will enable it to be taken as a pill. This Development Grant will resource optimization of this novel drug candidate for the treatment of heart attack."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022050"^"http://purl.org/au-research/grants/nhmrc/2022050"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Breaking drug resistance in community-acquired bacterial pneumonia (CABP),Development Grants"^"There is an urgent and critical need to develop new ways to treat infections caused by drug resistant bacterial pathogens (superbugs). Our new therapeutic approach using an antibiotic potentiator is an entirely new strategy to disrupt the antibiotic resistance mechanisms of multidrug-resistant bacteria. Our treatment using the antibiotic potentiator renders drug-resistant superbugs sensitive to existing, frontline antibiotics and will restore the efficiency of existing treatment regimens."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022057"^"http://purl.org/au-research/grants/nhmrc/2022057"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"StandingTall: Digital Fall Prevention Solution,Development Grants"^"Falls in older people worldwide are common, with one in three older people experiencing one or more falls per year. StandingTall is a tailored and progressive digital exercise program designed for older people to do at home by themselves. We will leverage the experience and intellectual resources of leading industry providers and consumers using a co-design partnership approach to ensure the successful commercialisation and implementation of StandingTall into clinical practice."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022075"^"http://purl.org/au-research/grants/nhmrc/2022075"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Mechanistically and chemically novel reaction-hijacking pro-inhibitors for malaria,Development Grants"^"Diseases caused by drug-resistant infectious agents, such as the malaria parasite, represent an enormous global health threat. New drugs are desperately needed to overcome drug resistance. We have discovered a new "Trojan horse" method to induce malaria parasites to make their own toxic molecules – making them the instruments of their own demise. In this project we will work with a major pharmaceutical company toward developing these new therapeutics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022121"^"http://purl.org/au-research/grants/nhmrc/2022121"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Developing a new type of drug for inflammatory lung disease,Development Grants"^"Millions of Australians have breathing difficulties due to viral/bacterial infections or environmental allergens/pollutants (dust mites, pollen, food, smoke) that trigger inflammation leading to lung disease (e.g. asthma, COPD, fibrosis). We have discovered a new type of drug that blocks inflammation in human cells and damage in mouse models of lung disease. This study can improve drug potency, selectivity and effectiveness and provide proof of concept preclinical data to enable clinical trials."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022218"^"http://purl.org/au-research/grants/nhmrc/2022218"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a novel optical stimulation therapy for Obstructive Sleep Apnoea,Development Grants"^"Obstructive sleep apnoea is a common sleep disorder where the upper airway collapses repeatedly during sleep, interrupting breathing. It is associated with accidents and elevated risk of cardiovascular disease. Current treatments are poorly adhered to by patients, and there is a substantial market for new therapies that are patient-friendly. This project aims to bring a new minimally invasive light-stimulation therapy, Optosleep, to the stage where it can be tested in human patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022337"^"http://purl.org/au-research/grants/nhmrc/2022337"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Hybrid 3D-printed imaging catheter for more accurate cardiovascular disease detection,Development Grants"^"Most heart attacks are caused by high-risk plaques. A significant unmet need in cardiology is to reliably detect high-risk plaques before they are life-threatening. This project will deliver the first-in-human study and commercialisation of our novel hybrid 3D-printed imaging catheter. This novel device is likely to enable accurate detection of high-risk plaques and prevent (recurrent) heart attacks. This high-tech device is ideal for manufacturing in Australia and has great export potential."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022449"^"http://purl.org/au-research/grants/nhmrc/2022449"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of nanomedicine for non-alcoholic steatohepatitis,Development Grants"^"Non-alcoholic steatohepatitis (NASH) is a leading cause for liver cancer. The failure of promising drugs is due to their inability to address all aspects of this complex disease. In this proposal, we provide compelling evidence that nanoparticles shed by amniotic epithelial cells (a perinatal stem-like cell) have multivalent properties in the context of NASH. We propose the development of these ‘amniotic exosomes’ as a regenerative medicine for NASH."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022583"^"http://purl.org/au-research/grants/nhmrc/2022583"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"EarGenie: A diagnostic system to transform the management of infants with hearing loss,Development Grants"^"After an infant is diagnosed with a hearing loss via new-born screening, it is critically important that a hearing aid or cochlear implant is provided as soon as possible: otherwise language development is significantly and permanently impacted. In this project we develop a novel hearing assessment system that will reduce the delay between diagnosis and provision of the optimal hearing solution for each infant from 9-24 months down to 2-6 months, thus leading to improved quality of life."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022585"^"http://purl.org/au-research/grants/nhmrc/2022585"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of novel GPR52 agonists for the treatment of schizophrenia,Development Grants"^"We are developing a novel class of drug candidates as better treatments for schizophrenia, a debilitating psychiatric disorder. Current therapeutics address only one component of the disorder and cause significant side-effects, often leading to discontinuation of treatment. There is a well-recognized and significant unmet need for novel, effective treatment options with fewer side effects that also address the negative symptoms and cognitive impairments core to schizophrenia."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022625"^"http://purl.org/au-research/grants/nhmrc/2022625"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a therapeutic monoclonal antibody,Development Grants"^"This project specifically relates to the development of a product - a humanised monoclonal antibody. The project has now reached an early proof-of-principle-stage of product development and represents a highly promising commercial opportunity for Australia, with annual sales of monoclonals exceeding $100 billion in 2021. To be able to progress our basic discoveries into a commercial product a humanised antibody is required."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022635"^"http://purl.org/au-research/grants/nhmrc/2022635"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Splice switching oligonucleotides for the treatment of chronic kidney disease,Development Grants"^"RNA can now be used to safely and selectively treat human diseases. RNA can be used as a template to make a new protein, such as in mRNA vaccines. But RNA can also be used change how coding elements are spliced together and the protein that results from them. This strategy has recently been used to great effect in difficult-to-treat diseases, like muscular dystrophy. We will now apply this same disruptive RNA technology to develop a novel treatment for chronic kidney disease."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022674"^"http://purl.org/au-research/grants/nhmrc/2022674"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of a Plasmodium vivax multi-analyte lateral flow assay to accelerate malaria elimination,Development Grants"^"To efficiently eliminate Plasmodium vivax (Pv), malaria control programs require novel, easy-to-use tools to identify and treat people with hidden dormant Pv liver-stage infections. We have developed the first test to meet this requirement: a novel serological test that recognises specific patterns in a person's immune response to malaria. We are now developing a field-deployable rapid diagnostic test to ensure translation of this public health opportunity to accelerate malaria elimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022693"^"http://purl.org/au-research/grants/nhmrc/2022693"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The development of DMX8.1 as a novel treatment for immunotherapy-refractory cancers,Development Grants"^"Optimal treatment is critical for cancer patient outcome, however, a significant proportion of patients fail to respond and relapse. Using clinically-relevant tumour models, this proposal is aimed at validating the efficacy of a novel drug that can be used either alone or in combination with other therapeutic agents to define the best combination and sequence of treatments to allow immunotherapies to be more effective in more patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022723"^"http://purl.org/au-research/grants/nhmrc/2022723"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Preclinical Validation of a Targeted Theranostic Agent for MRI Guided Radiotherapy and Radiosensitisation of Aggressive Brain Tumours,Development Grants"^"This project aims to validate preclinically FerroTrace-FAPi, a theranostic agent designed to improve and facilitate image guided radiotherapy. Successful outcomes would enable and improve aggressive image-guided treatment of brain tumours with acceptable neurological toxicity, including in the near future with proton beam radiotherapy. It would also pave the way to rapid commercialisation of FerroTrace-FAPi via the FDA orphan-drug designation pathway."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018644"^"http://purl.org/au-research/grants/nhmrc/2018644"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Small Steps for Big Changes: Implementing an Evidence-Based Diabetes Prevention Program into Diverse Urban Communities,International Collaborations"^"Small Steps for Big Changes is an evidence-based type 2 diabetes prevention program. Following initial success, we are now scaling up the program to deliver it in community settings across both Canada and Australia. Our trial will investigate how community-, organisation-, provider-, and patient-level factors contribute to implementation outcomes when organisations deliver the same program in different contexts. We will also examine cost-effectiveness and program impacts on diabetes prevention."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018862"^"http://purl.org/au-research/grants/nhmrc/2018862"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Choose To Move Sydney,International Collaborations"^"Physical activity is crucial for health across the lifespan and is key to healthy ageing. Choose To Move (CTM) was developed by researchers in British Columbia, Canada, in collaboration with older adults and community-based organisations and is effective in supporting older people to increase physical activity. This research will adapt CTM to suit the needs of older Arabic speaking people in Sydney, who are particularly inactive and not well supported by existing physical activity programs."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2020155"^"http://purl.org/au-research/grants/nhmrc/2020155"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Building CapaCITY/É for Sustainable Transportation,International Collaborations"^"Active and sustainable transport (such as walking and bike riding) are critical to supporting health, mobility and equity outcomes. However, cities globally are struggling to implement infrastructure to enable greater uptake of these modes of transport. Through partnerships with Australian government agencies and Canadian collaborators, we will develop a novel framework that will support governments in successfully implementing interventions to enable active and sustainable transportation."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2023127"^"http://purl.org/au-research/grants/nhmrc/2023127"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Supporting Healthy Lifestyle Choices to Promote Mental Health &amp; Wellbeing of Indigenous Youth Aging-Out-of-Care in Urban Settings,International Collaborations"^"First Nations children and young people comprise one third of children living in out-of-home care and for many the time spent in care undermines their connection to culture and community. Young people transitioning from care are vulnerable and often have limited capacity to connect with their culture and community. This project will apply a strengths-based approach to co-design culturally-grounded programs to support and improve the wellbeing of First Nations youth (12-17 years) in care."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018589"^"http://purl.org/au-research/grants/nhmrc/2018589"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Development of Innovative Antimicrobials for Combatting Multidrug-resistant Gram-negative Bacteria: An integrated multi-disciplinary approach,International Collaborations"^"The World Health Organization (WHO) has highlighted antibiotic resistance as a major global health crisis. Gram-negative bacteria top the WHO priority pathogen list due to the lack of therapeutic options, and toxic polymyxins are often the last resort. This project will be the first to integrate cutting-edge computational and experimental approaches to develop novel, safer polymyxins and their inhalation formulations. Our study targets the urgent global medical need for new antibiotics."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018677"^"http://purl.org/au-research/grants/nhmrc/2018677"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Gut leak and microbiome contribution to severe dengue disease,International Collaborations"^"Mosquito-borne dengue virus is a major health threat in tropical areas. When some patients are recovering from fever, their condition suddenly deteriorates with life-threatening bleeding and shock. We propose that severe disease is the result of virus-induced damage to the gut, allowing entry of bacterial products into the body. Together with collaborators in Thailand and Japan, we will investigate the impact of gut bacteria on dengue disease and possible probiotic treatments."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2018695"^"http://purl.org/au-research/grants/nhmrc/2018695"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Applying novel serological exposure markers to quantify residual malaria transmission in the Philippines,International Collaborations"^"Malaria is an infectious disease that still affects millions of people worldwide, including in the East Asian region. In the Philippines, recent outbreaks of malaria caused by Plasmodium vivax have occurred. Plasmodium vivax is difficult to eliminate due to hidden liver-stage parasites, known as hypnozoites. We will apply our novel surveillance tools to understand how these outbreaks are occurring; to identify the hidden hypnozoite reservoir; and to accelerate malaria elimination."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022885"^"http://purl.org/au-research/grants/nhmrc/2022885"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Taking steps against the burden of Parkinson’s disease,International Collaborations"^"Parkinson’s disease (PD) affects over 10 million people worldwide. Unstable gait and falls affect 70% of PD patients. This EU Joint Project investigates the mechanistic changes underpinning successful treadmill intervention that are enhanced by mechanically or virtual-reality triggered gait adaptations. Four clinical centers (Sydney, Tel Aviv, Bolongna and Kiel) will recruit 168 PD patients randomized 1:1 to intervention or control groups. Outcomes will improve fall prevention in people with PD."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022997"^"http://purl.org/au-research/grants/nhmrc/2022997"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"Facilitating focused ultrasound-mediated Tau clearance in Alzheimer's disease and other Tauopathies by understanding the underlying autophagic mechanisms,International Collaborations"^"Ultrasound (US) is routinely used for diagnostic imaging, but applicability of this non-invasive technology extends far beyond bio-imaging. We have shown that US clears toxic Tau typical of Alzheimer’s disease (AD). With a team of experts in AD, US technology and multimodal imaging we aim to understand the underlying Tau clearance mechanisms and monitor the process in relation to blood flow. The proposed work constitutes an important step towards developing an US therapy for AD patients."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2023333"^"http://purl.org/au-research/grants/nhmrc/2023333"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"The role of microglia in the effects of environmental enrichment in neurodegenerative disorders,International Collaborations"^"Environmental enrichment (EE) is a powerful preclinical manipulation with remarkable therapeutic promise for neurodegenerative diseases, however its molecular mechanisms remain elusive. Here, we will study the role of inflammatory brain cells in mediating clinical and pathological benefits of EE in models of Alzheimer’s disease (AD) and motor neuron disease (MND). Gene targets in microglia mediating benefits of EE will be identified which could be therapeutically exploited in neurodegeneration."^""^""^""^
"https://demo.researchdata.ardc.edu.au/view?key=http://purl.org/au-research/grants/nhmrc/2022398"^"http://purl.org/au-research/grants/nhmrc/2022398"^"activity"^"www.nhmrc.gov.au/grants/research-funding-statistics-and-data"^"grant"^""^""^"It’s time to flourish: Co-designed perinatal and early years care, self-determined by Aboriginal and Torres Strait Islander women, Resulting in policy and practice transformation and Exceptional service (ICARE).,Targeted Call for Research"^"Close the Gap targets and the consistent voices of Aboriginal and Torres Strait Islander people want our babies to be strong and healthy with the best start to life. This begins in pregnancy. This multi-faceted research will provide culturally appropriate and strength-based tools and supports during pregnancy and the early years to empower families. The study will generate new knowledge about empowerment, health system responses and improved data to track and understand the parent’s journey."^""^""^""^